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Gapdh   Glyceraldehyde-­‐‑3-­‐‑phosphate  7l  
Gdnf   Glial  derived  neurotrophic  factor  
GFP   Green  fluorescent  protein  
Gl   Lateral  gastrocnemius  
Gm   Medial  gastrocnemius  
Gsk3β   Glycogen  kinase  3β  
h   Hour  
HCM   Hypertrophic  cardiomyopathy  
Hdac   Histone  deacetylase  
Hgf/Sf   Hepatocyte  growth  factor/Scatter  factor  
HH   Hamburger-­‐‑Hamilton  
Hhd   Hedgehog  family  muscle  isoform  
HMC   Hypaxial  motor  column  
IGF1-­‐‑Akt/PKB   Insulin-­‐‑like  growth  factor  1-­‐‑Akt/protein  kinase  B  
IN   Interneuron  
Isl1/2   Islet  1/2  
KEGG   Kyoto  Encyclopedia  of  Genes  and  Genomes  
Kir2.1   Inward  rectifier  potassium  channel  
l   Liter  
LMC   Lateral    motor  column  
loxP   Floxed  
M   Molar  
M   Myotome  
MAFbx   Muscle  Atrophy  F-­‐‑box  
Marp   Muscle  ankyrin  repeat  protein  
MCS   Multiple  cloning  site  
min   Minute  
miRNA  206   microRNA  206  




MLC   Myosin  light  chain  1F/3F    
MLCK   Myosin  light  chain  kinase    
mm   Milli  
MMC   Medial  motor  column  
MN   Motor  neuron  
MRF   Myogenic  regulatory  factor  
mRNA   Messenger  ribonucleic  acid  
mTOR   Mammalian  target  of  rapamycin  
MuRF1   Muscle  RING  Finger  1  
Myfd   Myogenic  regulatory  factor  for  terminal  differentiation  
MyHC   Myosin  
MyHC-­‐‑emb/Myh3   Myosin  heavy  chain,  embryonic  isoform  
MyHC-­‐‑fast   Myosin  heavy  chain,  fast  isoform  
MyHC-­‐‑neo/Myh8   Myosin  heavy  chain,  neonatal  isoform  
MyHC-­‐‑slow/Myh7   Myosin  heavy  chain,  slow  isoform  
Myl2   Myosin  light  chain,  cardiac  slow  isoform  
Myl3   Myosin  light  chain,  skeletal  slow  isoform  
MyoG   Myogenin  
N   Notochord  
Nfat   Nuclear  factor  of  activated  T-­‐‑cells  
Ngf   Nerve  growth  factor  
NMJ   Neuromuscular  junction  
Ntf3   Neurotrophin  3  
Ntf5   Neurotrophin  4/5  
Ntrk2   Neurotrophic  tyrosine  kinase,  receptor,  type  2  
P   Peroneus  muscle  group  
PBS   Phosphate  buffered  saline  
pCAGGS   Chick  beta-­‐‑actin  promoter  
PCD   Programmed  cell  death    




PCR   Polymerase  chain  reaction  
PFA   Paraformaldehyde  
PGC   Preganglionic  chain  
Pkctd   Protein  kinase  C  muscle  isoform  
PL   Pollicis  longus  
PLD   Posterior  lattisimus  dorsi    
PMA   Peroneal  muscular  atrophy  
pMN   Motor  neurons  progenitor  domain  
PT   Pronator  teres  
qPCR   Quantitative  polymerase  chain  reaction  
r   Radial  bone  
RA   Retinoic  acid  
RNA   Ribonuclei  acid  
rpm   Revolutions  per  minute  
S   Sclerotome  
S6K   S6  kinase  
Sapd   Sarcomere  and  calcineurin  associated  protein  
SEM   Standard  error  of  the  mean  
Shh   Sonic  hedgehog  
Six   Sine  oculis  homeobox  
Snaid   Snail  homologue  muscle  isoform  
SNAREs   Soluble  N-­‐‑ethylmaleimide-­‐‑sensitive  factor  attachment    
protein  receptor    
t   Tibial  bone  
TeNT     Tetanus  toxin  light  chain  
TeTx   Tetanus  toxin  
tPA   Stop  sequence  
TTX   Tetrodotoxin  
Tuba1b   Tubulin,  alpha  1b  
TUNEL   Terminal  deoxynucleotidyl  transferase  dUTP  nick  end  labeling  




u   Ulnar  bone  
vAChT   Vesicular  acetylcholine  transporter  
VAMP2   Synaptobrevin  
VH   Ventral  horn  
VLL   Ventrolateral  dermomyotome  
w/v                                                                 Weight  per  volume  
α-­‐‑BTX   Alpha-­‐‑Bungarotoxin  
β-­‐‑BTX   Beta-­‐‑Bungarotoxin  
µμ                                                                       Micro  






"ʺIn   science   it   is   a   service   of   the   highest   merit   to   seek   out   those   fragmentary   truths  
attained  by  the  ancients,  and  to  develop  them  further."ʺ  Johann  Wolfgang  von  Goethe  
  
1.1. The  neuromuscular  system  
Higher  animal  life  is  defined  by  the  ability  to  perform  controlled  movement  set  forth  
via   the   activation   of   skeletal   muscle   by   motor   neurons   through   neuromuscular  
junctions   (NMJ).   The   vertebrate   NMJ   comprises   three   principle   cell   types:   the  
presynaptic  motor  neuron   (spinal   or   lower  motor  neurons),   the  postsynaptic  muscle  
fiber   and   the   Schwann   cell   (Sanes   and   Lichtman,   1999).   NMJs   transmit   electrical  
signals  from  motor  neurons  located  in  the  ventral  part  of  the  spinal  cord  to  the  target  
muscles.  These  electrical  impulses  (termed  action  potentials)  are  propagated  along  the  
length  of  the  motor  axon  where,  upon  arrival  at  the  presynaptic  motor  axon  terminal,  
cause   an   activation   of   voltage-­‐‑gated   calcium   ion   channels   (P/Q   types)   leading   to   an  
influx   of   extracellular   Ca2+,   finally   resulting   in   the   exocytosis   of   synaptic   vesicles  
containing  the  neurotransmitter  Acetylcholine  (ACh).  ACh,  which  serves  as  the  main  
neurotransmitter   in   the   neuromuscular   system,   is   released   into   the   synaptic   cleft  
where   it   binds   to   its   receptors   located   on   the   postsynaptic  muscle   fiber  membrane.  
Activation   of   these   muscle-­‐‑type   nicotinic   ACh   receptors   (AChRs)   leads   to   the  
depolarization  of  the  muscle  fibers  and  eventually  contraction,  the  basis  for  movement  
of  any  kind  to  occur.    
During   mouse   early   development,   muscle-­‐‑type   nicotinic   AChRs   clusters   are  
prepatterned  on  muscle   fibers  at  around  E12.5-­‐‑E13.5   in   the  diaphragm  (Creazzo  and  
Sohal,   1983)   independently   from   motor   innervation   (Lin   et   al.,   2001),   and   they   are  
initially  composed  of  α2βγδ  subunits  (embryonic-­‐‑type).  Subsequently,  a  conversion  to  





development   and   early   postnatal   period   to   allow   for   optimal   innervation   of  muscle  
fibers  (Yampolsky  et  al.,  2008).    
The  interaction  between  motor  neurons,  skeletal  muscles  and  glial  cells  is  fundamental  
to  NMJ  formation.  Factors  released   from  motor  neurons  have  been  shown  to  control  
postsynaptic   differentiation   directly   by   stimulating   receptors   on   muscle   cells   or  
indirectly   by   promoting   glial   cell   differentiation   and   function   (Wu   et   al.,   2010).   The  
tight-­‐‑knitted   relationship   between   motor   neurons   and   muscles   is   such   that   one   is  
unable  to  function  in  the  absence  of  the  other,  which  is  exemplified  by  neuromuscular  
disorders,  such  as  neuropathies.  Due  to  its  accessibility,  the  neuromuscular  system  is  a  
classical   model   for   tissue-­‐‑interaction   and   synaptogenesis   (Lei   et   al.,   2012).   Even  
though   a   plethora   of   classical   embryological   and   physiological   studies   have  
investigated   the   interaction   between   motor   neurons   and   muscle   fibers   during  
development,   the   precise   roles   these   interactions   play   in   the   formation   of   the  
neuromuscular   system   have   long   been   controversial,   while   the   underlying  
mechanisms  remain  poorly  resolved.    
  
1.2. Motor  neurons  
The  assembly  of  spinal  cord  circuits  that  drives  movements  requires  the  generation  of  
diverse  cell  types  (Dasen  and  Jessell,  2009).  Work  over  the  past  two  decades  has  begun  
to  shed  light  on  the  molecular  programs  that  function  during  embryonic  development  
to   determine   motor   neuron   differentiation   and   motor   neuron-­‐‑muscle   connectivity  
(Dasen   and   Jessell,   2009;   Bonanomi   and   Pfaff,   2010).   The   control   of   various   motor  
behaviors   demands   the   orchestrated   activation   of   different   muscles,   each   by   a  
committed  set  of  motor  neurons  (Dasen  and  Jessell,  2009).  Hence,  to  supplely  adapt  in  
response   to   biomechanical   challenges   posed   by   the   environment,   different   types   of  
motor   neurons   are   generated   which   can   be   categorized   according   to   their  





finally,   their   physiological   functions   (Dasen   and   Jessell,   2009;  Manuel   and   Zytnicki,  
2011).  
  
1.2.1. Motor  neuron  development  
During   spinal   cord   development,   spinal   motor   neurons   and   several   classes   of  
interneurons   are   generated   from   neural   progenitor   cells   upon   exposure   to   graded  
extrinsic   signals   along   the   dorsoventral   axis   of   the   neural   tube   (Dasen   and   Jessell,  
2009).      These   secreted   factors   comprising   sonic   hedgehog   (Shh),   fibroblast   growth  
factors   (FGFs)   and   retinoic   acid   (RA)   initiate   distinct   combinatorial   expression  
domains   of   transcription   factors   in   neural   progenitors,   thereby   defining   progenitor  
fates   (Briscoe   et   al.,   2000;   Jessell,   2000;   Shirasaki   and   Pfaff,   2002;   Dasen   and   Jessell,  
2009).  A  ventral-­‐‑to-­‐‑dorsal  gradient  of  Shh   is   the  main  signaling  pathway  responsible  
for  the  generation  of  the  most  ventral  cell  types,  including  motor  neurons,  whereas  a  
dorsal-­‐‑to-­‐‑ventral  gradient  of  bone  morphogenic  proteins  (BMP)  is  responsible  for  the  
generation  of  dorsal  interneurons  (Jessell,  2000).  Secretion  of  Shh  by  the  notochord  and  
floor   plate   generates   a   ventral-­‐‑to-­‐‑dorsal   gradient,   giving   rise   to   six   progenitor   cell  
domains   within   the   ventral   neural   tube   (Figure   1.1)   (Briscoe   et   al.,   2000).  
Homeodomain  proteins  expressed  by   the  progenitor  cells  have  been  suggested   to  be  
involved  in  identity  specification  in  the  classes  of  postmitotic  cells  that  arise  from  each  
progenitor  domain.  Motor  neurons  arise  from  one  of   the  progenitor  domains  termed  
motor   neurons   progenitor   (pMN)   domain   situated   in   the   ventricular   layer   and   they  
migrate   laterally   to   the   marginal   layer   of   the   prospective   ventral   horn   (Jansen   and  
Fladby,  1990).  In  response  to  Shh,  the  successful  acquisition  of  motor  neuron  cell  fate  
is   determined   by   the   spatiotemporal   expression   of   a   unique   profile   of   transcription  
factors,   the   homeodomain   proteins   Nkx6.1,   Nkx6.2,   Pax6   and   the   activities   of   basic  
helix-­‐‑loop-­‐‑helix  (bHLH)  protein  Olig2  in  the  pMN  domain,  (Briscoe  et  al.,  2000;  Cai  et  





capable   of   inducing   ectopic   motor   neurons   generation   (Marquardt   and   Pfaff,   2001;  
Novitch   et   al.,   2001),   which   involves   induction   of   the   expression   of   Neurogenin   2  
which   is   thought   to   act   as   a   generic   proneural   factor   to   promote   cell   cycle   exit,  
suppress  Notch   signaling  and  glial   fate,  while   factors   like  Hb9  and   Isl1  drive  motor  
neuron-­‐‑specific   programs   (Lee   et   al.,   2005).   The   expression   of   Neurogenin   2   in   the  
pMN   domain   is   downregulated   after   the   initial   phase   of   motor   neuron   generation,  
which  eventually  switches  to  generate  oligodendrocytes  instead;  a  process  thought  to  
be   initiated   by   a   ventral-­‐‑to-­‐‑dorsal   shift   in   Shh   gradient   (Richardson   et   al.,   2000;  
Marquardt   and   Pfaff,   2001;  Novitch   et   al.,   2001;   Takebayashi   et   al.,   2002;   Lee   et   al.,  
2005).  
Postmitotic  spinal  motor  neurons  express  a  set  of  homeodomain  transcription  factors  
(notably  Hb9  and  Isl2)  that  regulate  common  spinal  motor  neuron  features  (Pfaff  et  al.,  
1996;   Arber   et   al.,   1999;   Thaler   et   al.,   1999;   Sharma   et   al.,   2000),   while   additional  
factors,   including   Hox   family   transcription   factors,   promote   further   motor   neuron  
subtype   diversification   (Dasen   and   Jessell,   2009).   The   earliest   postmitotic   motor  
neurons  appear  at  embryonic  day  (E)  9.5  in  the  mouse  spinal  cord  (Dasen  and  Jessell,  
2009),  which  coincides  with  the  extension  of  their  axons  out  of  the  ventral  spinal  cord  
following   a   defined   trajectory,   such   as   the   limb   or   trunk   mesenchyme.   The   latest  
postmitotic   motor   neurons   are   generated   at   E12.5,   followed   by   the   initiation   of  
oligodendrogenesis.  
Movements   of   terrestrial   vertebrates   are   mediated   by   hundreds   of   anatomically  
distinct   muscle   groups   (Dasen   and   Jessell,   2009)   that   serve   different   functions.   The  
motor   neurons   that   innervate   these   peripheral   targets   are   organized   into   discrete  
clusters   that   occupy  distinct  domains   along   the   rostrocaudal   axis   of   the   spinal   cord,  
and   are   termed   motor   columns   (Jessell,   2000).   The   topographic   location   of   motor  
neurons  in  each  column  is  often  predictive  of  target  innervation  pattern  that  link  their  





1990;  Dasen  and  Jessell,  2009;  Bonanomi  and  Pfaff,  2010).    
  
Motor  neurons  having  similar  motor  axon  trajectories,  e.g.  projecting  into  the  limbs  or  
trunk   muscles,   extend   their   peripheral   axons   together.   Additional   levels   of  
organization  are  present  within  the  defined  motor  columns,  as  seen  by  the  segregation  
of  motor  columns  into  “divisions”  and  “pools”  (Dasen  and  Jessell,  2009).  At  both  the  
brachial   and   lumbar   level   of   the   spinal   cord,   the   lateral   motor   column   (LMC)   is  
divided  into  two  divisions  (Figure  1.2):  the  medial  division  (LMCm)  contains  neurons  
which  project   ventrally   and   the   lateral  division   (LMCl)  which   contains  neurons   that  
project   dorsally   within   the   limb   mesenchyme   (Landmesser,   1978;   Tosney   and  
Landmesser,   1985a;   Tosney   and   Landmesser,   1985c).   The   axons   of   the   LMCm  with  
  
Figure  1.1.  MN  generation  and  somite  maturation.    
Motor   neurons   and   ventral   interneurons   are   generated   in   progenitor   domains   pMN   and   pV0-­‐‑V3,  
respectively,   according   to   a   gradient   of   sonic   hedgehog   (Shh)   derived   from   the   floor   plate   and  
notochord.  Dorsal  interneurons  are  generated  via  bone  morphogenic  proteins  (BMPs)  gradient  derived  
from  the  roof  plate.  Paraxial  mesoderm  condensed  into  somites,  which  delaminate  to  give  rise  to  three  
distinct   structures.  The  sclerotome   (S)  generates   future   ribs  and  vertebrae,  whereas  migratory  muscle  
limb  precursors  are  derived  from  the  VLL  of  dermomyotome.  The  central  dermomyotome  gives  rise  to  
epithelial,   dorsal   dermis   and   smooth   muscles.   The   underlying   myotome   derived   from   the   DML   of  





earlier  birth  dates  will   innervate  future  extensor  muscles  whereas  axons  of  the  LMCl  
will  innervate  the  future  flexor  muscles  of  the  limb  (Jansen  and  Fladby,  1990).  
  
1.2.2. Motor  neuron  classes  
Since  being  discovered   in   the   late   19th   century  by  Sir  Charles  Scott   Sherrington,   the  
knowledge   about   motor   neurons   has   been   interminably   advancing.   As   of   now,   the  
21st   century,   it   is   known   that   motor   neurons   make   up   a   very   heterogeneous  
population   of   neurons;   they   innervate   different   muscle   fiber   types,   have   different  
intrinsic  electrical  and  molecular  properties,  morphology  and  exhibit  different  degrees  
of  vulnerability   to  degeneration   (Manuel  and  Zytnicki,  2011).  Briefly,  motor  neurons  
can   be   classified   into   alpha   (α)-­‐‑,   beta   (β)-­‐‑   and   gamma   (γ)-­‐‑motor   neurons.   α-­‐‑motor  
neurons   innervate   extrafusal   skeletal   muscle   fibers,   causing   their   contraction   hence  
allowing  movement.  They  are  the  most  abundant  within  the  classes  with  a  ratio  of  2:1  
to   γ-­‐‑motor   neurons   (Hunt   and   Kuffler,   1951;   Friese   et   al.,   2009),   and   besides   their  
intrinsic  properties,  they  can  be  subdivided  by  the  contractile  properties  of  the  muscle  
fiber   type   (type   I,   IIa,   IIb)   that   they   innervate.  A  single  α-­‐‑motor  neuron   innervates  a  
subset   of  muscle   fibers  with   the   same   contractile   properties  within   a  muscle,  which  
constitutes   a   motor   unit.   γ-­‐‑motor   neurons   innervate   intrafusal   fibers   in   the   muscle  
spindle,   receive   proprioceptive   feedback   from   muscle   spindles   in   the   muscles   and  
participate  in  regulating  muscle  tone  and  length  by  modulating  the  stretch  sensitivity  
of  muscle  spindles  (Hunt  and  Kuffler,  1951).  β-­‐‑motor  neurons,  on  the  other  hand,  are  a  
less   characterized   group.   They   are   thought   to   innervate   both   extra-­‐‑   and   intrafusal  






1.2.3. Organization  of  motor  neurons  within  the  spinal  cord  
Movements   of   terrestrial   vertebrates   are   mediated   by   hundreds   of   anatomically  
distinct   muscle   groups   (Dasen   and   Jessell,   2009)   that   serve   different   functions.   The  
motor   neurons   that   innervate   these   peripheral   targets   are   organized   into   discrete  
clusters   that   occupy  distinct  domains   along   the   rostrocaudal   axis   of   the   spinal   cord,  
and   are   termed   motor   columns   (Jessell,   2000).   The   topographic   location   of   motor  
neurons  in  each  column  is  often  predictive  of  target  innervation  pattern  that  link  their  
cell  bodies  to  their  synaptic  targets   located  in  the  periphery  (Hollyday  and  Jacobson,  
1990;  Dasen  and  Jessell,  2009;  Bonanomi  and  Pfaff,  2010).    
  
Motor  neurons  having  similar  motor  axon  trajectories,  e.g.  projecting  into  the  limbs  or  
trunk   muscles,   extend   their   peripheral   axons   together.   Additional   levels   of  
organization  are  present  within  the  defined  motor  columns,  as  seen  by  the  segregation  
of  motor  columns  into  “divisions”  and  “pools”  (Dasen  and  Jessell,  2009).  At  both  the  
brachial   and   lumbar   level   of   the   spinal   cord,   the   lateral   motor   column   (LMC)   is  
divided  into  two  divisions  (Figure  1.2):  the  medial  division  (LMCm)  contains  neurons  
which  project   ventrally   and   the   lateral  division   (LMCl)  which   contains  neurons   that  
  
  
Figure   1.2.   Spatial   organization  
of  motor  neuron  columns.    
LMCl  and  LMCm  can  be  found  at  
the   brachial   and   lumbar   level,  
whereas   PGC   and   HMC   can   be  
found   only   at   the   thoracic   level.  
MMC   is   present   throughout   the  
rostrocaudal   length   of   the   spinal  
cord.  Motor  neurons  from  lumbar  
LMCm   and   LMCl   innervate   the  
ventral   and   dorsal   hindlimb   bud,  
respectively.   (Adapted   from   Dasen  





project   dorsally   within   the   limb   mesenchyme   (Landmesser,   1978;   Tosney   and  
Landmesser,   1985a;   Tosney   and   Landmesser,   1985c).   The   axons   of   the   LMCm  with  
earlier  birth  dates  will   innervate  future  extensor  muscles  whereas  axons  of  the  LMCl  
will  innervate  the  future  flexor  muscles  of  the  limb  (Jansen  and  Fladby,  1990).    
  
1.3. Generation  of  skeletal  musculature  in  vertebrates  
Muscles  are  contractile  organs,  utilizing  myosin  II  motor  proteins  and  actin  filaments  
to   generate   force   and   movement.   In   vertebrates,   there   are   three   types   of   muscles:  
smooth,   cardiac   and   skeletal.   Smooth   muscle   is   found   in   visceral   organs   and  
vasculature,  cardiac  muscle  is  used  by  the  heart  for  pumping  blood,  whereas  skeletal  
muscles   are   responsible   for   body  movements   and   locomotion.  Of   these,   cardiac   and  
skeletal   muscles   have   a   striated   appearance   arising   from   the   highly   ordered  
arrangement  of  actin  and  myosin   filaments   (Braun  and  Gautel,  2011).  The  vertebrate  
skeletal   musculature   consists   of   functionally   distinct   components   generated   during  
embryogenesis  (Bryson-­‐‑Richardson  and  Currie,  2008).  
  
1.3.1. Delamination  and  migration  of  muscle  progenitor  cells  
During   embryonic   development,   skeletal   muscles   are   derived   from   the   paraxial  
mesoderm,   which   later   condenses   to   develop   into   spherical   epithelial   structures  
termed  somites.  A  total  of  65  pairs  of  somites  are  formed  in  the  mouse  embryo  (Tam,  
1981).   Somites   are   formed   in   a   rostrocaudal   sequence,   and   generate   three   distinct  
lineage-­‐‑restricted   cellular   compartments   under   inductive   influence   of   neighboring  
tissues:  the  sclerotome,  myotome  and  dermomyotome  (Figure  1.1)  (Christ  et  al.,  1992;  
McMahon   et   al.,   1998).   The   ventral   epithelial-­‐‑derived   sclerotome   gives   rise   to   the  
future  vertebrae  and  ribs  (Christ  and  Ordahl,  1995),  while  the  central  dermomyotome  





endothelial   and   smooth   muscles.   The   myotome   is   comprised   of   an   epaxial   and   a  
hypaxial  component.  The  epaxial  myotome  is   formed  by  cells   that  have  delaminated  
from  the  dorsomedial  lip  of  the  dermomyotome  and  gives  rise  to  deep  back  muscles,  
while   the   hypaxial   myotome   contains   cells   that   have   delaminated   from   the  
ventrolateral   lip   of   the   dermomyotome   and   contributes   to   abdominal   muscles   at  
thoracic  levels  (Tajbakhsh  and  Buckingham,  2000).  At  limb  bud  levels,  the  cells  located  
at   the  ventrolateral   lip  of   the  dermomyotome  will  migrate   to   invade  the   lateral  plate  
mesoderm  via  positional  cues  provided  by  the  mesenchymal  cells  of  the  limbs  where  
they  eventually  differentiate  into  skeletal  muscles  (Christ  and  Ordahl,  1995;  Brent  and  
Tabin,  2002;  Buckingham  et  al.,   2003).  This  migration   involves  critical  molecules   like  
hepatocyte  growth  factor/scatter  factor  (Hgf/Sf)  and  its  receptor  c-­‐‑Met  (Dietrich  et  al.,  
1999;  Bentzinger  et  al.,  2012).  In  the  mouse,  it  is  initiated  around  E9.25  in  the  forelimb  
and   is   completed   by   E11.0   in   the   hindlimb   (Bismuth   and   Relaix,   2010).   Genetic  
inactivation  of  either  Hgf/Sf  or  c-­‐‑Met  results   in  mice  devoid  of  skeletal   limb  muscles  
(Bladt  et  al.,  1995;  Schmidt  et  al.,  1995).    
  
1.3.2. Cellular  events  during  myogenesis  
The  migrating  precursor  cells  from  the  ventrolateral  lip  of  the  dermomyotome  invade  
the   limb   bud   as   myogenesis   —the   commitment   of   precursor   cells   to   the   muscle  
lineage—   begins   (Buckingham   et   al.,   2003).   This   is   a   process   tightly   regulated   by   a  
network   of   transcription   factors   leading   eventually   to   the   expression   of   myogenic  
determination  genes  and  differentiation  of  contractile  muscle  fibers.  
Three   types   of   muscle   cell   precursors   (termed   myoblasts)   arise   during   embryonic  
mouse   development,   initiating   two   waves   of   myogenesis   (Kelly   and   Zacks,   1969)  
(Ontell   and  Kozeka,   1984;  Ross   et   al.,   1987).  Embryonic  myogenesis  occurs   in  newly  
formed  somites  whereby  the  dorsal  progenitors  respond  to  inductive  signals  like  Shh  





expression   of  Myf5   and  MyoD   that   commit   cells   to  myogenesis   (Cossu   and   Borello,  
1999;   Pownall   et   al.,   2002).   For   example,  mice   deficient   for   Shh   have   reduced  Myf5  
expression   in   addition   to   lacking   epaxial   musculature   (Borycki   et   al.,   1999).   In   the  
mouse   embryonic   limb,   primary   myogenesis   begins   at   ~E11.5   and   ends   at   ~E14.5,  
generating  multinucleated  structures  called  primary  myotubes  resulting  from  the  end-­‐‑
to-­‐‑end   fusion  of  primary   (embryonic)  myoblasts  derived   from  Pax3+  progenitor   cells  
(Figure   1.3)   (Zhang   and  McLennan,   1995;  Buckingham  et   al.,   2003;  Hutcheson   et   al.,  
2009).  The  appearance  of  the  first  myotubes  in  the  limb  bud  arising  at  E12.5  coincides  
with   the   arrival   of   the   ventrally   and   dorsally   projecting   LMC   motor   axons   to   the  
ventral  and  dorsal  muscle  mass,  respectively  (Tosney  and  Landmesser,  1985c).  These  
muscle  masses  will  eventually  undergo  segregation  to  form  distinct  muscles.    
  
Fusion   of   myoblasts   into   multinucleate   syncytia   is   a   tightly   controlled   and  
fundamental   step   in  muscle   differentiation,  which   involves   cell  migration,   adhesion  
and  fusion  (Abmayr  and  Pavlath,  2012).  The  fusion  process  is  promoted  by  a  change  in  
membrane   potential,   which   requires   the   synchronized   activity   of   three   types   of   ion  
channels,   notably   inward   rectifier   K+   (Kir2.1),   ether-­‐‑a-­‐‑go-­‐‑go   (EAG)   and   T-­‐‑type   Ca2+  
channels.  After  primary  myogenesis,  secondary  myogenesis  commences  (Bernheim  et  
  
Figure   1.3.   Stages   of   myogenesis.  Muscle   progenitors   are   activated   to   form   myoblasts,   which   have  
proliferative  capability  and  are  committed  to  a  myogenic  fate.  Myoblasts  undergoing  differentiation  exit  
the   cell   cycle   and   elongate   to   form  myocytes.   The  myocytes   align   and   fuse   end-­‐‑to-­‐‑end   to   give   rise   to  
multinucleated  myotubes,  the  precursors  of  mature  myofibers.  During  terminal  differentiation,  myotubes  





al.,   1996;   Fischer-­‐‑Lougheed   et   al.,   2001).   This   entails   the   fusion   of   fetal   myoblasts  
which   are   cells   that   develop   from   distinct,   but   related   (Pax3   -­‐‑derived   Pax7+)  
progenitors  along  the  length  of  the  existing  primary  myotubes  (Figure  1.4)  (Duxson  et  
al.,  1989).    
  
The  secondary  fibers  are  encapsulated  by  the  same  basal  lamina  as  the  primary  fibers  
on  which  they  are  formed  and  where  they  elongate  to  eventually  become  independent  
fibers.   Secondary   fibers   can   be   distinguished   from   primary   fibers   by   their   relative  
small  size  (Kelly  and  Zacks,  1969).  Later  in  development,  from  E16.5  onwards,  a  third  
type   of   Pax7+   myoblasts   known   as   satellite   cells   can   be   morphologically   identified  
between  the  basal   lamina  and  the  sarcolemma.  These  cells  become  solely  responsible  
for   postnatal   muscle   growth   and   regeneration   (Figure   1.4)   (Sambasivan   and  
  
Figure  1.4.  Three  types  of  myoblasts  that  can  potentially  fuse  to  generate  multinucleated  myotubes.  
Embryonic  myogenesis   begins   at   ~E8.5   and   ends   ~E14.5.   Pax3+  myoblasts   exit   the   cell   cycle   and   they  
elongate   to   form   myocytes,   which   express   MRFs   at   different   time   points.   Primary   myotubes   are  
generated  from  the  fusion  of  myocytes  during  embryonic  myogenesis.  Fetal  myogenesis  (E15.5-­‐‑  before  
birth)   generates   secondary  myotubes,  which   form  on   the   scaffold  of   early-­‐‑formed  primary  myotubes  
via  the  fusion  of  Pax3-­‐‑derived  Pax7+  myoblasts.  Perinatal  growth  and  muscle  regeneration  is  mediated  
by  Pax7+  satellite  stem  cells,  which  are  located  between  the  sarcolemma  and  the  basal  lamina.  (Adapted  





Tajbakhsh,  2007;  Lepper  et  al.,  2011;  Murphy  et  al.,  2011).  
  
1.3.3. Molecular  events  during  myogenesis  
Generation  and  terminal  differentiation  of  skeletal  muscle  is  controlled  by  members  of  
myogenic  regulatory  factors  (MRFs)  (Braun  and  Gautel,  2011).  The  MRFs  belong  to  the  
basic  helix  loop  helix  (bHLH)  family  of  proteins.  The  basic  domain  of  bHLH  proteins  
mediates  DNA  binding,  while  the  helix-­‐‑loop-­‐‑helix  segment  forms  heterodimers  with  E  
proteins.  MRF-­‐‑E   protein   complexes   bind   to   E-­‐‑box  motifs   located   upstream   of  many  
muscle-­‐‑specific   genes   (Massari   and   Murre,   2000).   MRFs   act   together   with   other  
transcriptional   cofactors   to   drive   the   expression   of   genes   required   for   the   skeletal  
muscle  developmental  program  (Kablar  and  Rudnicki,  2000).  There  are  four  members  
in   this   family,   comprising   myogenic   factor   5   (Myf5),   myogenic   differentiation   1  
(Myod1/MyoD),   muscle-­‐‑specific   regulatory   factor   4   (Mrf4   or   Myf6)   and   myogenin  
(Bryson-­‐‑Richardson   and   Currie,   2008;   Braun   and   Gautel,   2011).   While   ectopically  
expressing  any  of  the  factors  is  sufficient  to  confer  a  myogenic  fate  in  nonmuscle  cells,  
the   MRFs   each   display   distinct   temporospatial   expression   patterns   and   seem   to  
perform  different  roles  in  the  myogenic  lineage  (Figure  1.5)  (Rawls  et  al.,  1995).  Myod1  
and  Myf5  are  thought  to  play  roles  in  muscle  cell  determination  upstream  of  the  other  
MRFs   (Berkes   and   Tapscott,   2005).   Determination   genes   like  MyoD   and  Myf5   are  
implicated   in   the   maintenance   of   muscle   progenitor   lineages   and   are   considered  
markers   of   terminal   commitment   to   the   muscle   lineage   (Pownall   et   al.,   2002).  
However,   although   they   can   initiate   certain   gene   regulatory   processes   of   myogenic  
specification  (i.e.  expression  of  early  muscle  differentiation  markers,  etc.),  their  actions  
alone   are   insufficient   to   drive   the   regulatory   program   for   muscle   differentiation  
during   later   development,   underscoring   the   requirement   for   other  MRFs.  Myogenin  
appears  to  be  crucial  for  the  terminal  differentiation  of  committed  myoblasts,  whereas  





cells  and  as  a  determination  gene  in  proliferating  myoblasts  (Kassar-­‐‑Duchossoy  et  al.,  
2004).    
  
Gene   targeting   in  mice  has   shed   light  on   the   role  of  MRFs  during  myogenesis.  Null  
mutations   in   myogenin   almost   completely   abolishes   skeletal   muscle   differentiation;  
mutant  myogenin  mice  have  severe  reduction   in  skeletal  muscle  mass,   resulting   from  
diffuse  myofiber  formation  and  an  abundance  of  undifferentiated  myoblasts  (Hasty  et  
al.,  1993;  Nabeshima  et  al.,  1993;  Ordahl  and  Williams,  1998).  Contrastingly,  mutations  
in   either  Myf5,  MyoD   or  Myf6   do   not   alter   the   patterning   and   amount   of   skeletal  
muscle  tissue  (Braun  et  al.,  1992;  Rudnicki  et  al.,  1992;  Zhang  et  al.,  1995).  Inactivating  
either  Myf5   or  MyoD   genes,   however,   causes   delayed   onset   of   differentiation   of   the  
epithelial-­‐‑derived  musculature  (back,  intercostals  and  abdominal  wall),  as  well  as  the  
hypaxial-­‐‑derived   musculature   (branchial   arches,   tongue,   limbs,   diaphragm,  
intercostals  and  abdominal  wall),  respectively  (Kablar  et  al.,  1997;  Kablar  et  al.,  1998).  
Simultaneous   inactivation   of  Myf5   and  MyoD   results   in   amyogenic   embryos   lacking  
both  differentiated  muscle  and  myoblasts  (Rudnicki  et  al.,  1992).  
  
Figure  1.5.  Timeline  of  Pax3,  Pax7  and  MRFs  expression  during  mouse  embryogenesis.  Colored  boxes  
indicate  timed  expression  of  Pax7  (green),  Pax3  (yellow),  Myf5  (purple),  MyoD  (blue),  myogenin  (MyoG)  
(brown)  and  Myf6  (light  green)  in  the  somite  and  limbs.  Pax7,  Pax3  and  Myf5  are  transiently  expressed,  
whereas   MyoD,   MyoG   and   Myf6   are   expressed   throughout   development.   Myf6   has   a   biphasic  
expression,   appearing  at  E12.0-­‐‑E13.0   and   reappearing  at   around  E14.0   in   the   limb  again.   It   is   the  most  





1.3.4.   Genetic  hierarchy  implicated  in  limb  myogenesis  
According   to   the  genetic  hierarchy   implicated  during  myogenesis   (Figure   1.6),   these  
MRF   genes   act   downstream   of   or   in   parallel   with   homeodomain-­‐‑and   paired  
containing   transcription   factors  Pax3  and  Pax7   in  different  phases  of   embryonic  and  
adult  myogenesis   (Bryson-­‐‑Richardson   and  Currie,   2008).   Pax3,   is   itself   regulated   by  
upstream   factors   that   coordinate   lineage   specification,   such  as   sine  oculis  homeobox  
protein  1  and  4  (Six1  and  Six4)  as  well  as  their  cofactors  eyes  absent  homologue  1  and  
2  (Eya1  and  Eya2)  (Figure  1.6).    
  
Pax7,  on  the  other  hand,   is  dispensable  for  early  myogenesis  (Tajbakhsh  et  al.,  1997),  
but   is   critical   for   the   specification   and   maintenance   of   satellite-­‐‑cell   populations  
responsible  for  postnatal  muscle  growth  and  regeneration  (Seale  et  al.,  2000;  Relaix  et  
al.,   2005).   Inductive   signals   (for   e.g.,   Wnts,   Shh,   BMPs,   Notch-­‐‑Delta1)   from   axial  
structures  also  act  to  regulate  expression  of  MRFs  (Bentzinger  et  al.,  2012).  Aside  from  
MRF   members,   other   transcription   factors,   such   as   the   Mef2   family,   which   contain  
MADS-­‐‑box-­‐‑motifs,  act  in  concert  with  the  other  myogenic  factors  to  promote  myoblast  
differentiation  (Black  and  Olson,  1998;  Buckingham  et  al.,  2003)  
  
  
Figure   1.6.   The   genetic   hierarchy   of   limb   myogenesis.  
Muscles   from  the   limbs  are  derived   from  trunk  somites  and  
expression   of   all   MRFs   is   essential   for   driving   myogenic  
differentiation.  Upstream,  Six  and  Eya  proteins  regulate  Pax3,  
which   controls   the   proliferative   myogenic   precursor   pool.  





1.3.5. Organization  of  muscles  
Two  major   classifications   can   be   used   to   distinguish   vertebrate  muscles:   the   cardiac  
and  skeletal  muscles  which  are  collectively  termed  as  striated  muscles,  as  opposed  to  
the   smooth   muscles.   Assembly   of   discrete   units   termed   sarcomeres   into   myofibrils  
accounts  for  the  striated  appearance  of  the  muscles.  A  sarcomere,  the  basic  contractile  
unit   of   the   muscle,   is   composed   of   antiparallel   actin   and   myosin   filaments,   titin  
filaments  as  well  as  crosslinking  proteins  like  α-­‐‑actinin,  desmin  and  myomesin  (Figure  
1.7).   Additionally,   the   sarcomere   contains   accessory   proteins   found   at   the   Z-­‐‑disk  
and/or   the   I-­‐‑band   to   control   transcription   and   protein   turnover   (Braun   and   Gautel,  
2011).    
  
Myofibrillogenesis   is   initiated   at   E9   when   cells   in   the   myotome   domain   of   cervical  
somites  begin  to  express  MRF  proteins  (Furst  et  al.,  1989).  Shortly  after,  the  sequential  
expression  of  muscle-­‐‑specific  proteins  can  be  detected:  desmin  first,  followed  by  titin,  
muscle-­‐‑specific  actin  and  myosin  heavy  chain  proteins  and  finally  nebulin  (Furst  et  al.,  
1989).  However,  it  is  only  after  fusion  of  myoblasts  to  myotubes  beginning  at  ~E13  in  
the  mouse  that  the  characteristic  myofibrillar  banding  pattern  can  be  observed  (Furst  
  
Figure  1.7.  Basic  unit  of  contraction.  A  sarcomere  is  the  basic  contractile  unit  of  the  cardiac  and  skeletal  
muscles.   The   core   sarcomere   consists   of   antiparallel   actin   and  myosin   filaments,   titin   filaments   and  
crosslinker  proteins  for  actin  such  as  myosin,  myomesin  and  α-­‐‑actinin.  In  addition,  there  are  accessory  
constituents   like   proteins   involved   in   transcriptional   regulation   and   turnover   control.   (Adapted   from  





et   al.,   1989).   Myofibril   assembly   starts   after   myotube   fusion   with   the   formation   of  
myofibrils   at   the   periphery   of   the   newly   fused  myotube   (Myhre   and  Pilgrim,   2012).  
The   myofibrils   are   formed   from   the   elaborations   of   the   actin   cytoskeleton   and  
aggregations   of   α-­‐‑actinin   (Myhre   and   Pilgrim,   2012).   They   then   attach   to   the   cell  
surface  and  are   centered  on  extracellular   complexes,   termed  costameres,   constructed  
from  premyofibril  templates,  which  are  established  in  the  prefusion  myoblasts  and  are  
composed   of   cortical   actin   and   nonmuscle  myosin   (Pardo   et   al.,   1983;   Sparrow   and  
Schock,   2009).   As   myotube   maturation   proceeds,   additional   myofibrils   will   fill   the  
interior   of   the   cell,   anchored   to   each   other   as   well   as   intracellular   organelles   via  
intermediate   filament   myofibrils,   and   eventually   undergo   reorganization   to   highly  
structured  bundles   spanning   the   length  of   the  cell   (Grosberg  et  al.,   2011;  Myhre  and  
Pilgrim,  2012).  
  
1.3.6. Types  of  muscle  fibers  arising  during  embryonic  myogenesis    
Embryonic   and   fetal   myoblasts   represent   intrinsically   disparate   myogenic   lineages  
that  separately  give  rise  to  myotubes  in  a  temporally  regulated  manner  (Biressi  et  al.,  
2007).  Consistent  with  this,  the  two  types  of  muscle  fibers  that  arise  through  fusion  of  
myoblasts   during   embryonic   myogenesis,   the   primary   (embryonic)   and   secondary  
(fetal)  myofibers   also  differ   in  many   features.  These   include   the   expression  of   genes  
involved   in   skeletal  muscle   development   and  physiology,   as  well   as   the   differential  
expression   of   muscle   creatine   kinase   (Ckm),   β-­‐‑enolase   (Eno3),   protein   kinase   theta  
(Pkcθ)   and   myosin   heavy   chain   (MyHC)   isoforms   (Bonner   and   Hauschka,   1974;  
Barbieri  et  al.,  1990;  Ferrari  et  al.,  1997).  This  difference  between  embryonic  and  fetal  
myotubes   is   in   part   attributed   to   the   activities   of   transcription   factor   Nfix,   whose  
expression   is   activated  by  Pax7   in   fetal  muscles  and   is   thought   to  be   responsible   for  
controlling   the   switch   from   embryonic   to   fetal   myogenesis   (Messina   et   al.,   2010).  





1989),  it  is  during  secondary  myogenesis  that  myofibers  begin  to  differentially  express  
distinct  myosin  isoforms  that  will  discriminate  the  future  fast-­‐‑  and  slow-­‐‑twitch  muscle  
fibers   in   the   adult   (Lyons   et   al.,   1990).   Primary   myotubes   in   rodents   express   both  
embryonic   myosin   heavy   chain   (MyHC-­‐‑emb)   and   adult   slow   myosin   heavy   chain  
(MyHC-­‐‑slow),   whereas   secondary   myotubes   express   MyHC-­‐‑emb   and   neonatal  
myosin  heavy  chain  (MyHC-­‐‑neo).  Primary  myotubes  are  the  precursors  of  adult  slow  
muscle  fibers,  with  only  a  minority  of  them  suppressing  MyHC-­‐‑slow  and  expressing  
adult  fast  myosin  heavy  chain  (MyHC-­‐‑fast)  (Jansen  and  Fladby,  1990).  Most  secondary  
myotubes,  on  the  other  hand,  develop  into  fast  fibers.    
The  initial  specialization  into  different  fiber  types  is  attributed  to  the  innate  properties  
of   distinct   myoblasts   lineages,   and   is   thought   to   occur   largely   independent   from  
innervation,   although   the   precise   influence   (or   absence   thereof)   of   innervation   for  
embryonic  muscle   fiber   type   specification   remains   contested   (Schiaffino   et   al.,   2007;  
Rana   et   al.,   2009).   It   remains   unclear   whether   developing   fibers   expressing  MyHC-­‐‑
emb  and/or  MyHC-­‐‑neo  represent  particular  functional  contractile  structures  or  if  they  
are   just   provisional   transitional   structures   that   appear   before   the   emergence   of  
definitive  fiber  types  after  birth  (Schiaffino  and  Reggiani,  2011).  
  
1.4. Nerve-­‐‑muscle  interaction  
The   neuromuscular   system   is   virtually   the   only   neural   system   in  which   the   precise  
target   and   functional   output   of   the   innervating   neurons,   the   motor   neurons,   are  
known.  Given  the  tight  relationship  of  motor  neurons  and  the  muscle  fibers  that  they  
innervate,   it   is   not   surprising   that   the   development   and   maintenance   of   both  
components  require  extensive  forward-­‐‑  and  reverse-­‐‑crosstalk.  For  instance,  about  60-­‐‑
67%  of  motor  neurons   initially   generated   are   eliminated  via  programmed   cell   death  
(PCD)   starting   from   E13   in   the   thoracic   and   lumbar   spinal   cord   (Lance-­‐‑Jones,   1982;  





developmental   elimination   process   remains   speculative.   Blocking   AChRs   with  
nicotinic  blocking  agents  was  observed   to  block   the   intrinsic   apoptotic  program  and  
preserve   the   initial   motor   neuron   number   (Oppenheim,   1991;   Hory-­‐‑Lee   and   Frank,  
1995).  At  the  same  time,  nicotinic  blocking  agents  failed  to  block  motor  neuronal  cell  
death   after   removal   of   the   limb   buds,   suggesting   that   muscle-­‐‑derived   factors   or  
retrograde   signals   regulate  motor   neuron   elimination   during   development   (Pittman  
and  Oppenheim,   1979;  Caldero   et   al.,   1998).      Furthermore,   experiments   have   shown  
that   removal   of   target  muscles   causes  motor   neuron   degeneration,  while   increasing  
the   target   size   augments   motor   neuron   survival   (Hollyday   and   Hamburger,   1976;  
Oppenheim,   1991).   Conversely,   there   is   evidence   to   support   the   presence   of  
anterograde   signals   provided   by   the   motor   neurons   to   the   muscles   (Altar   and  
DiStefano,  1998).    
During  the  development  of  the  neuromuscular  junction,  AChR  clusters  are  small  and  
dispersed  at   the  endplate  of   the  muscles   (median  positioned).  Nerve-­‐‑derived  signals  
such   as   agrin   are  known   to   induce  maturation   and  maintenance  of   the  postsynaptic  
AChR   clusters,   thus   resulting   in   denser,   larger   clusters   and   their   alignment   with  
presynaptic  motor  axon  terminals  (Lin  et  al.,  2001).  Cross-­‐‑innervation  studies  done  by  
Buller   et   al.   (1960)   also   demonstrated   that   certain   properties   (e.g.   contractile  
properties)   of   muscles   partially   depended   on   motor   innervation.   While   there   is   a  
broad   consensus   regarding   the   interdependence   of  motor   neurons   and  muscles,   the  
extent  of  this  interdependence  remains  contested,  however.  
  
1.4.1. Dependence  of  muscles  on  innervation  
During   myogenesis,   motor   nerves   branch   extensively   within   muscles   after   the  
cleavage  of  pre-­‐‑muscle  mass  and  after  most  or  all  the  primary  myotubes  have  formed  
(Tosney  and  Landmesser,  1985b;  Dahm  and  Landmesser,  1988;  Ontell  et  al.,  1988).  The  





(McLennan,  1983a;  Ross  et  al.,  1987).  The  nerve  was  initially  thought  to  be  important  
for  the  continued  differentiation  and  survival  of  muscle  fibers,  while  the  initial  steps  of  
myogenesis   would   occur   self-­‐‑autonomously   (Hamburger,   1939;   Hamburger   and  
Waugh,  1940;  Bradley,  1970).  These  conclusions  were  based  on  early  pioneering  work  
by   Victor   Hamburger   and   others   who   performed   surgical   manipulations   in   chick  
embryos,   including   neural   tube   or   limb   extirpation   and   grafting   experiments  
(Hamburger,   1939;   Hamburger   and   Waugh,   1940;   Bradley,   1970),   although   these  
experiments  did  not  include  sham-­‐‑operated  controls  to  account  for  potential  effects  of  
the   surgery   proper   (Hunt,   1932;  Hamburger,   1939).  Nevertheless,   these   experiments  
have  undeniably  paved  the  way  for  much  of  the  work  that  followed  involving  neural  
influence  on  muscle  development.    
  
1.4.2. Primary  myotubes  and  denervation    
It   is   established   that   the   early   cleavage   of   pre-­‐‑muscle  mass   occurs   independently   of  
innervation   (Hunt,   1932;   Hamburger,   1939;   Shellswell,   1977;   Butler   et   al.,   1982).  
However,  the  role  of  innervation  in  the  formation  of  primary  and  secondary  myofibers  
and  the  extent  of  interdependence  between  the  nerve  and  developing  muscles  remain  
controversial.   In   the   1980s,   it   was   generally   accepted   that   primary   myotubes   form  
independently  of  the  nervous  system  (McLennan,  1994).  This  was  based  on  many  lines  
of   evidence   that   observed   that   primary   myotubes   form   prior   to   the   muscle   being  
extensively   innervated,   and   that   a   normal   number   of   myotubes   were   formed   in  
denervated  muscles  (Harris,  1981;  Butler  et  al.,  1982;  Phillips  and  Bennett,  1984;  Ross  et  
al.,   1987).  Crow  and  Stockdale   (1986)  as  well   as  other   investigators  have  also   shown  
that   in   the   developing   chick,   the   fiber   specialization   of   early   myotubes   (primary  
myotubes,   based   on   MyHC-­‐‑slow   expression)   appears   to   be   unaffected   after   d-­‐‑
tubocurarine   (d-­‐‑tbc)-­‐‑induced   neuromuscular   contact   disruption   or   brachial   spinal  





1986).   However,   this   conclusion   was   eventually   challenged   by   Fredette   and  
Landmesser  (1991),  who  proposed  a  crucial  role  for  innervation  on  primary  myotube  
formation   and   maintenance.   This   was   based   on   using   d-­‐‑tbc   to   induce   paralysis   or  
denervation   (lumbosacral   spinal   cord   removal)   in   the   chick   embryos,   upon  which   it  
was  observed  that  the  formation  of  primary  myotubes  of  the  iliofibularis  muscle  was  
affected   in   the   late   stage   of   primary  myogenesis,   along  with   degeneration   of   earlier  
formed  myotubes.  Additionally,  this  was  supported  by  evidence  from  the  mouse  that  
formation   of   primary  myotubes   in   the   soleus  muscle  was   prevented   almost   entirely  
after  laser  ablation  of  the  spinal  cord  during  embryonic  development  at  E14.5  (Hughes  
and  Ontell,  1992).  
  
1.4.3. Influence  of  innervation  on  secondary  myotubes  
Secondary   myogenesis   has   generally   been   thought   to   be   greatly   dependent   on   the  
nerve  (Ross  et  al.,  1987;  Harris,  1981;  McLennan,  1983;  Phillips  and  Bennett,  1984).  This  
conclusion   was   based   on   results   obtained   by   using   blockers   (β-­‐‑bungarotoxin,  
tetrodotoxin  and  d-­‐‑tbc)  to  induce  muscle  denervation  or  paralysis  in  avian,  duck  and  
rat   embryos  which   revealed   that   secondary  myotube   formation  was   either   severely  
hampered   or   completely   abolished   in   these   conditions   (Harris,   1981;   McLennan,  
1983b;  Phillips  and  Bennett,  1984;  Sohal  and  Sickles,  1986;  Ross  et  al.,  1987;  Wilson  and  
Harris,   1993).   These   observations   were   in   conflict   with   results   obtained   by   several  
other  studies,  which  concluded  that  a  large  number  of  secondary  myotubes  could  be  
observed   even   after   paralysis   or   denervation   (Condon   et   al.,   1990;   Fredette   and  
Landmesser,   1991a;   Hughes   and   Ontell,   1992).   As   a   result,   two  main   but   disparate  
hypotheses  have  arisen:  (1)  the  first  advocating  that  a  subset  of  late-­‐‑forming  primary  
myotubes   is   nerve-­‐‑dependent,   whereas   secondary  myotubes   form   independently   of  
innervation,  but  instead  rely  on  the  surviving  primary  myotubes  to  provide  scaffolds  





the  second  proposed  that  primary  myotube  formation  is  a  cell-­‐‑autonomous  event,  but  
secondary  myogenesis  depends  on  the  regulatory  or  permissive  effect  of   innervation  
(Ross  et  al.,  1987;  Harris,  1981;  Butler,  1982;  Phillips  and  Bennett,  1984).  Hence,  to  date,  
whether   the   presence   of   the   motor   nerve   is   required   for   the   formation   of   primary  
and/or  secondary  myotubes  remains  unresolved.  Furthermore,  it  is  unclear  if  primary  
and   secondary   myotubes   display   differential   responses   to   denervation   and   if   they  
have   distinct   requirements   from   the   nerve   (e.g.   different   degree   of   dependence)   for  
their  formation  and  maintenance.  
  
1.4.4. Nerve  aspects  that  could  regulate  muscle  development  
Even   though   secondary   myogenesis   is   generally   accepted   to   be   dependent   on   the  
nerve  (Ross  et  al.,  1987;  Harris,  1981;  McLennan,  1983;  Phillips  and  Bennett,  1984),  the  
functional   significance   of   the   initial   interaction   between   the   nerve   and  muscle  with  
regards   to  myotube   formation   is   still   poorly   understood.  Administration   of   d-­‐‑tbc   to  
chick   embryos   before   the   establishment   of   nerve-­‐‑muscle   contact   has   been   found   to  
abolish  secondary  myotube  formation  (Sohal  and  Sickles,  1986;  McLennan,  1983c).   In  
contrast,   administration   of   the   same   drug   before   neuromuscular   terminal   formation  
had   no   effect   on   secondary   myogenesis   (Dahm   and   Landmesser,   1988).   Similarly,  
denervation  in  rodent  muscles  by  β-­‐‑bungarotoxin  (β-­‐‑BTX)  after  the  nerve  has  entered  
the  muscle   results   in   secondary  myotube   formation,  whereas  denervation  before   the  
nerve   has   entered   the   muscle   results   in   a   profound   inhibition   of   secondary  
myogenesis   (Harris,  1981;  Ross  et  al.,  1987;  Wilson  and  Harris,  1993).   In  brief,  earlier  
studies  have   reported   that   the   extent  of   secondary  myogenesis   inhibition  appears   to  
correlate   with   the   time   of   physical   and   chemical   denervation,   such   that   earlier  
treatment   had   a   more   pronounced   effect   compared   to   later   treatment   on   embryos  
(Harris,  1981;  Phillips  and  Bennett,  1984;  Ross  et  al.,  1987;  Condon  et  al.,  1990).  Thus,  





which  specific  aspect  of  the  nerve  (i.e.  nerve  contact,  nerve  activity,  or  nerve-­‐‑derived  
neurotrophic   factors)   would   predominantly   be   required   for   secondary   myotube  
formation.  
  
1.5. Spontaneous  motility  and  nerve  activity  
A  common  feature  during  nervous  system  development  is  the  occurrence  of  rhythmic  
spontaneous  episodes  of  activity  which  is   thought  to  be  highly  relevant  for  neuronal  
circuit   formation   and   fine-­‐‑tuning,   especially   in   circuits   involved   in   motor   pattern  
generation   (Hanson   and   Landmesser,   2003).   Spontaneous   motility   in   vertebrates   is  
generated   approx.   1   day   after   the   innervation   of   muscles   by   spontaneously   active  
spinal   motor   neurons   at   the   appropriate   developmental   stage   (Moody   and   Bosma,  
2005).   In   the   mouse,   spontaneous   activity   in   the   developing   motor   neurons   was  
predominantly   recorded   in   lumbar  motor   nerves   in   E11.4-­‐‑14.5   spinal   cord   (Hanson  
and   Landmesser,   2003).   By   E12.5,   spontaneous   motility,   which   is   propagated   in   a  
rostral-­‐‑to-­‐‑caudal  fashion,  could  be  detected  as  small  random  movements  in  the  mouse  
(i.e.   70%  of   the  movements   is   initiated  near   the  head)  before  proceeding   to   a  highly  
patterned  motility  with  alternative  flexor  and  extensor  motor  output  as  well  as  activity  
that  alternates  between  the  two  sides  of  the  body  as  development  progresses  (Moody  
and   Bosma,   2005).   Further,   E15   is   thought   to   be   the   stage   which   corresponds   to   a  
transitional  period  in  the  maturation  of  rhythmic  patterns  during  which  two  disparate  
rhythms  are  expressed,  as  development  of  a  more  mature  phenotype  (characterized  by  
irregular   short-­‐‑duration   events)   that   likely   reflects   the   emergence   of   evoked   nerve  
activity  in  the  embryo  (Yvert  et  al.,  2004).  
The   relative   conservation  of   the   initiation  of   spontaneous   activity   between   the   chick  
and  mouse  suggests  that  spontaneous  activity  is  important  to  development  in  general  
(Moody   and   Bosma,   2005).   Because   spontaneous   activity   persists   throughout   the  





differentiation   are   likely   to   be   influenced   by   changes   in   these   pattern   of   activity   as  
development   progresses   (Moody   and   Bosma,   2005).   In   brief,   spontaneous   motor  
neuron  activity   is  known  to  be  crucial   for  many  aspects  of  development,  such  as   the  
pruning  of  supernumerary  inputs  to  the  NMJ,  matching  axons  with  target  motor  units,  
and  most  importantly,  facilitating  the  increase  of  intracellular  Ca2+  in  myoblasts  in  the  
absence  of  action  potentials,  thereby  triggering  their  fusion  (Moody  and  Bosma,  2005).  
Mice   deficient   for   γ-­‐‑subunit   of   AChR   failed   to   develop   spontaneous   muscle   action  
potentials   (triggered   by   miniature   end   plate   potentials),   exhibited   lower   density   of  
cross-­‐‑striation   in  muscle   fibers  and  died  within   two  days  after  birth,   suggesting   that  
spontaneous  activity  may  play  additional  roles  in  myogenesis  (Takahashi  et  al.,  2002).  
Unfortunately,   the   extent   to   which   spontaneous   activity   might   promote   muscle  
formation   and/or   maintenance   during   embryogenesis   and   the   critical   stage   for   this  
requirement  remains  elusive.    
  
1.5.1. Evoked  and  spontaneous  vesicular  release  
Neurons   communicate   primarily   by   releasing   neurotransmitters   stored   in   small  
organelles   of   similar   size   and   shape,   known   as   synaptic   vesicles   (Jahn   and   Sudhof,  
1994).  Two  types  of  synaptic  vesicular  release  can  be  observed  at   the  neuromuscular  
synapse.   One   is   the   less   well-­‐‑understood   action   potential-­‐‑independent   spontaneous  
transmitter   release,   first   discovered   by   Bernard  Katz   and   colleagues   (Kavalali   et   al.,  
2011).   This   typically   occurs   with   a   low   probability   and   involves   fusion   of   a   single  
synaptic   vesicle   (Fatt   and   Katz,   1952;   Katz   and   Miledi,   1964).   On   the   other   hand,  
evoked   (action   potential-­‐‑dependent)   transmitter   release   is   elicited   by   a   Ca2+   influx  
(Deitcher   et   al.,   1998).   Under   physiological   conditions,   the   unitary   synaptic  
transmission  events  (in  muscles,  end  plate  potential–  EPP)  that  occur  from  the  fusion  
of  individual  synaptic  vesicles  are  to  a  large  extent  similar  to  one  another  in  terms  of  





whether   vesicles   were   exocytosed   spontaneously   or   induced   by   action   potentials  
(Kavalali  et  al.,  2011).  Traditionally,  these  two  types  of  vesicular  release  were  thought  
to  have  similar  exocytotic  apparatus,  differing  only   in   their   rate-­‐‑limiting   response   to  
different  Ca2+   concentrations.  However,   recent   studies  on  neuronal  SNAREs   (soluble  
N-­‐‑ethylmaleimide-­‐‑sensitive   factor  attachment  protein   receptors)   consisting  of  SNAP-­‐‑
25,   synaptobrevin   (also   known   as   VAMP2)   and   syntaxin1   that   make   up   the   core  
multiprotein  complex   (Jahn  and  Scheller,   2006;  Sudhof  and  Rothman,  2009)   revealed  
differences   underlying   the   two   types   of   vesicular   release   and   suggested   that   they  
utilize   distinct  molecular   interactions   of   the   same   fusion  machinery   (Kavalali   et   al.,  
2011).   Synaptobrevin,   the   protein   involved   in   vesicle   docking   and/or   fusion   and   a  
substrate   for   tetanus  toxin  (TeTx),  was   interestingly  found  to  abolish  Ca2+-­‐‑dependent  
evoked  release  completely,  whereas  the  rate  of  spontaneous  release  of  a  single  vesicle  
persists  albeit  being  reduced  (Deitcher  et  al.,  1998;  Schoch  et  al.,  2001).    
  
1.5.2. Acetylcholine  (ACh)  
Increase   in   intracellular   Ca2+   induced   by   nerve   activity   can   trigger   the   secretion   of  
developmentally  active  molecules,   including  neurotransmitters,   that  could  play  roles  
during  different  developmental  processes  (Moody  and  Bosma,  2005).  ACh  is  the  main  
neurotransmitter   in   the   vertebrate  motor   system   and   it   underlies   both   spontaneous  
and   evoked   synaptic   activity   at   all   vertebrate  NMJs   (Misgeld   et   al.,   2002).   As   such,  
neurotransmission   is   the   only   established   role   for   ACh   in   the   nervous   system,  
although   it  has   long  been  hypothesized   to  be   involved  as  a   regulator   in  myogenesis  
based   on   the   effect   on   muscles   after   neurotransmission   blockade   (or   in   vitro   data)  
(Drachman  and  Coulombre,  1962;  Drachman,  1964;  Giacobini   et  al.,   1973;  Hall,   1975;  
Entwistle   et   al.,   1988;   Krause   et   al.,   1995).   From   these   studies,   neuromuscular  
transmission   and   resulting   muscle   activity   were   thought   to   constitute   trophic  





However,   later   studies   suggest   that  not   all   effects   of   the  nerve  on  muscles  might  be  
mediated  by  ACh;  paralysis  of  the  rat  IV  lumbrical  muscle  by  TTX  (Ross  et  al.,  1987),  
duck  superior  oblique  muscle  by  α-­‐‑BTX  (Sohal  and  Holt,  1980)  and  chick  iliofibularis  
muscle  by  d-­‐‑tbc  (McLennan,  1983b)  was  found  to  result   in   lesser  degeneration  and  a  
prolonged   survival   of   primary   myotubes   when   compared   to   denervation   of   these  
muscles  by  β-­‐‑BTX  or  spinal  cord  segment  removal.  Based  on  this  observation,  synaptic  
ACh  was   suggested   to  upkeep  primary  myotubes  not  by  acting  as   a   sole   factor,   but  
instead  by  acting   in  combination  with  other   factors   (McLennan,  1994).  This   idea  was  
well  supported  by  the  finding  that  constant  electrical  stimulation  of  aneural  chick  PLD  
(posterior   latissimus   dorsi)  muscle   delays   their   degeneration,   but   fails   to   reinstate  
muscles   to   their  normal  size   (Bloom  et  al.,  1985).  Knocking  out   the  Chat  gene,  which  
encodes   for   the   choline   acetyltransferase   enzyme   used   in   the   biosynthesis   of   ACh,  
revealed  hyperinnervation  of  muscles  and  synaptic  maturation  defects  (Misgeld  et  al.,  
2002).  More   importantly,   diaphragm  muscles  were   considerably   thinner  with   fewer  
muscle   fibers   in   the  Chat  mutants,   suggesting   that  ACh-­‐‑mediated  neurotransmission  
might   be   a   crucial   myogenic   requirement   for   myotube   formation   and/or   survival  
(Misgeld  et  al.,  2002).  
  
1.6. Adult  denervation  pathway    
Fiber  type  diversification  in  the  embryos  is  thought  to  occur  independently  of  neural  
influence,   as   shown   by   experiments   using   β-­‐‑BTX   to   destroy   motor   neurons   in   rat  
fetuses   prior   to   muscle   innervation   (Condon   et   al.,   1990).   Although  muscle   growth  
was  drastically  reduced  by  the  loss  of  motor  neurons,  muscles  of  fetuses  still  contained  
fibers   expressing   either   MyHC-­‐‑neo   or   MyHC-­‐‑slow   with   differential   distribution.  
However,  in  postnatal  animals,  neuronal  activity  is  one  of  the  most  important  aspects  
in  maintaining   fiber   type  profile   of   skeletal  muscles   (Schiaffino   and  Reggiani,   2011).  





development   of   slow   muscle   fibers:   for   example,   postnatal   denervation   of   the   rat  
soleus  resulted  in  the  progressive  decline  and  eventual  disappearance  of  slow  myosin  
4  weeks  after  denervation  (Gambke  et  al.,  1983).    
To   maintain   homeostasis,   a   balance   between   anabolic   (synthetic)   and   catabolic  
(degenerative)  processes  is  necessary.  During  embryonic  myogenesis,  myotubes  grow  in  
length,   resulting   from   the   end-­‐‑to-­‐‑end   fusion   of   myoblasts   to   form   multinucleated  
myotubes   (Zhang   and   McLennan,   1995).   More   importantly,   muscle   growth   during  
embryonic  development  is  characterized  by  an  increase  in  fiber  numbers,  generated  from  
the   two   waves   of   myogenesis   (primary   and   secondary).   Therefore,   embryonic   muscle  
growth   is   principally   dependent   on   the   precise   limitation   of   differentiation,   which   is  
executed  by  proliferative  and  Pax3-­‐‑promoting  signals  such  as  BMP4  (Amthor  et  al.,  1999).  
Conversely,   subsequent   growth   in   postnatal   muscle   fibers   is   due   to   hypertrophy   (an  
increase  in  muscle  fiber  size),  with  no  net  formation  of  new  muscle  fibers.  An  exception  
to  this  is  during  muscle  regeneration,  when  satellite  cells  are  activated  to  replace  injured  
muscle  fibers  (Lepper  et  al.,  2011).  Muscle  growth  in  postnatal  muscle  is  achieved  either  
by   increased   protein   content,   decreased   protein   breakdown,   or   both   (Boonyarom   and  
Inui,  2006),  and  is  regulated  primarily  by  components  in  the  highly  conserved  signaling  
pathway,  the  insulin-­‐‑like  growth  factor  1-­‐‑Akt/protein  kinase  B  (IGF1-­‐‑Akt/PKB)  pathway  
(Schiaffino  and  Mammucari,  2011).  
Contrastingly,   aging,   starvation,  pathologic   states,   inactivity  or  denervation   can   lead   to  
muscle   atrophy   (decrease   in   total   muscle   mass).   In   the   adult,   denervation-­‐‑induced  
atrophy   occurs   primarily   through   ubiquitin-­‐‑mediated   proteolysis   via   the   proteasome  
(Beehler  et  al.,  2006),  although  muscle  atrophy  in  general  can  be  governed  by  at  least  five  
proteolytic  pathways,   including  the   lysosomal,  Ca2+-­‐‑dependent,  caspase  systems,  matrix  
metalloproteinases  and  the  ubiquitin  proteasome  pathway  (Ventadour  and  Attaix,  2006).  
During   atrophy,   the   muscle   cell   undergoes   degeneration   with   structural   changes  





changes,   such   as   reduction   of   mitochondria   numbers   (Rifenberick   et   al.,   1973),  
accumulation   of   connective   tissue   and   the   loss   of   myonuclei   by   apoptosis   (Oki   et   al.,  
1995).    
Through   the   years   many   factors   have   been   associated   with   adult   denervation,   most  
importantly   including   the   E3   ubiquitin   ligases,   Muscle   RING   Finger   1   (MuRF1)   and  
Atrogin-­‐‑1/Muscle   Atrophy   F-­‐‑box   (MAFbx),   which   are   effectors   known   to   mediate  
atrophy-­‐‑related   degradation   triggered   by   denervation   and   are   established   as   universal  
markers  of   atrophy   (Bodine  et   al.,   2001;  Ventadour  and  Attaix,   2006).   In   five  models  of  
atrophy   namely:   denervation,   immobilization,   unweighting,   treatment   with   cachectic  
cytokine   interleukin-­‐‑1   and   treatment   with   glucocorticoid   dexamethasone   (Goldberg,  
1969;   Bodine   et   al.,   2001;   Moresi   et   al.,   2010;   Macpherson   et   al.,   2011),   the   two   genes  
encoding   E3   ubiquitin   ligases   were   found   to   be   upregulated   and   overexpression   of  
Atrogin-­‐‑1   in   differentiated   C2C12   skeletal   myotubes   produced   atrophy   (Bodine   et   al.,  
2001).   Conversely,   knocking   out   either  MuRF1   or   Atrogin-­‐‑1   conferred   a   resistance   to  
neurogenic   atrophy   (atrophy   resulting   from   denervation)   (Bodine   et   al.,   2001).   Until  
recently,   it   was   unclear   whether   muscle   atrophy   induced   by   different   triggers   is  
governed   by   a   common   signaling  pathway   or  whether   several   pathways   exist   that   can  
result  in  muscle  atrophy  (Bodine  et  al.,  2001;  Moresi  et  al.,  2010).  In  2010,  work  done  by  
two   independent   groups   has   shed   light   on   part   of   the   signaling   ensemble   underlying  
adult   denervation   and   found   that   myogenin,   a   member   of   the   MRF   family,   induces  
neurogenic  atrophy  (Moresi  et  al.,  2010;  Macpherson  et  al.,  2011).  During  denervation  in  
the  adult,  muscle  fibers  appear  to  regress  to  an  immature  state  by  re-­‐‑expressing  some  of  
MRFs,  which  are  normally  downregulated  either  during  or  after  embryonic  myogenesis  
(Merlie  et  al.,  1994;  Williams  et  al.,  2009).  Myogenin  was  found  to  be  a  key  regulator  of  
MuRF1   and   Atrogin-­‐‑1   expression,   two   effectors   responsible   for   neurogenic   atrophy   of  
muscle   fibers.   Denervation-­‐‑induced   myogenin   upregulation   appears   to   be   in   turn  
controlled  by   class   IIa   histone  deacetylases   (Hdacs)   4   and   5.  Consistent  with   this,  mice  





resistant  to  neurogenic  atrophy  (Moresi  et  al.,  2010).  It  has  been  shown  that  Hdac  4  and  
Hdac   5,  which   are   able   to   act   as   transcriptional   repressors   (Haberland   et   al.,   2009),   are  
upregulated   in   response   to   denervation   and   negatively   regulate   expression   of   Dach2  
(Cohen   et   al.,   2007),   a   known   transcriptional   repressor   of   myogenin.   In   contrast,  
knowledge  about  signaling  pathways  involved  during  embryonic  denervation  is  far  less  
well   characterized,   in   part   due   to   the   technical   difficulties   in  manipulating   embryos   to  
create  a  nerve-­‐‑free  myogenic  environment.  
  
1.7. Aim  of  the  project  
Despite   a   plethora   of   classical   embryological   and   physiological   studies   that   have  
investigated   the   interaction   between   motor   neurons   and   muscle   fibers   during  
development,   the   extent   to  which   innervation   contributes   to   embryonic  myogenesis  
have  long  been  controversial,  while  the  underlying  mechanisms  remain  elusive  (Butler  
et   al.,   1982;   McLennan,   1983b;   Ross   et   al.,   1987;   Condon   et   al.,   1990;   Fredette   and  
Landmesser,  1991a;  Hughes  et  al.,  1992;  Wilson  and  Harris,  1993).  Because  of  technical  
difficulties  and/or  variations   in   creating  aneural   and  paralyzed  muscles   to   study   the  
role   innervation   plays   during   embryonic   myogenesis,   data   obtained   from   these  
studies  have  led  to  two  main  yet  divergent  conclusions  on  the  myogenic  requirements  
from  the  nerve  as  well  as  the  myogenic  response  to  denervation.  
Hence,   the   initial   aim   of   this   project   was   to   revisit   the   interdependence   between  
muscles  and  motor  neurons  during  development  through  selective  gene  manipulation  
in  the  mouse.  To  achieve  this,  a  combination  of  transgenic  mouse  lines  was  employed  
to   either   create   aneural   embryonic  muscles   by  wholesale   removal   of  motor   neurons  
from   the   onset   of   their   formation   or   to   produce   paralyzed   embryonic   muscles   by  
overexpressing  TeNT   specifically   in   the  motor   neurons   or   inactivating  Chat   to   block  
motor   neurotransmission.   In   using   and   carefully   controlling   this   genetic   approach,  





drugs  can  be  circumvented,  thus  facilitating  the  selective  in-­‐‑depth  analysis  of  the  role  
motor  innervation  has  during  embryonic  myogenesis.  Ultimately,  the  aim  of  this  work  
was   to   identify   molecular   pathways   regulated   by   innervation   to   drive   embryonic  
myogenesis   and/or   maturation   and  maintenance   of   muscle   fibers.   The   discovery   of  
genes   involved   in   embryonic   innervation-­‐‑dependent   myogenic   programs   may  





     




2. Materials  and  methods  
2.1. Consumables  and  plastic  ware  
Lab   consumables   were   from   Starlab   GmbH   (Hamburg),   Eppendorf   AG   (Hamburg)  
and   Sarstedt   AG   (Nürnstedt).   Dissection   instruments   were   purchased   from   Fine  
Science  Tools  GmbH.  
2.1.1. Antibodies  
Primary  antibodies  
Antigen   Host     Dilution   Code   Supplier  
Cleaved    
caspase-­‐‑3  
Rabbit   1:1000   5A1E   Cell  signaling  GmbH  
Desmin   Mouse   1:1000   D-­‐‑33   DAKO  GmbH  
Fast  myosin   Mouse   1:200   F59   Developmental  Studies    
Hybridoma  Bank  
General  myosin   Mouse     1:200   MF20   Developmental  Studies    
Hybridoma  Bank  
GFP   Rabbit   1:2000   A-­‐‑11122   Life  Technologies  GmbH  
Islet  1/2   Rabbit   1:2500   Isl  ½   Gift  from  S.L.  Pfaff  
Islet  1/2   Mouse   1:200   39.4D5   Developmental  Studies    
Hybridoma  Bank  
Laminin   Rabbit   1:500   L9393   Sigma  Aldrich  AG  GmbH  
Myf5   Rabbit   1:200   C-­‐‑20   Santa  Cruz  Biotech  GmbH  
Neonatal  myosin   Mouse   1:4000   My-­‐‑32   Sigma  Aldrich  AG  GmbH  
NeuN   Mouse   1:1000   MAB377   Merck  Millipore  GmbH  
Neuronal  nuclei   Mouse   1:1000   NeuN   Merck  Millipore  GmbH  
NF  (160  kDa)   Mouse   1:200   4H6   Developmental  Studies    
Hybridoma  Bank  
Parvalbumin   Rabbit   1:2000   PV   Covance  GmbH  






Mouse   1:50      Developmental  Studies    
Hybridoma  Bank  
Pax7   Mouse   1:50      Developmental  Studies    
Hybridoma  Bank  
Slow  myosin   Mouse   1:2000   NOQ7.5.4D   Sigma  Aldrich  AG  GmbH  




Rabbit   1:2000   ABN100   Synaptic  Systems  GmbH  
α-­‐‑Bungarotoxin  





1:5000   B-­‐‑35451   Life  Technologies  GmbH  
  
Secondary  antibodies  and  nuclei  dye  
Target     Conjugate   Host     Dilution   Supplier  
Mouse   Alexa  fluorescent  dye   Donkey   1:2000   Life  Technologies  GmbH  
Rabbit   Alexa  fluorescent  dye   Donkey   1:2000   Life  Technologies  GmbH  
Sheep   Alexa  fluorescent  dye   Donkey   1:2000   Life  Technologies  GmbH  
Nuclei  dye   DAPI      1:1000   Sigma  Aldrich  AG  GmbH  
  
2.1.2. Enzymes  
Enzyme   Supplier  
DNA  Ligation  Kit   Takara  Bio  Inc  
Dream  Taq  DNA  Polymerase   Thermo  Fisher  Scientific  GmbH  
Phusion  High  Fidelity  DNA  Polymerase   New  England  Biolabs  GmbH  
Platinum  Taq  DNA  Polymerase  High  Fidelity   Life  Technologies  GmbH  
Restriction  enzymes   Thermo  Fisher  Scientific  GmbH  




Shrimp  Alkaline  Phosphatase   Thermo  Fisher  Scientific  GmbH  
SP6  RNA  Polymerase   Roche  Diagnostics  GmbH  
T4  DNA  Ligase   Thermo  Fisher  Scientific  GmbH  
T4  Polynucleotide  Kinase   Thermo  Fisher  Scientific  GmbH  
T7  RNA  Polymerase   Roche  Diagnostics  GmbH  
  
2.1.3. Kits  
Kit   Supplier  
Antigen  Unmasking  Solution  Kit   Vector  Laboratories  Inc  
cDNA  synthesis  Kit   Roche  Diagnostics  GmbH  
Click-­‐‑iT  EdU  Alexa  Fluor  Imaging  Kit   Life  Technologies  GmbH  
Illumina  Total  Prep  RNA  Amplification  Kit   Life  Technologies  GmbH  
PrimeScript  First  Strand  cDNA  Synthesis  Kit     Takara  Bio  Inc  
QIAGEN  Plasmid  Maxi  Kit   Qiagen  GmbH  
QIAprep  Spin  Miniprep  Kit   Qiagen  GmbH  
QIAquick  Gel  Extraction  Kit   Qiagen  GmbH  
Taqman  Universal  Probe  Library  (mouse)   Roche  Diagnostics  GmbH  
TOPO  TA  Cloning  Kit   Life  Technologies  GmbH  
    
2.1.4. Chemicals  and  reagents  
Chemical   Supplier  
Agar-­‐‑Agar     Carl  Roth  GmbH  
Agarose  NEEO   Carl  Roth  GmbH  
Ammonium  acetate   Carl  Roth  GmbH  
Ampicillin   Carl  Roth  GmbH  
Benzyl  alcohol  (BA)   Carl  Roth  GmbH  
Benzyl  benzoate  (BB)   Sigma-­‐‑Aldrich  AG  GmbH  
Blocking  reagent   Roche  Diagnostics  GmbH  




Bovine  serum  albumin  fraction  V  (BSA)   Carl  Roth  GmbH  
Calcium  chloride   Carl  Roth  GmbH  
Chloroform   Carl  Roth  GmbH  
Cupric  sulfate   Carl  Roth  GmbH  
D-­‐‑PBS  pH  7.2   Life  Technologies  GmbH  
Diethylpyrocarbonate  (DEPC)     Carl  Roth  GmbH  
Dimethyl  sulfoxide  (DMSO)   Sigma-­‐‑Aldrich  AG  GmbH  
DNA  Ladder  GeneRuler  1kb   Thermo  Fisher  Scientific  GmbH  
DNA  loading  dye  6x   Thermo  Fisher  Scientific  GmbH  
dNTP  Mix   Thermo  Fisher  Scientific  GmbH  
Ethanol  99.9%   Carl  Roth  GmbH  
Ethidium  bromide  solution  1%   Carl  Roth  GmbH  
Ethylenediaminetetraacetatic  acid  (EDTA)   Carl  Roth  GmbH  
Fast  green   Sigma-­‐‑Aldrich  AG  GmbH  
Glacial  acetic  acid   Carl  Roth  GmbH  
Glucose   Sigma-­‐‑Aldrich  AG  GmbH  
Glutaraldehyde   Sigma-­‐‑Aldrich  AG  GmbH  
Glycerol   Carl  Roth  GmbH  
Hydrochloric  acid   Carl  Roth  GmbH  
Isopropanol   Carl  Roth  GmbH  
L-­‐‑15  medium  Leibowitz   Sigma-­‐‑Aldrich  AG  GmbH  
Magnesium  chloride   Carl  Roth  GmbH  
Methanol     Carl  Roth  GmbH  
OCT  embedding  medium     Sakura  Finetek  GmbH  
Paraffin  pellets   Carol  Roth  GmbH  
Paraformaldehyde  (PFA)   Carl  Roth  GmbH  
PBS  pH  7.2     Life  Technologies  GmbH  
Phenol-­‐‑Chloroform   Carl  Roth  GmbH  
Polyacrylamide   Carl  Roth  GmbH  
Potassium  chloride   Carl  Roth  GmbH  
Potassium  hydroxide   Carl  Roth  GmbH  




Proteinase  K   AppliChem  GmbH  
Sodium  acetate   Carl  Roth  GmbH  
Sodium  chloride   Carl  Roth  GmbH  
Sodium  citrate   Carl  Roth  GmbH  
Sodium  dodecyl  sulfate  (SDS)   Carl  Roth  GmbH  
Sodium  hydroxide   Carl  Roth  GmbH  
Sucrose   Carl  Roth  GmbH  
Tris-­‐‑HCl   Carl  Roth  GmbH  
Triton  X-­‐‑100   Carl  Roth  GmbH  
TRIzol  reagent   Life  Technologies  GmbH  
Trypsin   Life  Technologies  GmbH  
Tryptone   Carl  Roth  GmbH  
Tween-­‐‑20   Carl  Roth  GmbH  
Xylene   Carl  Roth  GmbH  
Yeast  extract   AppliChem  GmbH  
1-­‐‑hexadecane   Sigma-­‐‑Aldrich  AG  GmbH  
β-­‐‑Mercaptoethanol   Carl  Roth  GmbH  
  
2.1.5. Solutions  
Solution   Reagents  
Antibody  staining  solution   PBS  pH  7.2;  1%  BSA;  1%  Triton  X-­‐‑100  
BABB  clearing  solution   66%  Benzyl  benzoate;  34%  Benzyl  alcohol  
Cupric  sulfate  solution   pH  5.0;  10  mM  Cupric  sulfate;  50  mM  Ammonium  acetate  
Dent’s  solution   80%  Methanol;  20%  DMSO  
LB  agar   LB  medium;  1%  [w/v]  Agar-­‐‑Agar  
LB  medium     5  g/l  Sodium  chloride;  5  g/l  Yeast  extract;  10  g/l  Tryptone  
Mounting  solution   PBS  pH  7.2;  50%  Glycerol  
PBST   PBS  pH  7.2;  0.1%  Tween-­‐‑20  
PFA  solution   PBS  pH  7.2;  4%  [w/v]  Paraformaldehyde  




Sucrose  solution   PBS  pH  7.2;  30%  [w/v]  Sucrose  
TAE  buffer   40  mM   Tris;   1  mM   EDTA   adjust   pH   7.5   with   glacial   acetic  
acid  
Tail  biopsy  lysis  buffer   0.1  M  Tris  pH  8.0;  30  mM  NaCl;  0.2  mM  EDTA;  0.05%  SDS;  
0.5  mg/ml  Proteinase  K  
  
2.1.6. Vectors  
Plasmid   Supplier  
p2TK-­‐‑CMV-­‐‑2A-­‐‑eGFP   Workgroup  Marquardt  
p2TK-­‐‑MLC-­‐‑EGFP-­‐‑F   Gift  from  D.  Duprez  (Wang  et  al.,  2011)  
pCAGGS-­‐‑T2TP   Gift  from  K.  Kawakami  (Sato  et  al.,  2007)  
pCRII-­‐‑TOPO   Life  Technologies  GmbH  
PGKdtabpA     Addgene  Inc  
    
2.1.7. Software  
Software   Application   Supplier  
Adobe  Creative  Suite  CS5   Image  processing   Adobe  Systems  Inc  
Bead  Studio   Microarray  data  analysis   Illumina  Inc  
DAVID   Microarray  data  analysis   http://david.abcc.ncifcrf.gov  
ImageJ   Image  quantification   http://rsbweb.nih.gov/ij/  
Microsoft  Office  2007   Data  input   Microsoft  Corp  
Primer3   Primer  design   http://primer3.sourceforge.net  
Prism  5.0   Statistical  analysis   GraphPad  Software  Inc  
Vector  NTI   DNA  sequence  analysis   Life  Technologies  GmbH  




2.2. Chick  embryos  
Lohmann   LSL   strain   fertilized   eggs   (Horstmann   Geflügelzucht   GmbH)   were   used.  
Before  electroporation,  they  were  incubated  (Hemel-­‐‑Brutgeräte)  for  65  h  at  37.8˚C  and  
80%  humidity.    
  
2.3. Mouse  lines  
All   animal   experiments   have   been   carried   out   in   accordance   with   the   animal  
protection  law  of  the  Federal  Republic  of  Germany  and  were  approved  by  the  district  
government.  Animals  were  housed  under  standard  conditions  in  the  institute’s  animal  
facility  with  access  to  food  and  water  ad   libitum.  When  a  vagina  plug  was  confirmed  
on   the  morning   after  mating   on   the  previous   evening,   the  period   of   pregnancy  was  
designated   at   0.5   post-­‐‑conception   (dpc).   All   stages   of   embryos   in   this   study   were  
obtained  by  cervical  dislocation,  and  analyzed  by   routine  histological  and  molecular  
biological  procedures.  
  
2.3.1. R26fxDTAxOlig2Cre  mice  
Olig2  is  a  bHLH  transcription  factor  essential  for  driving  the  differentiation  of  motor  
neurons  and  at   later  stages,  oligodendrocytes  (Takebayashi  et  al.,  2002).  Olig2Cre  mice  
which  carry  an  insertion  of  Cre  expressed  under  control  of  Olig2  promoter  were  bred  
to   the   Rosa26fxDTA   (R26fxDTA)   strain   to   conditionally   ablate   premitotic   motor   neurons.  
R26fxDTA   carries   an   insertion   of   the   Diptheria   toxin   subunit   A   (DTA)   gene   in   the  
ubiquitously   expressed  Rosa26  locus   (Ivanova   et   al.,   2005).   Transcription   of  
the  R26fxDTA  allele   ceases   prematurely   in   R26fxDTAxOlig2Cre   mice   because   of  
a  loxP  flanked  (floxed)  transcriptional  termination  sequence  before  the  DTA  sequence.  
Cre-­‐‑mediated  recombination  cleaves  the  floxed  termination  sequence  and  drives  DTA  
expression,   thereby   resulting   in   conditional   cell   death   of   Cre-­‐‑expressing   premitotic  




motor   neuron  progenitors.  Cell   specific   ablation   is   brought   about   by   catalyzation   of  
ADP  ribosylation  of  eukaryotic  elongation  factor  2  by  DTA.  
  
2.3.2. Isl2fxDTAxOlig2Cre  mice  
Olig2Cre  mice  were  bred  to  Islet2fxDTA  (Isl2fxDTA)  strain  which  carries  a  targeted  insertion  
of  the  Diptheria  toxin  subunit  A  (DTA)  cassette  into  the  sequences  encoding  the  3’  UTR  
of  the  Insulin  related  protein  2  (Isl2)  gene.  Isl2  is  one  of  the  first  homeodomain  proteins  
to  be  expressed  in  the  postmitotic  motor  neurons.  Cre-­‐‑mediated  recombination  drives  
DTA   expression   specifically   in   the   postmitotic  motor   neurons,   resulting   in   their   cell  
death.    
  
2.3.3. R26fxTeNT  xOlig2Cre  mice  
Rosa26fxTeNT   (R26fxTeNT)  mice   carrying   an   insertion   of   Tetanus   toxin   light   chain   (TeNT)  
fragment   expressed   under   control   of   the   ubiquitous   promoter  Rosa26   (Zhang   et   al.,  
2008),   a   kind  gift   from  Prof.  Martyn  Goulding   (The  Salk   Institute),  were  bred   to   the  
Olig2Cre  strain  to  conditionally  block  neurotransmission  in  motor  neurons.  To  generate  
R26fxTeNTxOlig2Cre  mice,   the   lacZ  sequences  downstream  of  PGKneo-­‐‑tPA  cassette   in   the  
Rosa26   locus   (Soriano,   1999)   were   replaced   with   a   sequence   encoding   a   GFP-­‐‑TeNT  
fusion   protein   (Yamamoto   et   al.,   2003).   The   transcription   of   the  R26fxTeNT   allele  
ceases   prematurely   in   R26fxTeNT  mice   because   of   a  loxP  flanked   (floxed)   termination  
sequence   upstream   of   the   TeNT   sequence.   Cre-­‐‑mediated   recombination   cleaves   the  
floxed   termination   sequence   and   drives   TeNT   expression,   thereby   resulting   in  
conditional  neurotransmission  blockade  of  Cre-­‐‑expressing  motor  neurons.  
  




2.3.4. Chat  null  mice  
Choline   acetyltransferase   (Chat)   null  mice  were   obtained   from  Prof.   Samuel   Pfaff   (The  
Salk  Institute)  as  part  of  a  collaboration.  Chat   is  a  critical  enzyme  responsible  for  the  
biosynthesis  of  acetylcholine  (ACh),  the  main  neurotransmitter   in  the  neuromuscular  
system.  Chat  is  encoded  by  a  large  gene  that  includes  14  coding  exons  in  the  3’  region  
which  are  used  in  all  transcript  variants  (Brandon  et  al.,  2003).  The  catalytic  portion  of  
the   protein   that   affects   the   efficiency   of  ACh   synthesis  was   targeted   for   deletion.  A  
targeting  vector   containing   a  neomycin   resistance   cassette   expressed   in   the   opposite  
orientation  from  Chat  was  used  to  replace  exons  11,  12,  and  13  (Ohno  et  al.,  2001).    
  
2.3.5. R26fxDTAxMyogCre  mice  
MyogCre   mice   carry   an   insertion   of   Cre   recombinase   expression   cassette   expressed  
under   control   of   1.5-­‐‑kb   mouse   myogenin   promoter   and   the   1.0-­‐‑kb   mouse   MEF2C  
enhancer   (Li   et   al.,   2005).   Myogenin   is   a   member   of   the  MRFs   and   is   expressed   in  
differentiating   myoblasts.   MyogCre   mice   were   bred   to   Rosa26fxDTA   (R26fxDTA)   mice   to  
specifically   ablate   myogenin-­‐‑expressing   myoblasts.   Cre-­‐‑mediated   recombination  
cleaves   the   floxed   termination   sequence   and   drives   DTA   expression   specifically   in  
myogenin-­‐‑expressing  myoblasts,  resulting  in  their  cell  death,  and  thereby  preventing  
muscle  formation  (muscle  loss  seen  first  at  E14.5)  (Gensch  et  al.,  2008).    
  
2.3.6. Myf5-­‐‑/-­‐‑;MyoD-­‐‑/-­‐‑:Hb9-­‐‑GFP  mice  
Hb9-­‐‑GFP  is  a  transgenic  mouse  line  expressing  the  enhanced  green  fluorescent  protein  
(eGFP)  under  control  of  the  Hb9  promoter,  enabling  the  genetic  labeling  of  postmitotic  
motor  neurons   (Lee   et   al.,   2004).  This  mouse   line  was   crossed  with  Myf5+/-­‐‑;MyoD+/-­‐‑  
mice  described  in  (Rudnicki  et  al.,  1993).    
  





Tail   biopsies   of   mice   were   incubated   in   DNA   lysis   buffer   at   56   ˚C   overnight.  
Thereafter,   the   solution  was   centrifuged   for   10  min   at   12000   revolutions  per  minute  
(rpm),   and   the   supernatant   was   collected   and   mixed   with   500   µμl   isopropanol.   The  
mixture  was   centrifuged   again   for   10  min   at   12000   rpm.  Thereafter,   the   supernatant  
was  discarded  and  the  pellet  obtained  was  washed  with  70%  ethanol  by  centrifugation  
for   5  min   at   12000   rpm.   The   pellet   was   left   to   air-­‐‑dry   before   dissolving   in   50  µμl   of  
distilled   water   and   incubating   at   37   ˚C   for   a   minimum   of   1   h   before   use   for   PCR  
(polymerase  chain  reaction).    
PCR  reaction  set  up  
Component   Amount  (µμl)  
DNA   1  
dNTPs     0.5  
Forward  primer     0.5  
Reverse  primer   0.5  
Taq  polymerase   0.25  
Double  distilled  water   19.75  
Conditions  for  Mastercycler  epGradient  S  (Eppendorf  AG)  
Condition   Time  













72  ˚C    
  
5  min  




Primers  used  for  genotyping  
Mouse  allele   Primer  
Rosa  WT     F:    AAAGTCGCTCTGAGTTGTTAT  
R:  GGAGCGGGAGAAATGGATATG  
Rosa  Mutant   F:    AAAGTCGCTCTGAGTTGTTAT  
R:  GCGAAGAGTTTGTCCTCAACC  
Isl  2  WT   F:  GCCATGAGAACGCGGTGCAGGGC  
R:  CGGAGTCTCCAGTCTCAGCGGTGC  
Isl  2  Mutant   F:  ACGACGCTGCGGGATACTCT  
R:  CAACGCTAGAACTCCCCTCA  
TeNT  WT   F:  AAAGTCGCTCTGAGTTGTTAT  
R:  GGAGCGGGAGAAATGGATATG  
TeNT  Mutant   F:  AAAGTCGCTCTGAGTTGTTAT  
R:  CATCAAGGAAACCCTGGACTACTG  
Olig  Cre   F:  TAAAGATATCTCACGTACTGACGGTG  
R:  TCTCTGACCAGAGTCATCCTTAGC  
MyoG  Cre   F:  TGTGCAGCAACAGCTTAGAG  
R:  AGGCTAAGTGCCTTCTCTACAG  
Myf5+/-­‐‑;MyoD+/-­‐‑:HB9-­‐‑GFP   Phenotype  obvious;  genotyping  not  performed  
Myf5-­‐‑/-­‐‑;  MyoD-­‐‑/-­‐‑:HB9-­‐‑GFP   Phenotype  obvious;  genotyping  not  performed  
Chat     A   phosphoglycerate   kinase–neomycin   (pgk-­‐‑neo)-­‐‑
specific  oligonucleotide,  a  Chat  exon  13  oligonucleotide,  
and  a  shared  Chat  intronic  oligonucleotide  was  used  for  








2.5. Immunohistochemistry    
Mice  were  sacrificed  on  desired  post-­‐‑conception  day  (dpc).  Embryos  were  freed  from  
uterus  of  the  mother  and  eviscerated  in  ice  cold  PBS.  They  were  fixed  in  4%  PFA  with  
conditions  listed  below.  After  fixation,  embryos  were  washed  with  PBS  overnight  on  a  
shaker.   From   this   step,   embryos  were   either   processed   for   either   paraffin   or   frozen  
immunohistochemistry.  All  steps  were  carried  out  at  4  ˚C.  
Fixation  time  for  mouse  samples  from  different  developmental  stages  
Age     Time  (h)  for  limb  sample   Time  (h)  for  spinal  cord  sample  
E10.5   1   1  
E12.5-­‐‑13.5   2   2  
E14.5-­‐‑16.5   4   3  
E17.5-­‐‑18.5   12-­‐‑16   5  
  
2.5.1. Immunohistochemistry  -­‐‑  Paraffin  sections  
Hindlimb  samples  were  dehydrated  at  4˚C  every  4  h  through  ascending  ethanol  steps  
(30%,   50%,   70%,   80%,   90%,   100%),   then   subsequently   transferred   to   ethanol-­‐‑xylene  
solution   (1:1   ratio)   and   finally   to   xylene   at   room   temperature   (RT)   every   4   h.   For  
paraffin  infiltration,  dehydrated  tissues  were  incubated  first  with  xylene-­‐‑paraffin  (1:1  
ratio)   for  4  h  then  incubated  in  paraffin  three  times  for  1  h  each  time  at  60  ˚C  before  
routine  embedding.  Serial   sections  were  cut  on  a  Leica   rotary  microtome  at  8-­‐‑15  µμm  
thickness,   laid  across  a  42  ˚C  water  bath  to  remove  creases  and  samples  were  picked  
up  on  Superfrost  Plus  microscope   slides   (Thermo  Fischer  Scientific  GmbH).  Sections  
were   dried   at   37   ˚C   overnight   before   use   or   storage.   During   sectioning,   a   reference  
point   was   established   to   compare   similar   planes   of   distal   hindlimb   and   forelimb  
between  control  and  mutant  mice.  The  reference  point  was  defined  as  the  first  section  
containing   both   the   fibula   and   tibia,   or   ulnar   and   radial   bones.   For   all   experiments,  
only   sections   with   an   equal   distance   from   the   reference   point   were   compared.   For  




immunohistochemistry,  sections  were  deparaffinized  and  rehydrated  by  a  descending  
series   of   ethanol   (100%,   90%,   80%,   70%,   50%,   30%),   5   min   per   step.   Sections   were  
briefly   rinsed   with   PBS   for   5   min   and   were   placed   in   a   slide-­‐‑holding   chamber  
containing   antigen   retrieval   solution   diluted  with   double   distilled  water   (1:50).   The  
solution,  together  with  the  slides,  were  heated  using  a  lab  microwave  for  5  min  at  900  
W  until  boiling  point,  and   the  power  was   reduced   to  90  W  for   the  next  15  min.  The  
slides  were  left  to  cool  in  the  solution  for  a  minimum  of  20  min.  Thereafter,  they  were  
rinsed  with  PBS  3  times,  5  min  each  time  before  incubation  with  primary  antibodies.  
The   primary   antibodies   were   diluted   (in   their   respective   working   dilution)   in  
immunostaining   solution   containing   1%   Triton-­‐‑X   1%   BSA   in   PBS   and   500   µμl   of  
solution  was  used  per   slide.   Slides  were   then   incubated   at   4   ˚C   overnight   (12-­‐‑18  h).  
Afterwards,   they  were  washed  with  PBS   for  4   times,   5  min  each   time  at  RT   to   rinse  
away   unbound   primary   antibodies.   Secondary   antibodies   were   also   diluted   in  
immunostaining  solution  (1:1000)  and  500  µμl  of  solution  was  used  per  slide.  The  slides  
were  incubated  at  RT  for  1  h,  then  washed  again  with  PBS  for  4  times,  5  min  each  time  
to   get   rid   of   excess   secondary   antibodies,   and   rinsed   with   double   distilled   water  
briefly.   To   get   rid   of   autofluorescence   from   sections,   the   slides  were   then   incubated  
with  cupric  sulfate  solution  for  30  min  in  the  dark  at  RT.  The  slides  were  washed  once  
with  double  distilled  water  prior  to  mounting  and  visualization  under  a  microscope.    
  
2.5.2. Immunohistochemistry  -­‐‑  Frozen  sections  
Spinal   cord   samples  with  vertebrae   intact   or  whole   embryos  were   equilibrated  with  
30%  sucrose   in  PBS  at  4   ˚C  on  a  shaker.  The   tissues  were   then  processed   for   routine  
embedding   in   plastic   embedding   molds   containing   OCT   on   dry   ice.   OCT   blocks  
containing   samples   were   stored   at   -­‐‑20   ˚C   until   use.   Sections   of   20-­‐‑30   µμm   thickness  
were   cut   on   a   Leica   cryostat   (CM1900,   Leica   Microsystems   GmbH)   at   -­‐‑20   ˚C   and  
collected   on   Superfrost   Plus   microscope   slides   (Thermo   Fischer   Scientific   GmbH).  




Slides  were  subsequently  left  to  air  dry  at  RT  for  approximately  3  h  and  stored  at  -­‐‑20˚C  
thereafter   or   used   immediately.   For   immunostaining,   slides   were   rinsed   four   times  
with   PBS   for   15  min   each   time   to   remove   residual   OCT   and   to   rehydrate   samples.  
Slides  were  placed  in  a  humidified  chamber  prior  to  primary  antibody  incubation.  The  
primary   antibodies   were   diluted   (in   their   respective   working   dilution)   in  
immunostaining  solution  and  500  µμl  of  solution  was  applied  to  each  slide.  Slides  were  
then   incubated   at   4˚C   overnight   (12-­‐‑18  h).  Afterwards,   the   slides  were  washed  with  
PBS   for   4   times,   5  min   each   time   at   RT   to   rinse   away  unbound  primary   antibodies.  
Secondary   antibodies   were   also   diluted   in   immunostaining   solution   and   500   µμl   of  
solution   was   applied   to   each   slide.   The   slides   were   incubated   at   RT   for   1   h,   then  
washed   again  with   PBS   for   4   times,   5  min   each   time   to   get   rid   of   excess   secondary  
antibodies   and   finally   mounted   with   cover   slips   using   50%   glycerol   in   PBS   before  
visualization  under  a  microscope.    
For  whole  mount  analyses,  E18.5  hindlimb  samples  were  fixed  in  4%  PFA  solution  for  
12-­‐‑18  h,  whereas  E18.5  diaphragms  were   fixed   for  2  h.  The  samples  were  washed   in  
PBS   overnight,   bleached  with  Dent’s   solution   for   8   h,   then   rehydrated   overnight   by  
using  PBST.  Following  this,  samples  were  incubated  in  primary  antibody  solution  for  
3  days,  and  then  washed  with  PBST  overnight  before  secondary  antibody  incubation  
for  another  3  days.  Finally,  the  samples  were  washed  in  PBST  again  overnight  before  
dehydration   by   using   a   graded   series   of   methanol   solution   up   to   100%.   For   better  
visualization,  the  samples  were  cleared  with  BABB  solution  before  mounting  between  
cover  slips.  All  steps  were  carried  out  at  4  ˚C.  
  
  




2.6. Microarray  experiments  
2.6.1. Sample  processing  for  microarray  experiments  
Hindlimbs  of  embryonic  mice  (E15.5)  were  dissected  with  the  skin  and  feet  removed,  
and   subsequently   collected   individually   in   microcentrifuge   tubes   containing   1   ml  
TRIzol.   Tail   biopsies   were   also   simultaneously   obtained   in   separate   tubes   for  
genotyping   afterwards.   RNA   (ribonucleic   acid)   of   hindlimbs   was   extracted   as  
described   in   Section   2.14.13.,   measured   for   concentration   and   quality   control   using  
NanoDrop   (Perkin   Elmer),   before   storing   at   -­‐‑80   ˚C   until   use   for   RNA   amplification.  
Before   use,   RNA   was   left   to   thaw   on   ice   for   10   min   before   proceeding   with  
amplification   steps.   An   input   of   500   ng   of   total   RNA   was   used   per   sample   in  
synthesizing   labeled-­‐‑aRNA   (amplified   RNA)   from   Illumina   Total   Prep   RNA  
Amplification   Kit.   Amplification   of   RNA   was   done   according   to   manufacturer’s  
instructions   to  generate  biotin-­‐‑labeled  aRNA.  The  biotinylated-­‐‑aRNA  was  stored  at   -­‐‑
80   ˚C   until   further   use   in  microarray   hybridization   experiments.   A   total   of   1   µμg   of  
biotinylated  aRNA  per  sample  was  used  for  hybridization.    
  
2.6.2. Hybridization  
Illumina   MouseRef-­‐‑8   v2.0   expression   BeadChips   were   used   for   microarray  
experiments.  aRNA  samples  were  sent  to  Max  Planck  Institute  of  Molecular  Genetics  
(Berlin)   to   be   hybridized   on   above-­‐‑mentioned   BeadChips   as   part   of   a   collaboration.  
Microarray   hybridization,   imaging   and   data   analysis   were   performed   by   Dr.   Lars  
Wittler  and  Dr.  Phillip  Grote  at  the  Max-­‐‑Planck  Institute  of  Molecular  Genetics,  Berlin.  
The  output  was  an  expression  profile  data  (excel  sheet  format).  
  




2.6.3. Pathway  analysis  
The  processed  microarray  data   (Illumina   IDs,   along  with   the   respective   fold   change  
values)  were  uploaded  to  Ingenuity  Pathway  Analysis  Suite  (Ingenuity  Systems).  Data  
were   analyzed   with   the   default   settings   except   stringency   and   selection   of   filter  
parameters,  which  were   set  as   ‘high’  and   ‘experimentally  verified’,   respectively.  The  
data  were  analyzed  in  the  context  of  canonical  pathways,  molecular  and  physiological  
functions,   diseases   and   networks.   Later,   the   analyzed   data  were   exported   using   the  
export   function   and   was   modified   for   representation   using   Photoshop   CS5.  
Additionally,   the   data  were   also   analyzed   using   the   freeware  DAVID   (Database   for  
Annotation,   Visualization   and   Integrated   Discovery)   bioinformatics   resource.   The  
gene   list   (Illumina   IDs)   containing   selected   genes   with   fold-­‐‑change   of   p<0.05   were  
uploaded   to  DAVID  and  were   analyzed  using   the  default   settings   (Huang  da   et   al.,  
2009b;  Huang  da  et  al.,  2009a).  Further,  the  functional  annotation  tool  enabled  selected  
genes  to  be  mapped  to  KEGG  (Kyoto  Encyclopedia  of  Genes  and  Genomes)  pathways  
(Kanehisa  and  Goto,  2000).  For  Panther  gene  expression  analysis,  gene  lists  containing  
significantly   up-­‐‑   or   downregulated   genes  were   uploaded   to   the  workspace   and   the  
species  genome  (Mus  musculus)  was  selected.  The  data  were  analyzed  in  the  context  of  
molecular  and  biological  processes  (Mi  et  al.,  2010;  Mi  et  al.,  2012).    
  
2.7. RNA  sequencing  experiments  
2.7.1. Sample  processing  for  RNA-­‐‑seq  experiments  
Hindlimb   samples  of  E14.5   embryonic  mouse  hindlimbs  were   collected  as  described  
for  microarray  experiments   (Section  2.6)  and  were  sent   to  a   transcriptomic   facility  at  
the   Göttingen   Center   for   Molecular   Biosciences   Institute   (Göttingen,   Germany)   for  
RNA  isolation  and  further  processing  (RNA  sequencing,   imaging  and  data  analysis).  
The  concentrated  RNA  was  checked  for  quality  and  quantity  on  a  Pico-­‐‑chip  (Agilent  




RNA   6000)   using   the   Bioanalyzer   2000   (Agilent   Technologies).   RNA   sequencing  
output  was  an  expression  profile  data  (excel  sheet  format).  
  
2.7.2. Pathway  analysis  
Candidate   genes   were   selected   and   analyzed   with   criteria   and   tools   described   for  
microarray  pathway  analysis.      
  
2.8. Quantitative  reverse-­‐‑transcription  PCR  (qPCR)  
RNA   as   obtained   as   described   in   Section   2.14.13.   cDNA   (complementary  
deoxyribonucleic  acid)  was  reversely  transcribed  from  RNA  of  mouse  hindlimbs  using  
Roche   cDNA   synthesis   kit   according   to   manufacturer’s   instructions   (1   µμg   of   input  
RNA  was   used   per   sample).   Primer   design   for   genes   of   interest   was   performed   by  
obtaining  the  accession  number  of  the  gene  of  interest  (longest  transcript  variant  was  
chosen)   from   http://www.pubmed.com   and   inputting   its   accession   number   on   Roche  
website   for   real-­‐‑time   qPCR   assay   design   http://www.roche-­‐‑applied-­‐‑
science.com/sis/rtpcr/upl/ezhome.html.   Optimal   left   and   right   primers   with   sequence  
specific   for   gene   of   interest   was   obtained   along   with   a   compatible   Taqman   probe  
number.   qPCR   experiments   were   performed   on   a   Lightcycler   480   machine   (Roche  
Diagnostics  GmbH)  with  55  cycles  per  run,  and  with  an  in-­‐‑run  efficiency  factor.  Each  
reaction   was   perfomed   in   duplicate   and   normalized   to   levels   of   loading   controls  
Alpha-­‐‑tubulin   (TUBA3),   or   Hypoxanthine-­‐‑Guanin-­‐‑Phosphoribosyltransferase   (HPRT),  
which   tested   to   have   no   differential   expression   between   control   and   mutant   mice.  
Values  obtained  from  mutant  muscles  were  normalized  to  control  levels  (%).  
  
  




2.9. Electron  microscopy  experiments  
2.9.1. High  pressure  freezing  and  Freeze  substitution  
Complete  limbs  of  E15.5  embryos  were  fixed  in  2.5%  glutaraldehyde  in  PBS  for  3  h  on  
ice  and  briefly  washed  in  PBS.  Muscles  were  gently  teased  apart  and  frozen  in  200  µμm  
deep   aluminium   platelets   (Microscopy   Services,   Flintbek)   using   1-­‐‑hexadecane   as   a  
freezing  medium   using   a   BalTec   HPM   10.   Freeze   substitution   was   carried   out   in   a  
Leica  EM  AFS  at  -­‐‑90°C  for  24  h  in  0.1%  tannic  acid,  followed  by  2%  OsO4  for  22  h  (each  
w/v  in  dry  acetone)  with  slowly  increasing  temperature,  according  to  (Rostaing  et  al.,  
2006).  All  electron  microscopy  steps  were  performed  by  Dr.  Christoph  Wrede  as  part  
of  a  collaboration.    
  
2.9.2. Imaging  
50  nm  longitudinal  sections  were  cut  using  a  Leica  UC6  ultramicrotome.  Sections  were  
transferred  on  Formvar-­‐‑coated  copper  single  slot-­‐‑grids.  Grids  were  placed  for  45  min  
on  drops  of  4%  (w/v)  uranyl  acetate  (diluted  in  distilled  water),  followed  by  distilled  
water.  Air-­‐‑dried  grids  were   incubated  on  drops  of   lead  citrate   (Reynolds,  1963)   for  2  
min   in   a   CO2-­‐‑free   atmosphere,   and   rinsed   in   distilled   water.   Specimens   were  
examined   in   a  Zeiss   EM  902A,   equipped  with   a   1024   ×   1024  CCD  detector   (Proscan  
CCD  HSS  512/1024;  Proscan  Electronic  Systems,  Scheuring,  Germany).  
    
2.10. Pulse-­‐‑chase  experiments  
Click-­‐‑iT  EdU  Fluor  555  Imaging  Kit  was  obtained  from  Roche  diagnostics  GmbH  and  
EdU  was  dissolved  in  PBS  at  a  stock  concentration  of  10  mg/ml.  Pregnant  mice  were  
injected   with   EdU   intraperitoneally   at   a   concentration   of   50   mg   kg-­‐‑1   body   weight.  
Injection  was  performed  at  14.5  and  15.5  dpc  consecutively  to  cover  onset  of  secondary  




myogenesis.  Embryos  were  retrieved  at  E18.5  and  were  processed  in  the  same  way  as  
described   in   Section   2.5.1.   EdU   detection   was   done   according   to   manufacturer’s  
instructions.  Following  washing  steps,   immunohistochemistry  was  performed  on  the  
slides.  The  slides  were  then  counterstained  with  DAPI  before  mounting.  
  
2.11. Imaging  
Fluorescence   images   (transverse   sections   and   whole   mounts)   were   visualized   and  
taken  using  a  Leica  SP2  TCS/MP  confocal/two-­‐‑photon  microscope  (Leica  Microsystem  
GmBH)   with   488   nm,   543   nm   and   633   nm   laser   lines.   Pictures   were   taken   at  
resolutions   of   either   1024   x   1024   or   2048   x   2048   pixels.   The   images  were   processed  
using  Adobe  Photoshop  CS5.  
  
2.12. Quantification  
Adobe  Photoshop  CS5   or   Image   J  was   used   for   all   quantification   done.   For   all   data  
sets,   a  minimum  of   three   animals   from   each   genotype   (n=3)   per   stage  was   used   for  
quantification,  unless  otherwise  stated.    
For  muscle  mass  quantification,  five  planes  of   increasing  distance  (two  sections  were  
randomly  chosen  from  each  plane)  from  the  reference  point  were  selected  per  animal.  
An  outline  was  made  at  the  border  of  each  muscle  contained  within  the  sections  and  
the  pixels   occupied  by   the  muscles  were   summed  up.  Values  obtained   from  mutant  
mice  were  normalized  to  control  mice.  
For  cleaved  caspase-­‐‑3  quantification,  four  sections  equidistant  from  the  reference  point  
were   randomly   chosen   per   animal.   Only   cleaved   caspase-­‐‑3   positive   cells   that   were  
found  within  the  boundaries  of  muscles  were  counted  to  obtain  an  absolute  number  of  
cleaved  caspase  3+  cells.  




Muscle   fiber   density   and   cross-­‐‑sectional   area  was   quantified   by   randomly  placing   a  
box   of   defined   area   (60   x   60   pixels)   within   the   soleus   (S)   and   tibialis   anterior   (TA)  
muscle.  The  number  of  muscle   fibers   found  within   this  box  was  counted.  The  cross-­‐‑
sectional   area   (CSA)   of   these   muscle   fibers   was   also   quantified   by   outlining   the  
perimeter  of  each  individual  fiber  and  obtaining  the  pixels  contained  within  the  area.  
Values  obtained  from  mutant  mice  were  normalized  to  control  mice.  
For   counts   of   Pax7+,   EdU+   or   slow  MyHC+  myofibers   to   total   laminin+  myofibers   on  
transverse  TA  and  S  muscles  control  and  mutant  limbs,  three  sections  of  each  muscle  
equidistant  from  the  reference  point  were  selected  per  animal.  Counts  of  nine  sections  
were   averaged   for   three   individuals   of   each   genotype.   The   cell   counter   function   in  
Image  J  (http://rsb.info.nih.gov/ij)  was  used  to  obtain  the  proportion  of  Pax7+  cells:total  
laminin+  cells,  slow  MyHC+  fibers:total  laminin+  fibers  or  EdU+  cells:total  laminin+  cells  
on   E18.5   hindlimb   transverse   sections.   Images   for   quantification   were   taken   at   63x  
magnification.  
    
2.13. Statistical  analysis  
Prism   5.0   software   was   used   for   all   statistical   analysis   unless   otherwise   stated.  
Statistical   comparisons   between   control   and   mutant   mice   were   established   using   a  
two-­‐‑tailed   Student’s   t   test   with   unequal   variance,   where   applicable   and   unless  
otherwise   stated.   Data  were   represented   as   the  mean   ±   standard   error   of   the  mean  
(SEM).    
    
2.14. Molecular  biology  
The  following  methods  described  were  performed  according  to  ‘Molecular  cloning:  a  
laboratory  manual  (Sambrook  and  Russell,  2001)  unless  otherwise  stated.  
  




2.14.1. Polymerase  chain  reaction  
The  amplification  of  DNA  fragments  was  performed  using  either  Platinum  Taq  DNA  
Polymerase   High   Fidelity,   Phusion   High   Fidelity   DNA   Polymerase   or   Dream   Taq  
DNA   Polymerase   on   the   Mastercycler   epGradient   S   (Eppendorf   AG).   The   reaction  
mixture   and   the   PCR   conditions   used   were   set   up   according   to   the   manufacturer'ʹs  
protocols.  Amplified  DNA   fragments  were   detected   via   agarose   gel   electrophoresis.  
DNA   fragments   with   correct   band   length   with   reference   to   a   loading   ladder   were  
isolated  and  extracted  using  QIAquick  Gel  Extraction  Kit.  
  
2.14.2. DNA  restriction  enzyme  digestion  
DNA  digestion  (vectors  or  inserts)  was  performed  to  yield  3’  overhangs  or  blunt  ends  
according  to  appropriate  restriction  enzymes  used.  The  DNA  was  incubated  with  the  
enzymes  and   the   reaction  buffers  at  optimal   reaction   temperatures  as   recommended  
by   the  manufacturer   for   at   least   3  h,   16-­‐‑18  h   if  performing  double  digestion.  Double  
digestions   were   carried   out   with   reaction   buffers   that   will   enable  maximal   enzyme  
activity  for  both  endonucleases.    
    
2.14.3. Alkaline  phosphatase  treatment  
To   prevent   self-­‐‑ligation,   the   vector   DNA  was   dephosphorylated   by   adding   Shrimp  
Alkaline  Phosphatase   to   the   completed   restriction  digest  mixture  of   the  vector  DNA  
and  incubated  for  30  min  at  37°C.  
    
2.14.4. Agarose  gel  electrophoresis  
The  separation  of  DNA  fragments  was  performed  by  agarose  gel  electrophoresis  with  
1%   [w/v]   agarose   dissolved   in   TAE   buffer   by   heating,   followed   by   addition   of  




0.05  µμl/ml   of   ethidium   bromide   solution   and   transferring   into   a   gel   cast.   Combs   of  
suitable  sizes  were  placed  in  the  warm  agarose  solution,  depending  on  the  number  of  
wells  needed.  After  solidifying,  the  gel  was  immersed  into  a  gel  tank  containing  TAE  
buffer.  DNA  samples  were  mixed  with  5x  DNA  loading  dye  and  loaded  into  the  wells.  
An   electrical   current  was   applied   until   a   definite   separation   of   the   DNA   fragments  
was  achieved.    
    
2.14.5. DNA  purification  from  agarose  gels  
After   agarose   gel   electrophoresis,   gels   were   removed   from   the   gel   tanks   and   DNA  
bands  were  visualized  under  UV  light  illumination.  DNA  fragments  with  correct  band  
length  were  extracted  from  the  agarose  gel  and  later  purified  by  using  the  QIAquick  
Gel  Extraction  Kit.  
  
2.14.6. DNA  ligation  
Digested   vector   and   insert   DNA   concentration   were   determined   and   the   ligation  
mixture  of  DNA  fragments  was  prepared  with  a  molar  vector  to  insert  concentration  
ratio  of  1:9.  Thereafter,   the  reaction  mix  was   incubated  with  T4  DNA  Ligase  and  the  
provided  buffer  at  22°C  for  a  minimum  of  6  h  or  with  the  DNA  Ligation  Kit  (Takara  
Bio  Inc)  at  16°C  for  at  least  2  h.  For  PCR  products  with  low  concentrations,  the  TOPO  
TA  Cloning  Kit  (Life  Technologies  GmbH)  was  used  according  to  the  manufacturer’s  
instructions.    
    
2.14.7. Plasmid  preparation  
Bacterial   cells  were   grown   from   single   colonies   on   agar  plates   or   bacterial   stocks.  A  
toothpick  was  used  to  pick  a  single  colony  of  bacteria  and  was  then  cultured  in  5  ml  




LB  medium   containing   ampicillin   at   37   ˚C   overnight   with   180   rpm   shaking.   Small-­‐‑
scale  plasmid  isolation  was  performed  using  the  QIAprep  Spin  Miniprep  Kit  (Qiagen  
GmbH)  following  manufacturer’s   instructions.  Extracted  DNA  was  eluted  in  30  µμl  of  
elution   buffer.   Positive   clones   were   verified   via   restriction   digest   and   sequencing.  
Large-­‐‑scale  plasmid   isolation   (for   in   ovo   electroporation)  was  performed  by  growing  
100  µμl   of   E.coli   culture   from   glycerol   stock   in   200  ml   LB   medium   with   ampicillin  
overnight   at   37°C   with   180   rpm   shaking.   Plasmid   DNA   was   extracted   using   the  
QIAGEN   Plasmid   Maxi   Kit   according   to   the   instruction   manual   and   eluted   in   an  
appropriate  volume  of  buffer.  
    
2.14.8. DNA  and  RNA  concentration  measurements  
Concentration   and  quality   of   nuclei   acids  were  measured  using  Nanodrop  ND-­‐‑1000  
UV-­‐‑Vis   spectrophotometer   (Peqlab   Biotechnologies   GmbH)   based   on   UV   light  
absorption  of  nuclei  acids  at  specific  wavelengths.  
  
2.14.9. Sequencing  
DNA  sequencing  was  commercially  carried  out  by  Qiagen  genomic  services   (Qiagen  
GmbH).  DNA   samples  were   submitted   at   a   concentration   of   500  ng  per   reaction   for  
sequencing.  Only  plasmids  with  entirely  precise  sequences  were  selected  for  use.  
  
2.14.10. Preparation  of  chemically  competent  E.coli  
Chemically   competent   E.coli   cells   of   the   One   Shot   TOP10   strain   (Life   Technologies  
GmbH)   were   used   for   all   molecular   cloning   experiments.   The   preparation   was  
performed  according  to  Inoue  et  al.  (Inoue  et  al.,  1990)  and  stored  at  -­‐‑80°C  until  use.  
  





Chemically   competent  E.coli   cells  were   transformed   by   adding   100  µμl   of   the   soluble  
cell  suspension  to  a  maximum  amount  of  10  µμl  ligated  DNA  ligation  mixture.  The  cells  
were   incubated   30  min   on   ice,   heat   shocked   at   42°C   for   1  min   and   chilled   on   ice  
afterwards  again  for  1  min.  E.coli  were  grown  in  1  ml  of  antibiotic-­‐‑free  LB  medium  at  
37°C  for  1  h  on  a  shaking  (850  rpm)  heatblock  and  centrifuged  for  2  min  at  3000  rpm  
before  they  are  subsequently  plated  on  an  agar  plate  containing  ampicillin.  The  plates  
were  incubated  overnight  at  37°C  for  16-­‐‑18  h.  
  
2.14.12. Preservation  of  E.coli    
The  preservation  of   the  E.coli   clones  was  achieved  by  mixing  500  µμl  of   soluble  E.coli  
culture   with   500  µμl   100%   glycerol   in   a   microcentrifuge   tube,   vortexing   shortly   and  
storing  the  mixture  at  -­‐‑80°C  until  further  use.    
  
2.14.13. RNA  extraction  
Total   RNA  was   obtained   from  muscle   and   spinal   cord   samples   of   E13.5,   E15.5   and  
E18.5   mouse   embryos.   The   tissue   was   collected   in   a   microcentrifuge   tube   and  
homogenized  in  1  ml  TRIzol  reagent  per  100  mg  of  tissue  using  a  dounce  homogenizer  
followed   by   incubation   at   RT   for   5   min.   The   samples   were   incubated   with   0.2  ml  
chloroform  per  1  ml  TRIzol  for  3  min  and  centrifuged  for  15  min  at  4°C  at  12000  rpm.  
The  aqueous  phase  containing  the  RNA  was  carefully  removed  so  as  to  not  disturb  the  
interphase,   transferred   into   a   new   microcentrifuge   tube   and   incubated   with   0.5  ml  
isopropanol   per   1  ml   of   TRIzol   and   3  µμl   of   polyacrylamide   for   10  min   at   RT.   After  
centrifugation  for  15  min  at  4°C  at  12000  rpm,  the  supernatant  was  discarded  and  the  
RNA   pellet   was   washed   with   1  ml   cold   75%   DEPC-­‐‑ethanol.   The   samples   were  
centrifuged  again  for  5  min,  4°C  at  7500  rpm  and  subsequently  air-­‐‑dried  and  eluted  in  




DEPC-­‐‑H2O.   Incubation   of   the   eluted   pellet   at   50°C   for   10   min   was   occasionally  
performed  to  aid  in  dissolving  the  RNA  pellet.      
  
2.14.14. cDNA  synthesis    
The  cDNA  used  for  gene  amplification  and  in  situ  probe  generation  was  synthesized  
using   the   cDNA   synthesis   Kit   (Roche   Diagnostics   GmbH)   or   the   PrimeScript   First  
Strand  cDNA  Synthesis  Kit  (Takara  Bio  Inc).  
  
2.15. P2TK-­‐‑MLC-­‐‑V5-­‐‑MCS-­‐‑2A-­‐‑eGFP  plasmid  construction  
This   plasmid   was   designed   to   study   gain-­‐‑of-­‐‑function   of   candidate   genes   obtained  
from  microarray  data  specifically   in  muscles  of  chick  embryos,  when  combined  with  
Tol2  transposon-­‐‑based  constructs  which  will  facilitate  genomic  integration  upon  in  ovo  
somite   electroporation   (Kawakami   and   Shima,   1999;   Sato   et   al.,   2007;   Wang   et   al.,  
2011a).   This   plasmid   was   modified   from   the   original   vector   pT2K-­‐‑MLC-­‐‑EGFP-­‐‑F  
(described   in  Wang  et  al.,  2011),  a  kind  gift   from  D.  Duprez.  The  pT2K-­‐‑MLC-­‐‑EGFP-­‐‑F  
plasmid   contains   the   enhancer   and  promoter   region   of   the  mouse  myosin   light   chain  
1F/3F   locus.   The   promoter   and   enhancer   region   was   excised   from   the   pT2K-­‐‑MLC-­‐‑
EGFP-­‐‑F  vector  using  XhoI  and  NcoI   restriction  enzymes  and   inserted   into   the  p2TK-­‐‑
CMV-­‐‑2A-­‐‑eGFP   vector,   a   vector   that   was   constructed   in   the   lab,   replacing   the   CMV  
enhancer   that  was  used   to  drive  ubiquitous   expression  of   transgenes.  From   this,   the  
p2TK-­‐‑MLC-­‐‑2A-­‐‑eGFP   vector   was   generated.   To   create   insertion   sites   for   genes   of  
interest,   V5-­‐‑tag   and  multiple   cloning   site   (MCS)   sequences  with  NcoI   and   EcoRI   as  
restriction   sites   were   designed   as   long   oligonucleotide   primers   (5’CATGTTGGGT  
AAGCCTATCC   CTAACCCTCT   CCTCGGTCTC   GATTCTACGC   CATGGATGCA  
GGAATTCAA3’;  3’CATGTTGAAT  TCCTGCATCC  ATGGCGTAGA  ATCGAGACCG  
AGGAGAGGGT  TAGGGATAGG  CTTACCCAA5’).    




The  oligonucleotides  were  annealed  together  and  later  digested  with  NcoI  and  EcoRI.  
T4   Polynucleotide   Kinase   was   added   to   the   completely   digested   annealed  
oligonucleotides  and   incubated   for  1  h   to  allow  for   the  addition  of  phosphates   to  5’-­‐‑
hydroxyl   terminus   of   oligonucleotides   before   sticky-­‐‑ended   ligation   into   the   p2TK-­‐‑
MLC-­‐‑2A-­‐‑eGFP   vector,   to   yield   the   final   p2TK-­‐‑MLC-­‐‑V5-­‐‑MCS-­‐‑2A-­‐‑eGFP   vector.   In  
summary,  the  p2TK-­‐‑MLC-­‐‑V5-­‐‑MCS-­‐‑2A-­‐‑eGFP  vector  consists  of  six  essential  parts:  1)  the  
MLC1F/3F  enhancer  and  promoter  region  to  specifically  drive  transgene  expression  in  
muscle  cells,  2)  V5  epitope  tag  sequence  for  protein  detection,  3)  gene  insertion  sites,  4)  
followed  by  sequence  for  2A  peptide  bridge  which  is  5)  upstream  reporter  gene  eGFP  
(enhanced   green   fluorescent   protein)   and   6)   Tol2   sites   which   flanked   the   expression  
cassette  for  transposase-­‐‑mediated  stable  genomic  integration.  The  pCAGGS-­‐‑T2TP  was  
co-­‐‑electroporated   for   a   stable   genetic   integration   of   transgenes   in   the   transfected  
muscle  cells.  
  
2.16. In  ovo  electroporation  
In   ovo   electroporation   of   DNA   constructs   was   performed   between   Hamburger-­‐‑
Hamilton   (HH)   stages   15-­‐‑18   by   using   the   ECM   830   electroporation   system   (BTX  
Instrument   Division,   Harvard   Apparatus   Inc)   with   the   following   settings:   5   square  
wave  pulses   (interval   of   200  msec)   of   28  V   for   55  ms   in   the  LV   99ms/500  V  modus.  
Prior   to   electroporation,   a   small  puncture  was  made   into   the   eggshell   and  a   syringe  
was  inserted  into  the  egg  to  remove  5  ml  of  albumen.  Thereafter,  an  oval  window  was  
made   from   the   small   puncture   to   visualize   the   embryo.   The   egg   was   placed   on   a  
homemade  egg  holder.  Needles   for   injections  were  pulled   from  glass   capillaries  and  
were   filled   with   plasmid   mixed   with   fast   green   dye   (10%   of   plasmid   volume).   All  
plasmids   were   injected   at   final   concentrations   of   3.0   µμg/µμl   in   TE   buffer.   The  molar  
ratio   for   expression   vector   and   transposase   vector  was   2:1.   For   somite   injection,   the  
needle   was   pushed   through   somite   number   25-­‐‑30   and   the   p2TK-­‐‑MLC-­‐‑V5-­‐‑MCS-­‐‑2A-­‐‑




eGFP  and  pCAGGS-­‐‑T2TP  plasmids  were   injected   into   the   somite   coeloem  by  mouth  
pressure   whilst   slowly   retracting   the   needle.   In   order   to   genetically   ablate   motor  
neurons  in  the  chick  embryo,  neural  tube  electroporation  was  performed.  The  needle  
containing  PGKdtapa  vector  was   inserted  at   a   45˚   angle   into   the  neural   tube   lumen.  
Electroporation  was  done  immediately  after  injection  by  applying  150  µμl  of  Lebowitz-­‐‑
15  medium  onto  the  amniotic  sac,  and  then  placing  the  embryo  between  two  platinum  
electrodes   (for   somite   electroporation,   the   side   of   injected   somites   was   always  
positioned   next   to   the   cathode   electrode).   The   oval   window   was   sealed   with  
cellophane   tape   and   the   egg   returned   to   the   incubator   until   the   desired   stage   was  






3.1. Creating  aneural  muscles  by  genetic  ablation  of  motor  neurons  
To  address  the   impacts  of  denervation  on  embryonic  myogenesis,  genetic   tools  more  
powerful   than   manual   dissection   or   pharmalogical   agents   can   be   used   to   generate  
aneural   muscles.   Advancement   in   technology   has   allowed   for   the   generation   of  
transgenic   mouse   lines,   one   of   them   being   R26fxDTA,   that   are   used   for   specifically  
ablating  cells  of  any  lineage  (Ivanova  et  al.,  2005).  Diphtheria  toxin  (DT),  secreted  by  
Cornynebacterium  diphtheriae   is  made  up  of   two   subunits:  DTA,   and  DTB.  Target   cell  
death  is  brought  about  by  the  DTA  subunit  of  the  toxin.  This  subunit  is  responsible  for  
the   inactivation  of   elongation   factor   2,   resulting   in   the   cessation  of  protein   synthesis  
(Maxwell   et   al.,   1986;   Palmiter   et   al.,   1987;   Breitman   et   al.,   1990).   Using   a   Cre/loxP  




Figure  3.1:  Strategy  to  genetically  ablate  motor  neurons  in  mouse.    
(a)   To  generate  mice  with  premitotic  motor  neuron  ablation,  Olig2Cre  mouse   line  was   crossed  with   the  
R26fxDTA  mouse  line  to  generate  R26fxDTAxOlig2Cre  mice.  Cre-­‐‑mediated  excision  of  floxed  region  will  lead  to  
DTA   expression   in   motor   neuron   progenitors.   (b)   To   generate   a   mouse   line   with   postmitotic   motor  
neuron  ablation,  Olig2Cre  mouse  line  was  crossed  with  the  Isl2fxDTA  mouse  line  to  generate  Isl2fxDTAxOlig2Cre  
mice.  Cre-­‐‑mediated   recombination  will   result   in  postmitotic  motor  neuron  cell  death.  DTA,  diphtheria  





First,   a   mouse   line   engineered   to   drive   Cre-­‐‑mediated   recombination   in   Olig2-­‐‑
expressing  cells  was  bred  to  R26fxDTA  to  generate  R26fxDTAxOlig2Cre  mice.  Since  ROSA26  
is   a   ubiquitous   promoter   and   Olig2   is   expressed   specifically   in   motor   neuron  
progenitors,  Cre-­‐‑mediated  excision  of  a  “floxed”  genomic  region  flanked  by  two  loxP-­‐‑
sites   region  will   facilitate  DTA  expression  and  ablation  of  motor  neuron  progenitors  
(Figure   3.1   a).  Olig2   is   known   to  be   critical   in   the  generation  of   oligodendrocytes   at  
later   stages   of   development   (Nabeshima   et   al.,   1993).   To   address   if   possible  
phenotypes   are   associated  with   oligodendrocyte   ablation,   a   second  mouse   line   was  
generated  by  crossing  Olig2Cre  mice  with  Isl2fxDTA  mice  to  generate  Isl2fxDTAxOlig2Cre  mice  
(Figure  3.1  b).  Isl2  is  one  of  the  first  homeodomain  proteins  to  be  expressed  in  newly  
postmitotic   motor   neurons   (Jessell,   2000;   Dasen   and   Jessell,   2009).   Therefore,   in  
Isl2fxDTAxOlig2Cre   embryos,   Cre-­‐‑mediated   recombination   will   specifically   eliminate  
postmitotic  motor   neurons,  while   in  R26fxDTAxOlig2Cre  mice   generation   of   postmitotic  
motor  neurons  will  be  suppressed  from  the  outset  by  ablating  their  progenitors.  
  
  
Figure  3.2:  Motor  neuron  ablation  does  not  affect  somite  delamination.  
(a-­‐‑b)   E18.5   (b)   R26fxDTAxOlig2Cre   mutant   mice   devoid   of   motor   neurons   exhibit   normal   gross  
morphology,  perinatal  lethality  and  remained  in  fetal  position  as  compared  to  (a)  controls.  (c-­‐‑d)  Somite  
formation   and   further   delamination   is   unaffected   after   motor   neuron   ablation.   Muscle   precursors    
(Myf5+   and   Pax3+)   are   formed   in   both   (c)   control   and   (d)   mutant   mice.   E,   embryonic   day.   Myf5,  





Both   Isl2fxDTAxOlig2Cre   and   R26fxDTAxOlig2Cre   mice   exhibit   perinatal   lethality,   due   to  
respiratory   failure   caused   by   the   lack   of   innervation   of   the   diaphragm.   Phenotypic  
analysis   performed   revealed   no   abnormal   gross   morphology,   but   a   kyphosis-­‐‑like  
position   of   mutant   mice   compared   to   controls,   after   wholesale   removal   of   motor  
neurons   (Figure   3.2   a-­‐‑b).   At   the   same   time,   somite   formation   and   delamination   of  
myoblasts   was   unaffected   by   motor   neuron   ablation.   This   is   evidenced   by   the  
observation  that  Pax3+  and  Myf5+  muscle  precursors  were  formed  in  both  control  and  
mutant  mice  (Figure  3.2  c-­‐‑d).    
Postmitotic   motor   neurons   expressing   vesicular   acetylcholine   transferase-­‐‑positive  
(vAChT)   are   generated   already   by   embryonic   day   (E)   9.5   (earliest   time   point  
investigated)  in  the  ventral  part  of  the  spinal  cord,  and  can  be  observed  to  project  their  
axons   into   the   periphery   by   E10.5   (Figure   3.3   a).   At   the   same   time,   vAChT+   motor  
neurons   were   not   detected   in   the   spinal   cord   of   both   Isl2fxDTAxOlig2Cre   and  
R26fxDTAxOlig2Cre  mouse  lines,  indicating  that  they  were  either  not  generated  or  ablated  
soon  after  being  generated  (Figure  3.3  b-­‐‑c).  Accordingly,  motor  axon  projections  were  
absent  in  both  mutant  mice.  To  verify  that  other  cell  types  were  not  ablated,  I  stained  
transverse  spinal  cord  sections  of  E10.5  mice  with  Isl½,  another  generic  motor  neuron  
marker  which  also   labels   sensory  neurons   located   in   the  dorsal   root  ganglion   (DRG)  
(Figure   3.3   d-­‐‑f).   Nuclei   staining   located   in   ventral   part   of   the   spinal   cord   was  
completely  absent  from  R26fxDTAxOlig2Cre  mice  (Figure  3.3  e).  A  faint  staining  of  several  
cells  was  observed  seen  in  the  ventral  spinal  cord  of  Isl2fxDTAxOlig2Cre  mice  (Figure  3.3  
f).   These   were   hypothesized   to   be   newly   formed   postmitotic   motor   neurons   which  
have   yet   to   accumulate   a   threshold   level   of   Isl2   protein   to   be   sufficient   to   drive  
expression   of   the   DTA   allele   and   will   be   ablated   after   this   threshold   is   reached.  
Furthermore,   to   rule   out   that   the   absence   of   motor   neurons   observed   at   E10.5   was  







Figure  3.3:  Specificity  of  motor  neuron  ablation  in  mutant  mouse  lines.  
(a-­‐‑c)   At   E10.5,  motor   neurons  were   formed   in   (a)   control  mice   but  were   absent   from   the   VH   of   the  
spinal  cord  of  (b)  R26fxDTAxOlig2Cre  and  (c)  Isl2fxDTAxOlig2Cre  mice.  (b-­‐‑c)  Peripheral  motor  axon  projections  
were  also  absent  in  mutant  mice.  (d-­‐‑f)  Isl½+  staining  was  present  in  the  DRG  and  motor  neurons  of  (d)  
control  mice,  but  was  absent  from  the  VH  of  the  spinal  cord  of  (e)  R26fxDTAxOlig2Cre  mice.  (f)  Isl½  protein  
is   expressed   at   very   low   levels   in   a   few   cells   in   Isl2fxDTAxOlig2Cre      spinal   cord.   (g-­‐‑i)  At  E18.5,   vAChT+  
motor  neurons  located  in  the  VH  of  the  spinal  cord  of  (g)  control  mice  were  not  detected  in  the  spinal  
cord   of   (h)  R26fxDTAxOlig2Cre   and   (i)   Isl2fxDTAxOlig2Cre   mice.  However,   vAChT+   cholinergic   interneurons  
located   near   the   central   canal  were   still   present   in   the   spinal   cord   of   both  mutant  mouse   lines.   VH,  
ventral  horn;  DRG,  dorsal  root  ganglion,  MN,  motor  neurons.  vAChT,  cholinergic  neuron  marker;  Isl½,  
pan   motor   neuron   and   DRG   marker;   NeuN,   pan   neuronal   marker.   Arrows   indicate   cholinergic  
interneurons,  bold  lines  mark  midline  of  spinal  cords  and  dotted  lines  demarcate  border  of  spinal  cords  





iAt   E18.5,   both   Isl2fxDTAxOlig2Cre   and   R26fxDTAxOlig2Cre   exhibited   virtually   complete  
absence   of   motor   neurons   (large   NeuN+   and   vAChT+   cells)   while   cholinergic   V0c  
interneurons  adjacent  to  the  central  canal  remained  unaffected  (Figure  3.3  h-­‐‑i),  thereby  
demonstrating   the   specificity   of   the   two  mouse   lines   in   ablating  motor  neurons   and  
producing  embryos  with  aneural  skeletal  muscle.  
  
3.2. Analysis  aneural  skeletal  muscles    
3.2.1. Removal  of  motor  neurons  results  in  skeletal  muscle  hypoplasia  
It   has   long   been   assumed   that   muscles   depend   on  motor   neurons   for   their   normal  
development   (Hunt,   1932;   Shellswell,   1977;   Butler   et   al.,   1982;   McLennan,   1994).  
However,   the   exact   role   of   innervation   for   embryonic   myogenesis   remains  
controversial   (Butler   et   al.,   1982;   Ross   et   al.,   1987;  Condon   et   al.,   1990;   Fredette   and  
Landmesser,   1991a;   Hughes   and   Ontell,   1992;   Wilson   and   Harris,   1993),   while   the  
underlying   mechanisms   remain   elusive.   Many   uncertainties   seem   to   be   due   to  
technical   limitations   of   previous   studies   addressing   the   role   of   innervation   for  
embryonic  myogenesis,  which  exclusively  relied  on  classical  embryological  methods,  
such   as   manual   surgical   removal   of   neural   tube   segments.   To   sidestep   these  
limitations,   I   therefore   investigated   muscle   development   in   completely   aneural  
R26fxDTAxOlig2Cre   embryos.   I   have   analyzed   fore-­‐‑   and   hindlimb   transverse   sections   of  
mutant  mice  at   late-­‐‑embronic  stages   (E18.5)  and   found  a  drastic   reduction   in  muscle  
mass   (determined   by   staining   with   MF20,   a   pan   myofiber   marker)   in   both  
R26fxDTAxOlig2Cre   and   Isl2fxDTAxOlig2Cre   mouse   lines   (Figure   3.4   a-­‐‑f).   The   reduction   in  
muscle  mass  was  not  limited  to  only  the  limbs,  but  muscles  in  other  parts  of  the  body  
such  as   the  diaphragm  and   intercostal  muscles   (data  not   shown).  This   indicates   that  
the   lack   of   motor   neurons   resulted   in   systemic   skeletal   muscle   hypoplasia.  
Additionally,   some   groups   of   muscles   appeared   to   be   more   severely   affected  





while  muscles  like  tibialis  anterior  (TA),  extensor  digitorum  longus  (EDL)  and  soleus  
(S)   were   reduced,   other   muscle   groups   such   as   gastrocnemius   (Gm   and   Gl)   were  
almost  completely  abolished  (Figure  3.4  b-­‐‑c).    
  
Figure  3.4:  Removal  of  motor  neurons  results  in  general  skeletal  muscle  hypoplasia.  
(a-­‐‑c)   Transverse   distal   hindlimb   sections   of   E18.5   (a)   control,   (b)   R26fxDTAxOlig2Cre   and   (c)  
Isl2fxDTAxOlig2Cre  mice.  Muscle  mass  were  reduced  without  motor  innervation,  but  some  muscles     were  
more   affected   than   others.   Gm   and  Gl  muscles   disappeared   almost   completely,  while   other  muscles  
such   as   TA   and   S  muscles  were   significantly   reduced.   (d-­‐‑f)   Similarly,  muscles   of   the   distal   forelimb  
were   also   severely   affected   by   the   absence   of   motor   neurons.   (d)   E18.5   control   distal   forelimbs  
contained   many   groups   of   muscles   that   were   absent   in   the   forelimb   of   (e)   R26fxDTAxOlig2Cre   and   (f)  
Isl2fxDTAxOlig2Cre  mice.  E,  embryonic  day;  t,   tibia  bone;  f,   fibula  bone;  r;  radial  bone;  u,  ulnar  bone;  TA,  
tibialis  anterior;  EDL,  extensor  digitorum  longus;  P,  peroneus  muscle  group;  F,  fibula  muscle  group;  S,  
soleus;  Gm,  medial   gastrocnemius;  Gl,   lateral   gastrocnemius;  BR,   brachioradials;  ECR,   extensor   carpi  
radialis  brevis;  EDC,  extensor  digitorum  commusis;  EDL,  extensor  digitorum  longus;  FCR,  flexor  carpi  
radialis;  FCU,  flexor  carpi  ulnaris;  FDP,  flexor  digitorum  profundus  caput  fadiale;  PL,  pollicis   longus;  
PT,   pronator   teres.   Laminin,   basal   lamina   marker;   MF20,   pan  myosin   marker.   Dotted   lines   indicate  





To   determine   the   degree   of   skeletal   hypoplasia,   the   remaining   muscle   mass   was  
quantified   in   both   fore-­‐‑   and   hindlimb   sections   throughout   different   developmental  
stages   (Figure   3.5   a-­‐‑d).   Examination   of   R26fxDTAxOlig2Cre   and   Isl2fxDTAxOlig2Cre   mice  
revealed   that   the   onset   of   muscle   loss   begins   at   E14.5,   with   an   initial   reduction   of  
about  17%  and  12%  when  normalized  to  control  mice,  respectively  (Figure  3.5  a  and  c).  
Muscle  loss  became  more  pronounced  during  subsequent  stages  of  embryogenesis.  At  
E15.5,   muscle   mass   of   mutant   mice   was   reduced   by   43%.   At   E18.5,   which   was   the  
latest   stage   that   could   be   analyzed   due   to   the   perinatal   lethality   of   the   phenotype,  
muscle  mass  was  reduced  by  60%  (Figure  3.5  a).  
  
Both  R26fxDTAxOlig2Cre  and   Isl2fxDTAxOlig2Cre  mice  displayed  a  highly   similar  pattern  of  
muscle  loss  (Figure  3.5  a  and  c),  taking  into  account  that  motor  neurons  were  ablated  
at  different   time  points   in   these   two  mutant  mice.  This   suggests   that   the   severity   of  
muscle  loss  is  not  determined  by  whether  motor  neurons  were  ablated  at  progenitor-­‐‑  
  
Figure  3.5:  Quantification  of  muscle  loss  in  R26fxDTAxOlig2Cre  and  Isl2fxDTAxOlig2Cre  mice.  
(a)   In   the   hindlimb,  muscle   loss   starts   at   E14.5   and   progresses   gradually   until   E18.5,   the   end   stage   of  
R26fxDTAxOlig2Cre   and   Isl2fxDTAxOlig2Cre   mice.   (b)   Quantification   of   cross   sectional   area   for   muscles  
remaining   in   the   distal   forelimb   of  R26fxDTAxOlig2Cre  mice   at   E18.5   revealed   that  mutant  muscles  were  
reduced  by  about  48%.  (c-­‐‑d)  Quantification  of  (c)  hind-­‐‑  and  (d)  forelimb  muscles  in  Isl2fxDTAxOlig2Cre  mice  
showed  progressive  muscle   loss  with  a  similar  pattern  that  was  observed  in  R26fxDTAxOlig2Cre  mice.  The  
severity  of  muscle   loss   is  not  determined  by  whether  motor  neurons  were  ablated  at  progenitor-­‐‑  or   at  
postmitotic-­‐‑stage.  Data  are  presented  as  mean  ±  SEM  (two-­‐‑tailed  Student’s  t  test  with  unequal  variance,  





or  postmitotic-­‐‑stage,  but   rather  by   the   fact   that   they  were  eliminated  before  exerting  
their   influence   on   their   target   muscles   (as   can   be   seen   that   the   formation   and  
delamination  of  somites  was  not  prevented).  Accordingly,  muscle  mass  remaining  in  
the  hindlimb  of  Isl2fxDTAxOlig2Cre  mice  was  about  65%  at  E15.5  and  45%  at  E18.5  when  
normalized   to   age-­‐‑matched   controls   (Figure   3.5   c).   Forelimb   sections   were   only  
examined  at  E18.5  and  muscle  mass  remaining  was  52%  and  37%  for  R26fxDTAxOlig2Cre  
mice  and  Isl2fxDTAxOlig2Cre  mice,  respectively  (Figure  3.5  b  and  d).  Taken  together,  the  
formation  and/or  maintenance  of  muscle  requires  the  presence  of  the  nerve,  while  the  
observed  muscle  defects  are  specific  to  the  loss  of  motor  innervation,  rather  the  timing  
of  motor  neuron  ablation  or  the  later  ablation  of  oligodendrocytes  in  R26fxDTAxOlig2Cre  
mice.  
  
3.2.2. Abnormal  muscle  fiber  morphology  in  R26fxDTAxOlig2Cre  mice    
In   the  adult,  myotubes   in  denervated  and  paralyzed  muscles  have  been  described  to  
undergo   atrophy   induced   by   protein   breakdown   (Drachman,   1964;   Giacobini   et   al.,  
1973;   Hall,   1975;   Pittman   and   Oppenheim,   1979).   Contrastingly,   my   examination   of  
aneural   embryonic   muscle   fibers   in   R26fxDTAxOlig2Cre   mice   revealed   an   unexpected  
increase   in  muscle   fiber   cross   sectional   area   (CSA).  Muscle   fibers   from   two  muscles,  
tibialis   anterior   (TA;   an   extensor   muscle)   and   soleus   (S;   a   flexor   muscle)   were  
examined  at  E14.5  and  E18.5.  At  E14.5,   the  diameter  of  mutant  muscle   fibers   (Figure  
3.6  b  and  d)  appeared  slightly  larger  when  compared  to  control  muscle  fibers  (Figure  
3.6  a  and  c).  Mutant  muscle  fibers  from  both  muscles  showed  a  similar  phenotype  and  
seemed  to  be  affected  equally.  This  aberrance  was  further  investigated  at  E18.5,  where  
the   increase   in   CSA   of  mutant  muscle   fibers   became  more   evident   as  muscle   fibers  
appeared   “swollen”,   varied   in   size   and  were   irregularly   shaped   (Figure   3.6   e-­‐‑h).   In  





appearance  with  centralized  cell  nuclei   (Figure  3.6  f  and  h),   instead  of  the  peripheral  
localization  of  nuclei  in  mature  control  fibers  (Figure  3.6  e  and  g).    
  
Figure  3.6:  Muscle  fibers  undergo  hypertrophy  after  motor  neuron  ablation.    
(a-­‐‑d)  Transverse  section  of  E14.5  TA  muscle  fibers  from  (a)  control  and  (b)  R26fxDTAxOlig2Cre  mice  stained  
with   antibodies   specific   for   laminin,  MF20.  Nuclei  were   stained  with  DAPI.   (c-­‐‑d)  Transverse   section  of  
E14.5  control  and  mutant  fibers  within  S  muscle.  (e-­‐‑h)  Transverse  section  of  E18.5  TA  muscle  fibers  from  
(e)   control   and   (f)  R26fxDTAxOlig2Cre  mice.  Cross   section  of  E18.5   (g)   control   fibers   and   (h)  mutant   fibers  
within  S  muscle.  Mutant  fibers  displayed  an  evident  increase  in  fiber  diameter  and  have  central  nuclear  
localization.  (i,  k)  Size  distribution  of  E18.5  (i)  TA  and  (k)  S  muscle  fibers.  (j,  l)  Quantification  of  muscle  
fiber  cross  sectional  area  (CSA)  in  E18.5  (j)  TA  and  (l)  S  muscle.  (m-­‐‑n)  Fiber  density  quantification  within  
(m)  TA  and   (n)   S  muscle   at  E18.5.  Data   are  presented  as  mean  ±   SEM   (two-­‐‑tailed  Student’s   t   test  with  
unequal  variance,  min  n=3  per  genotype)  and  as  normalized  values  to  control.  ***,  p<0.001;  **,  p<0.01;  *,  





Morphometric   quantification   also   revealed   a   shift   in   the   size  distribution  of   atypical  
mutant  muscle  fibers  from  both  TA  and  S  muscle  towards  larger  diameters  (Figure  3.6  
i  and  k),  supporting  the  finding  that  the  average  muscle  fiber  CSA  in  mutant  mice  was  
increased  by  44%  and  29%   in   the  TA  and  S  muscle,   respectively   (Figure  3.6   j   and   l).  
Muscle   fiber   density,   the   measure   of   number   of   muscle   fibers   contained   within   a  
defined  area  was  also  significantly  reduced  by  38%  within  mutant  TA  muscle  (Figure  
3.6   m).   However,   no   significant   difference   in   fiber   density   was   detected   within   S  
muscle   of   mutant   mice   with   a   29%   reduction   (Figure   3.6   n).   These   qualitative   and  
quantitative   data   thus   show   that   both   myotube   size   and   density   are   profoundly  
affected  by  innervation.  
  
Figure  3.7:  Abnormal  myofiber  morphology  and  organization  in  aneural  mice.    
(a-­‐‑b)   E18.5   ventral   hindlimb   of   (a)   control   and   (b)   R26fxDTAxOlig2Cre  mice   stained  with  MF20.  Mutant  
hindlimbs   appeared   smaller   compared   to   controls.      (c-­‐‑d)   Insets   of   boxed   areas   show   representative  
higher   magnification   images   of   whole   mount   hindlimb   preparation   of   (c)   control   and   (d)  
R26fxDTAxOlig2Cre   mice.   The   presence   of   debris   from   fragmented   muscle   fibers,   suggests   ongoing  





To   further   characterize   possible  morphological   defects   caused   by   removal   of  motor  
neurons,  I  performed  whole  mount  immunostaining  to  visualize  skeletal  muscle  fibers  
in  hindlimbs  derived  from  control  and  R26fxDTAxOlig2Cre  mice.  Hindlimbs  from  mutant  
mice  were  noticeably  thinner  and  irregular  in  appearance  (Figure  3.7  b),  and  contained  
less  muscle  mass  compared  to  control  hindlimbs  (Figure  3.7  a).  A  higher  magnification  
view   revealed   that   aneural   muscle   fibers   were   sparse   and   coarser   in   appearance  
(Figure   3.7   d),   consistent  with   previous   results.   Furthermore,   compared   to   controls,  
MF20+   cell   debris   was   found   within   mutant   muscle   fibers,   suggesting   ongoing  
degeneration  of  muscle  fibers  (Figure  3.7  c-­‐‑d).  
  
3.2.3. Loss   of   motor   neurons   in   mutants   also   leads   to   enhanced   cell   death   in  
skeletal  muscles  
It   has   long   been   established   that   the  maintenance   of   skeletal  muscle   fibers   requires  
innervation  (McLennan,  1994).  Denervation  in  the  adult  leads  to  structural  and  cellular  
changes  in  the  integrity  of  a  muscle  fiber,  ultimately  leading  to  muscle  atrophy  mainly  
caused   by   ubiquitin-­‐‑mediated   proteolysis   via   the   proteasome   (Beehler   et   al.,   2006).  
Degeneration   has   also   been   documented   in   early   embryonic   denervation   studies  
(Fredette  and  Landmesser,  1991a;  Wilson  and  Harris,  1993).  Consistently,  muscle  mass  
reduction   and   degenerative   signs   were   observed   upon   motor   neuron   ablation   in  
R26fxDTAxOlig2Cre   and   Isl2fxDTAxOlig2Cre   mice   (Figure   3.5   and   3.7).   I   hypothesized   that  
increased  cell  death  of  muscle  fibers  or  myogenic  cells  could  contribute  to  the  muscle  
mass  reduction.  To  test  this  hypothesis,  muscle  sections  were  stained  with  an  antibody  
specifically   recognizing   cleaved   caspase   3.   Caspase   3   is   an   executioner   caspase  
implicated   in   the   apoptosis   and   activation   of   caspase   3   induces   a   cell   to   follow   a  
preprogrammed  pathway  of  self-­‐‑destruction.  A  significant  increase  in  cleaved  caspase  





(Figure  3.8  b  and  c),  when  compared  to  a  basal  level  of  apoptotic  cells  that  was  present  
within  control  muscle  fibers  (Figure  3.8  a).    
  
Figure  3.8:  Aneural  muscle  fibers  undergo  progressive  apoptosis.    
(a-­‐‑c)  High  magnification   view   of   co-­‐‑immunohistochemistry   on   E15.5   (a)   control,   (b)  R26fxDTAxOlig2Cre  
and   (c)   Isl2fxDTAxOlig2Cre   transverse   distal   hindlimb   sections.   Cleaved   caspase   3+   cells   were   elevated  
within  muscle  fibers  of  both  mutant  mice.  Arrowheads  point  to  apoptotic  cells.  Scale  bar:  20  µμm.  (d-­‐‑e)  
Quantification   of   cleaved   caspase   3+   cells   in   control,   (d)   R26fxDTAxOlig2Cre   and   (e)   Isl2fxDTAxOlig2Cre  
transverse   distal   hindlimb   muscle   masses   at   different   developmental   stages.   Data   are   presented   as  
mean  ±  SEM  (two-­‐‑tailed  Student’s  t   test  with  unequal  variance,  min  n=3  per  genotype,  per  stage).  ***,  





The   number   of   apoptotic   cells   within   muscle   fibers   throughout   different  
developmental   stages   was   quantified   in   R26fxDTAxOlig2Cre   and   Isl2fxDTAxOlig2Cre   mice  
(Figure   3.8   d   and   e).   E13.5   was   the   earliest   possible   time   point   that   could   be  
investigated   after   muscle   cleavage   completion.   In   control   embryos,   two   waves   of  
apoptosis   could   be   observed   at   E13.5   and   E15.5,  which   can   be   attributed   to   normal  
levels   of   developmental   apoptosis.   Throughout   all   developmental   stages   analyzed,  
R26fxDTAxOlig2Cre   embryos   exhibited   a   significantly   higher   number   of   apoptotic   cells  
compared  to  control  embryos.  Accordingly,  on  transverse  distal  hindlimb  sections  of  
R26fxDTAxOlig2Cre  mice,   apoptotic   cells  were   increased   by   about   2.45-­‐‑,   3.10-­‐‑,   2.36-­‐‑   and  
2.44-­‐‑fold  when  compared  to  control  mice  at  E13.5,  E14.5,  E15.5  and  E18.5,  respectively  
(Figure  3.8  d).  At  the  same  time,  in  Isl2fxDTAxOlig2Cre  mutant  and  control  mice  a  pattern  
of  ongoing  apoptosis  virtually  identical  to  R26fxDTAxOlig2Cre  mice  was  detected  (Figure  
3.8  e).  In  the  former,  apoptotic  cells  were  elevated  by  about  2.38-­‐‑,  2.78-­‐‑,  2.71-­‐‑  and  2.33-­‐‑
fold   when   compared   to   control   mice   at   E13.5,   E14.5,   E15.5   and   E18.5,   respectively  
(Figure   3.8   e).   Consistently,   terminal   deoxynucleotidyl   transferase   dUTP   nick   end  
labeling   (TUNEL)   assay,   a   standard   test   for   DNA   fragmentation   associated   with  
apoptotic  nuclei  was  also  performed.  The  number  of  TUNEL+  nuclei  was  also  found  to  
be  elevated  in  muscle  fibers  of  mutant  mice  (data  not  shown).  Thus,  it  can  be  deduced  
that   skeletal   muscle   hypoplasia   triggered   by   motor   neuron   ablation   involves  
apoptosis.  
  
3.2.4. Slow  myosin  pattern  is  relatively  preserved  in  aneural  muscles  
An   important   aspect   of  muscle   development   is   the   diversification   of  myofibers   into  
different   fiber   types   (Rubinstein   and   Kelly,   1978;   Gunning   and   Hardeman,   1991;  






Figure  3.9:  Slow  myosin  pattern  was  preserved  in  aneural  muscles  until  E18.5.  
(a-­‐‑d)  E15.5  transverse  distal  hindlimb  section  showing  (a,  c)  general  and  (b,  d)  slow  muscle  pattern  in  
(a-­‐‑b)  control  and  (c-­‐‑d)  R26fxDTAxOlig2Cre  mice  Scale  bar:  250  µμm.  (e-­‐‑h)  Higher  magnification  view  of  E15.5  
transverse   TA  muscle   stained   with   (e,   g)   desmin   and   (f,   h)   slow  myosin   antibody   showing   general  
muscle  loss  in  (g)  R26fxDTAxOlig2Cre  when  compared  to  (e)  control  mice.  The  distribution  of  slow  MyHC+  
fibers  within  mutant  TA  muscle  was  altered   in  mutants.  Bold   lines  demarcate  TA  muscle  and  dotted  
lines   indicate   border   of   hindlimb   Scale   bar:   100  µμm.   (i-­‐‑l)  Transverse  distal   hindlimb   section   showing  
E16.5  (i,  k)  general  and  (j,  l)  slow  muscle  pattern  in  (i-­‐‑j)  control  and  (k-­‐‑l)  R26fxDTAxOlig2Cre  mice.  Scale  bar:  
250  µμm.  (m-­‐‑p)  Transverse  distal  hindlimb  section  showing  E18.5  (m,  o)  general  and  (n,  p)  slow  muscle  
pattern  in  (m-­‐‑n)  control  and  (o-­‐‑p)  R26fxDTAxOlig2Cre  mice.  Slow  myosin  pattern  is  relatively  preserved  in  
(h)  mutants,  similar  to  (f)  control  mice  until  E18.5.  Desmin,  general  muscle  marker;  NOQ7.1.1.1A,  slow  





It  is  accepted  that  adult  slow  fibers  arise  from  primary  myotubes  which  express  slow  
myosin  (slow  MyHC+),  whereas  myotubes  generated  mostly  from  the  second  wave  of  
myogenesis   do   not   express   slow   MyHC   and   will   later   differentiate   into   adult   fast  
fibers   (Jansen  and  Fladby,  1990;  Lyons  et  al.,   1990).  To  examine   the   impact  of  motor  
neuron  ablation  on  primary  myotube  generation,  transverse  distal  hindlimbs  were  co-­‐‑
immunostained   with   antibodies   against   slow   MyHC   and   laminin.   At   all   stages  
examined   (E15.5-­‐‑E18.5),   an   overview   of   transverse   hindlimb   sections   revealed   a  
reduction   in   general  muscle  mass   (Figure   3.9   a-­‐‑p).   Despite   this,   slow  MyHC+   fibers  
(primary  myotubes)  were   found   in  muscles  of  R26fxDTAxOlig2Cre  mice,  confirming  that  
primary  myotubes  were  formed  aneurally.  Moreover,  the  distribution  of  slow  MyHC+  
fibers  appeared  preserved  within  R26fxDTAxOlig2Cre  muscles  throughout  embryogenesis  
(Figure  3.9  d,  h,  l  and  p).  This  is  also  evidenced  by  quantification  of  the  ratio  of  slow  
MyHC+  laminin+  muscle  fibers  to  all  laminin+  fibers  at  E18.5  (Figure  3.10  a  and  b).    
  
Figure  3.10:  Quantification  of  slow  MyHC+  fibers  in  R26fxDTAxOlig2Cre  mice.    
No  significant  differences  could  be  detected  in  proportion  of  slow  MyHC+  to  all  laminin+  muscle  fibers  
between  (a)  TA  and  (b)  S  muscles  of  control  and  mutant  mice.  Data  are  presented  as  mean  ±  SEM  (two-­‐‑






From   the   observation   that  muscle  mass   in  R26fxDTAxOlig2Cre  mice  was   lost   by   10%   at  
E14.5   (the   stage   prior   to   initiation   of   secondary  myogenesis),   it   can   be   inferred   that  
existing   primary   myotubes   undergo   degeneration   in   the   absence   of   innervation.  
Additionally,   although   slow   MyHC+   fiber   distribution   was   relatively   preserved   in  
hindlimb   muscles   of   aneural   R26fxDTAxOlig2Cre   embryos,   the   TA   muscle   was   an  
exception  where   slow  MyHC+   fiber   distribution  was   altered   (refer   to   figure   legend,  
Figure   3.9   f   and   h).   Staining   by   desmin,   a   pan   myofiber   marker,   revealed   general  
muscle  reduction   in  TA  but  did  not  detect  a  separation   in   the   two  regions  of   the  TA  
muscle   (Figure   3.9   e   and  g),   indicating   that   the   change  was   specific   to   slow  MyHC+  
distribution.   Taken   together,   the   relatively   preserved   slow   MyHC   pattern   in  
hindlimbs  suggests  that  myogenesis  in  the  absence  of  innervation  did  not  have  severe  
impacts   on   primary   fiber   specification   or   formation.   The   alteration   in   TA   muscle  
pattern  could  reflect  (1)  degeneration  of  myotubes  (primary  and  secondary),  and/or  (2)  
a   decreased   capability   of   aneural   R26fxDTAxOlig2Cre   muscle   progenitors   to   undergo  
secondary  myogenesis,  hence  resulting  in  fewer  slow  MyHC-­‐‑  secondary  myotubes.  
  
3.2.5. Both  primary   and   secondary  myogenesis   are   affected   by   removal   of  motor  
neurons  
Secondary   fibers,   generated   later,   are   known   to  make   up   the  main   bulk   of  muscles  
(Ashby  et  al.,  1993b)  and  are  proposed   to  be   independent  of   innervation  (Condon  et  
al.,   1990;   Fredette   and  Landmesser,   1991a).   To  determine   if   secondary  myotubes   are  
generated  in  the  absence  of  motor  neurons  and  the  impacts  of  motor  neuron  removal  
has   on   secondary   myogenesis,   assessment   of   the   proliferation   of   primary   and  
secondary  muscle   fibers  was  necessary.  However,   there   are   currently   no  markers   to  
clearly  distinguish  between  the  two  types  of  muscle  fibers,  although  it   is  known  that  
they  express  different  MyHC  isoforms  (Furst  et  al.,  1989;  Lyons  et  al.,  1990).  Presently,  





primary  slow  MyHC+  from  secondary  slow  MyHC-­‐‑  muscle  fibers.  To  achieve  this,  EdU  
(5-­‐‑ethynyl-­‐‑2'ʹ-­‐‑deoxyuridine)  labeling  which  is  a  novel  alternative  for  measuring  newly  
synthesized   DNA   synthesis   during   the   S-­‐‑phase   of   cell   cycle   was   performed.  
Intraperitoneal  injection  of  EdU  into  pregnant  mice  at  desired  post  conception  stages  
(to   cover   the  onset  of   secondary  myogenesis   in   embryos,  EdU   injection  was  done  at  
both  14.5  and  15.5  dpc)  will   lead  to  the  incorporation  of  EdU,  a  nucleoside  analog  to  
thymidine  into  DNA  of  embryos  during  active  DNA  synthesis  (Figure  3.11  a-­‐‑d).    
  
Figure  3.11:  Secondary  myogenesis  occurs  in  aneural  muscles.    
(a-­‐‑d)  Co-­‐‑immunohistochemistry  on  E18.5   transverse  distal  hindlimb  sections  of   (a,   c)  TA  and   (b,  d)  S  
muscle   from   (a-­‐‑b)   control   and   (c-­‐‑d)  R26fxDTAxOlig2Cre   mice.   Sections   were   obtained   from   embryos   of  
pregnant   mice   injected   with   EdU   at   E14.5   and   E15.5.   Nuclei   of   muscle   fibers   generated   during  
secondary  myogenesis  were  incorporated  with  EdU.  Secondary  muscle  fibers  were  detected  in  muscles  
of   both   control   and   mutant   mice.   Scale   bar:   20   µμm.   (e-­‐‑f)   Quantification   of   EdU+   nuclei   on   E18.5  
transverse   sections   of   (e)   TA   and   (f)   S   muscle.   Mutant   mice   displayed   an   increase   in   EdU+   cells  
compared   to   controls.   Data   are   presented   as   mean   ±   SEM   (one-­‐‑tailed   Student’s   t   test   with   unequal  





The  detection  of  EdU  is  based  on  a  copper  catalyzed  click  reaction  between  an  azide  
and  an  alkyne.  Secondary  myotube   formation   in  aneural  muscles  of  R26fxDTAxOlig2Cre  
mice   was   confirmed   by   the   presence   of   EdU+   muscle   fibers   with   central   nuclei  
(presumably   secondary  myotubes)   in  E18.5   transverse  TA  and  S  muscles   sections  of  
motor   neuron-­‐‑deficient   R26fxDTAxOlig2Cre   mice   (Figure   3.11   c-­‐‑d),   contrary   to   earlier  
reports  (McLennan,  1983b;  Ross  et  al.,  1987;  Wilson  and  Harris,  1993).  This  finding  is  
supported  by  the  fact  that  absolute  muscle  mass  in  R26fxDTAxOlig2Cre  mice  increases  as  
development  proceeds,  and  even  though  muscle  growth  is  stunted  when  compared  to  
control  mice;  this  increase  in  muscle  mass  could  only  be  attributed  to  the  addition  of  
newly  formed  secondary  fibers  to  the  muscle  bulk.  This  conclusion  applies  at  least  to  
earlier  stages,  before  the  emergence  of  satellite  cells  at  E16.5  that  could  potentially  be  
activated   to   differentiate   into   muscle   fibers   to   contribute   to   muscle   mass   too.  
Secondary  myotubes  were  also  affected  by  the  absence  of  motor  innervation;  relative  
reduction  of  muscle  mass  in  R26fxDTAxOlig2Cre  mice  even  after  primary  myogenesis  has  
ended   when   compared   to   controls   (Figure   3.5   a-­‐‑b)   strongly   suggests   immense  
degradation   of   secondary   fibers   that   were   formed,   and   likely   a   compromised  
production  of   secondary   fibers   to  be   the  underlying  cause  of  muscle  mass   reduction  
during  later  embryogenesis.    
To  determine   the   number   of   secondary  myotubes   present  within  muscles   of   control  
and   R26fxDTAxOlig2Cre   mice,   the   proportion   of   EdU+   nuclei   to   total   nuclei   within  
hindlimb  sections  of  control  and  R26fxDTAxOlig2Cre  mice  was  quantified.  I  observed  that  
the   number   of   EdU+   nuclei   was   significantly   increased   in   both   mutant   TA   and   S  
muscles  (Figure  3.11  e  and  f).  Taking  into  account  that  satellite  cells  were  also  labeled  
by   EdU   during   their   proliferation   phase   initiating   at   E16.5   and   were   therefore  
inevitably  included  in  the  quantification  of  secondary  myotubes  performed  at  E18.5,  I  
postulated   that   the   higher   number   of   EdU+   nuclei   could   either   (1)   indicate   a  
compensatory  increase  in  EdU-­‐‑labeled  satellite  cells  which  are  present  in  the  muscles  





to   accommodate   the   early   loss   of   muscle   mass   in   R26fxDTAxOlig2Cre  mice.   The   latter  
hypothesis   seems   unlikely   because   a   rescue   in   muscle   mass   was   not   observed  
throughout  development,  even  until  birth.  
  
3.2.6. R26fxDTAxOlig2Cre   mice   display   a   compensatory   increase   in   satellite   cell  
numbers    
Muscle   satellite   cells   are   stem   cells   that   are   responsible   for  postnatal  muscle  growth  
and   regeneration   (Kassar-­‐‑Duchossoy   et   al.,   2005;   Sambasivan   and   Tajbakhsh,   2007;  
Lepper  et  al.,  2011;  Murphy  et  al.,  2011).  They  can  first  be  detected  by  E16.5  in  the  fetal  
muscles   (Kassar-­‐‑Duchossoy   et   al.,   2005;   Lepper   et   al.,   2011).   Since   an   increase   in  
apoptotic   muscle   cells   and   an   elevated   number   of   EdU+   nuclei   was   observed   in  
R26fxDTAxOlig2Cre  mice,  it  was  important  to  explore  if  there  is  some  compensatory  effect  
mediated  by   satellite   cells   after  motor  neuron   removal.   To   test   this,   I   performed   co-­‐‑
immunohistochemistry  on   transverse  distal  hindlimb   sections  of   control   and  mutant  
mice   by   using   Pax7,   a   known   satellite   cell   marker   and   laminin,   a   basal   lamina  
antibody.   In   agreement   with   results   obtained   from   Figure   3.6,   laminin  
immunostaining   revealed   large-­‐‑diameter,   irregularly   sized   mutant   muscle   fibers  
(Figure   3.12   b   and   f).  Moreover,   while   Pax7+   satellite   cells   were   encased  within   the  
basal  lamina  and  sarcolemma  of  muscle  fibers  in  control  mice  (Figure  3.12  c  and  e),  a  
large  proportion  of  satellite  cells  detected  on  mutant  sections  developed  cytoplasmic-­‐‑
like  processes   that  wrap  around   the  perimeter  of   single  muscle   fibers   (Figure   3.12  d  
and   f).   This   possibly   reflects   their   activation   and   hence   their   differentiation   into  
muscle   fibers  by  using   existing  muscle   fibers   as   scaffolds.  To  determine   satellite   cell  
numbers,   the  proportion  of  Pax7+   cell   number   to   total   laminin+  muscle   fiber  number  
was  quantified.  At  E18.5,   satellite   cells  were   significantly   elevated   in  both  TA  and  S  
R26fxDTAxOlig2Cre  muscle   (Figure  3.12  g  and  h).  Hence,   the   lack  of   innervation  did  not  





supposedly  as  a  compensatory  response  towards  the  loss  of  muscle  mass  induced  by  
the  absence  of  motor  neurons.    
  
Figure  3.12:  Compensatory  increase  in  satellite  cell  numbers.  
(a-­‐‑f)  Transverse  distal  hindlimb  sections  of  E18.5  (a,  c)  control  and  (b,  d)  R26fxDTAxOlig2Cre  mice  were  co-­‐‑
immunostained   with   (a-­‐‑b)   laminin   and   (c-­‐‑d)   Pax7,   a   muscle   satellite   cell   marker.   Merged   co-­‐‑
immunostained   images   of   (e)   control   (f)   and   R26fxDTAxOlig2Cre   mice.   Scale   bar:   20   µμm.   (g-­‐‑h)  
Quantification  of  satellite  cell:total  laminin+  cells  on  E18.5  transverse  sections  of  (g)  TA  and  (h)  S  muscle.  
Satellite  cells  were  increased  as  a  compensatory  response  to  motor  neuron  removal.  Data  are  presented  
as  mean  ±  SEM  (two-­‐‑tailed  Student’s   t   test  with  unequal  variance,  n=3  per  genotype).   ***,  p<0.001;   **,  





To  conclude,  contrary  to  hypotheses  generated  by  earlier  studies  which  proposed  that  
only  primary  or  secondary  myotube   formation  are  dependent  on   innervation   (Butler  
et   al.,   1982;   McLennan,   1983b;   Ross   et   al.,   1987;   Fredette   and   Landmesser,   1991a;  
Hughes  and  Ontell,  1992;  Wilson  and  Harris,  1993),  I  have  shown  that  the  formation  of  
both   primary   and   secondary   myotubes   occurs   aneurally   in   R26fxDTAxOlig2Cre   mice.  
Additionally,  their  continued  survival  depends  on  the  presence  of  innervation.  
  
3.2.7. Motor  innervation  is  required  for  myofiber  terminal  differentiation  
The  sarcomere,  being  mainly  composed  of  myosin  and  actin   filaments,  underlies   the  
contractile   properties   of   striated   muscle   fibers.   I   could   show   that   primary   and  
secondary   muscle   fibers   formed   nonetheless   in   embryonic   muscles   devoid   of  
innervation  prior  to  undergoing  apoptosis  (Figure  3.10  and  Figure  3.11).  Based  on  this,  
I   investigated   the   fiber  properties  of   existing   fibers   that  have  not  yet  degenerated   in  
R26fxDTAxOlig2Cre   mice.   Sarcomere   markers   (desmin   labeling   Z-­‐‑band,   MF20   labeling  
general  myosin)  were  used  to  identify  sarcomeres  in  E18.5  longitudinal  muscle  fibers.  
In  control  muscle  fibers,  sarcomeres  accounting  for  the  striated  appearance  to  muscle  
fibers   were   prominent   (Figure   3.13   a).   Notably,   this   pattern   of   myosin   filament  
intercalating   between   desmin+   Z-­‐‑bands   was   almost   completely   abolished   in  mutant  
muscle  fibers  (Figure  3.13  b).    
The  absence  of  sarcomeres  in  aneurally  generated  myofibers  could  result  from  either  
(1)   the   failure   to  maintain  myofiber   integrity,  hence   leading  to   loss  of  sarcomeres,  or  
(2)  block  in  myofiber  terminal  differentiation  and  thus,  failure  to  form  sarcomeres.  To  
test   these   possibilities,   analysis   of   sarcomeric   structures   using   electron   transmission  
microscopy  was  performed   in  E15.5  embryonic   limb  muscles.  This   stage  was  chosen  
for   analysis   because   it   marks   the   beginning   of   secondary   myogenesis   when   many  







Figure  3.13:  The  motor  nerve  is  required  for  the  terminal  differentiation  of  myotubes.  
(a-­‐‑b)   E18.5   (a)   control   and   (b)   mutant   longitudinal   muscle   fibers.   Sarcomere   pattern   was   almost  
completely  abolished  in  R26fxDTAxOlig2Cre  fibers  stained  with  desmin  and  MF20.  Scale  bar:  20  µμm.  (c-­‐‑d)  
Electron  micrograph  of  E15.5  (c)  control  and  (d)  mutant  muscle  fibers.  Besides  myobrils  being  fewer  in  
numbers,  Z-­‐‑bands  and  M-­‐‑line  were  absent  from  the  sarcomere  of  a  single  mutant  fiber.  Scale  bar:  200  
nm.  (e)  Known  genes  associated  with  the  sarcomere.  Highlighted  in  bold  are  downregulated  genes  in  






Table  3.1:  List  of  sarcomere-­‐‑associated  genes  in  control  and  R26fxDTAxOlig2Cre  mice.    
Relative  units  of  gene  expression  are  shown  under  ‘control’  and  ‘mutant’  field.  Data  under  ‘control’  and  
‘mutant’  field  are  presented  as  mean  relative  units  of  gene  expression.  (One-­‐‑tailed  Student’s  t  test  with  





Electron   transmission   microscopy   revealed   that   in   contrast   to   control   muscles  
myofibrils   were   fewer   in   numbers,   while   Z-­‐‑bands   and   M-­‐‑line   were   absent   in  
R26fxDTAxOlig2Cre  mutants  when   compared   to   controls   (Figure   3.13   c-­‐‑d).   These   results  
strongly   suggest   that   motor   innervation   is   critical   for   promoting   the   terminal  
differentiation   of   muscle   fibers,   including   the   formation   of   sarcomeres,   an   essential  
step  for  enabling  muscle  fibers  to  become  functionally  contractile.    
Consistent  with   these   results,  microarray   and  RNAseq   analysis   (decribed   in   Section  
3.4)  showed  that  the  regulation  of  sarcomere-­‐‑associated  gene  expression  was  severely  
affected   by   the   lack   of   motor   innervation   (Figure   3.13   e   shows   a   list   of   sarcomere-­‐‑
associated  genes   allocated   to  different   components  of   the   sarcomere,  whereby  genes  
shown   in   bold   are  differentially  downregulated   in  muscles   of   E15.5  R26fxDTAxOlig2Cre  
mice).   A   large   number   of   genes   encoding   proteins   that   are   localized   to   distinct  
components   of   the   sarcomere,   particularly   the   Z-­‐‑band,   A-­‐‑band,   M-­‐‑line   and   I-­‐‑band  
were  downregulated,  indicating  that  the  initiation  of  expression  of  these  components  
is  strictly  dependent  on  motor  innervation  (see  Table  3.1).  
  
3.3. Strategy  to  block  neurotransmission  genetically  
3.3.1. Using   tetanus   toxin   light   chain   to   eliminate   neurotransmission   in   motor  
neurons  
My   results   thus   far   show   that   mouse   embryos   in   which   motor   neurons   have   been  
genetically  removed  show  strongly  reduced  primary  and  secondary  myogenesis  and  
progressive   loss   of  muscle  mass   due   to  myofiber   loss.  However,   there   are   different  
aspects  to  which  motor  innervation  can  exert  its  influence  on  muscles;  effects  observed  
with   these   mice   did   not   preclude   influences   from   neural   activity,   nerve-­‐‑derived  
neurotrophins,  and  nerve-­‐‑contact.  To  specifically  study  the  impacts  of  neural  activity  





mice   to   generate  R26fxTeNTxOlig2Cre  mice  with   conditional   neurotransmission   block   in  
motor  neurons  (Figure  3.14  a).    
  
Tetanus  light  chain  (TeNT)  is  a  component  of  the  tetanus  toxin  (TeTx)  molecule  which  
is  derived   from  bacterium  Clostridium  tetani.  TeNT  cleaves  synaptobrevin,  a  synaptic  
protein   present   on   neurotransmitter-­‐‑containing   vesicles,   thus   hindering   the  
  
Figure  3.14:  Strategy  to  conditionally  block  neurotransmission  in  murine  motor  neurons.  
(a)  Scheme  to  generate  mice  with  blocked  motor  neurotransmission.  Action  potential-­‐‑dependent  vesicle  
release   was   prevented   by   crossing   the  Olig2Cre  mouse   line   with   the  R26fxTeNT  mouse   line   to   generate  
R26fxTeNTxOlig2Cre  mice.   (b-­‐‑c)   Gross   morphology   of   E18.5   (b)   control   and   (c)   mutant   mice.   Mutants  
displayed   flaccid   paralysis,   remained   in   their   fetal   position   and   die   perinatally.   (d-­‐‑g)   No   overt  
difference   in   vAChT+   motor   neurons   at   E10.5   was   found   between   (d)   control   and   (e)   mutant   mice.  
Axonal   projections  were   normal   for   both   controls   and  mutants.   Fused  GFP-­‐‑TeNT  protein   expression  
was   absent   in   the   spinal   cord   of   (e)   control  mice   but  was   present   in  motor   neuron   progenitors   and  
postmitotic  motor  neurons  of   (f)  mutant  mice.  TeNT,   tetanus   toxin   light   chain;   eGFP,   enhanced  GFP.  





association  of  vesicular  SNARES  with  membrane  SNARES  and  preventing  membrane  
fusion   as   a   consequence.   Hence,   Cre-­‐‑mediated   recombination   will   drive   TeNT  
expression   in   motor   neurons,   thereby   preventing   exocytosis.   To   date,   all   studies  
attempting   to   block   neurotransmission   to   create   paralyzed   muscles   utilized  
pharmacological   applications   of   paralyzing   agents   (Drachman,   1964;   McLennan,  
1983b;  Ross  et  al.,   1987;  Fredette  and  Landmesser,  1991a).  Similar   to  R26fxDTAxOlig2Cre  
and   Isl2fxDTAxOlig2Cre  mice,  mutant  mice  die  perinatally,  because  of  respiratory   failure  
caused   by   the   lack   of   innervation   to   the   diaphragm.   Additionally,   R26fxTeNTxOlig2Cre  
mutant   mice   show   overall   normal   gross   morphology,   but   exhibit   flaccid   paralysis  
accompanied   by   kyphosis-­‐‑like   posture   compared   to   controls   (Figure   3.14   b-­‐‑c).   To  
validate   the   specificity   of   TeNT   expression,   transverse   spinal   cord   sections   of   E10.5  
mice  were  analyzed.  R26fxTeNTxOlig2Cre  mice,  but  not  control  mice,  showed  expression  of  
fused   green   fluorescent   protein   (GFP)   and   TeNT   protein   in   the   postmitotic   motor  
neurons   as  well   as  motor  neuron  progenitors.  R26fxTeNTxOlig2Cre  mice   also   showed  no  
overt   morphological   differences   to   control   mice   (Figure   3.14   f-­‐‑g).   vAChT+   motor  
neurons   were   present   in   the   ventral   horn   of   the   spinal   cord   and   they   extend   their  
motor  axons  into  the  periphery  normally  (Figure  3.14  d-­‐‑e).    
  
3.3.2. TeNT  protein  is  temporally  expressed  in  mutant  motor  neurons  throughout  
development  
The   robust   expression   of   fused   GFP-­‐‑TeNT   protein   detected   in   E10.5   mutant   spinal  
cord  prompted  me  to  confirm  the  stable  expression  of  TeNT  protein  in  motor  neurons  
throughout   the   stages   that   would   be   investigated   for   further   muscle   analysis.  
Transverse  lumbar  spinal  cord  sections  of  E12.5  embryos  did  not  reveal  any  difference  
in  vAChT+  (Figure  3.15  a-­‐‑b)  and  Isl½+  motor  neuron  numbers  (Figure  3.15  c-­‐‑d)  between  





distinguishable   from  control  spinal  cord  by   the  presence  of   fused  GFP-­‐‑TeNT  protein  
(Figure  3.15  e-­‐‑f).    
  
At   E18.5,   vAChT+   lumbar   motor   neurons   of   both   control   (Figure   3.15   g)   and  
R26fxTeNTxOlig2Cre   mice   (Figure   3.15   h)   appeared   to   be   segregated   normally   into  
respective  motor   columns.   Strikingly,   the  numbers   of   Isl½+   nuclei  within   the  ventral  
part  of  the  spinal  cord  were  elevated  in  the  mutants  (Figure  3.15  j)  when  compared  to  
  
Figure  3.15:  TeNT  expression  is  specific  to  motor  neurons.    
(a-­‐‑d)  No  overt  difference  could  be  detected  on  E12.5  transverse  lumbar  spinal  cord  of  (a,  c)  control  and  
(b,  d)  R26fxTeNTxOlig2Cre  stained  with  (a-­‐‑b)  vAChT  and  (c-­‐‑d)  Isl½.  (e-­‐‑f)  Fused  GFP-­‐‑TeNT  protein  was  not  
detected  within  E12.5   spinal   cord  of   (e)   control  mice,  but  was  present   in   (f)  mutant   spinal   cord.   (g-­‐‑j)    
Immunostaining  of  (g-­‐‑h)  vAChT  and  (i-­‐‑j)  Isl½  on  E18.5  transverse  lumbar  spinal  cord  sections  revealed  
an   increase  of  motor  neuron  numbers   in   (h,   j)  mutant  mice  as  compared   to   (g,   i)  controls.   (k-­‐‑l)  TeNT  
expression  is  consistently  absent  from  the  spinal  cord  of  E18.5  (k)  controls,  but  was  strictly   limited  to  
motor  neurons  of   (l)  mutant  mice.  Dotted   lines   indicate  midline  of   spinal   cord,   bold   lines  demarcate  





controls   (Figure   3.15   i   and   see   further   below).     Most   importantly,   fused   GFP-­‐‑TeNT  
protein   was   expressed   stably   in   and   was   limited   to   E18.5   mutant   motor   neurons  
(Figure   3.15   l).   Conversely,   fused   GFP-­‐‑TeNT   protein   expression   was   undetected   in  
age-­‐‑matched   control   spinal   cord   (Figure   3.15   k).   For   all   stages   analyzed,   TeNT  
expression  was  detected  in  R26fxTeNTxOlig2Cre  embryos  but  not  in  controls.  
  
3.3.3. Perturbing   vesicular   release   in   motor   neurons   results   in   skeletal   muscle  
hypoplasia  
After   verifying   that   TeNT   is   expressed   at   all   embryonic   developmental   stages,  
morphometric  analysis  of  muscles  was  performed  on   transverse  distal  hindlimb  and  
forelimb   sections   of   control   and   mutant   mice   (Figure   3.16   a-­‐‑d).   At   E18.5,   muscle  
groups   were   found   to   be   drastically   reduced   or   absent   in   the   hindlimbs   of  
R26fxTeNTxOlig2Cre   mice   (Figure   3.16   b),   when   compared   to   controls   (Figure   3.16   a).  
Interestingly,  despite  the  reduction  in  muscle  mass,  cleavage  of  muscle  groups  such  as  
the   peroneal   muscle   was   normal   in   R26fxTeNTxOlig2Cre   mice   with   blocked  
neurotransmission,   whereas   peroneal   muscle   cleavage   was   defective   in  
R26fxDTAxOlig2Cre   mice   lacking   motor   neurons.   For   yet   unknown   reasons,   forelimbs  
were  consistently  less  affected  compared  to  hindlimbs  in  R26fxTeNTxOlig2Cre  mice  (Figure  
3.16  c-­‐‑d).  Muscle  mass  remaining  in  distal  hindlimb  at  various  developmental  stages  
was   quantified   to   determine   the   onset   of   muscle   loss   in   R26fxTeNTxOlig2Cre  mice.   No  
significant   difference   between   muscle   masses   of   control   and   mutant   mice   could   be  
detected   at   E14.5   and   E15.5   (Figure   3.16   e),   a   stark   contrast   to  mice  with  wholesale  
motor  neuron  removal  (see  previous  sections).  Reduction  of  muscle  mass  thus  seemed  
to   occur   between   E15.5   and   E18.5,   suggesting   a   link   to   the   coinciding   normal   time  







Apoptosis  was   assumed   to   be   responsible   for   the   loss   of  muscle  mass   in  mice  with  
perturbed   neurotransmission   as   more   apoptotic   cells   were   detected   within   muscle  
fibers   of   mutant   mice   than   controls   (Figure   3.17   a-­‐‑b)   at   E15.5.   To   confirm   this,   the  
number   of   apoptotic   cells   within  muscle   fibers   throughout   different   developmental  
stages   was   quantified   (Figure   3.17   c).   Later   in   development,   analysis   on   E18.5  
  
Figure  3.16:  Blocked  neurotransmission  leads  to  reduced  muscle  mass.  
(a-­‐‑d)   Transverse   E18.5   distal   (a-­‐‑b)   hindlimb   and   (c-­‐‑d)   forelimb   of   (a,   c)   control   and   (b,   d)  
R26fxTeNTxOlig2Cre   embryos.   In   the   hindlimb,   muscle   mass   in   mutants   was   reduced   in   some   muscle  
groups,  whereas  other  muscles  such  as  Gm  and  Gl  were  completely  abolished.  All  scale  bars:  250  µμm.  
(e)   Quantification   of   cross   sectional   area   of   hindlimb   muscle   mass   in   control   and   mutant   mice   at  
different  developmental   stages.  No  significant   reduction   in  muscle  mass  was  detected  at   early   stages  
(E13.5-­‐‑E15.5)   whereas   at   E18.5,   muscle   mass   remaining   in   mutant   mice   was   63.22±6.33%   of   control  
muscle  mass.  Data  are  presented  as  mean  ±  SEM  (two-­‐‑tailed  Student’s  t  test  with  unequal  variance,  min  





transverse  sections  showed  that  cleaved  caspase  3+  cells  were  appreciably  elevated  in  
mutants   by   1.65-­‐‑fold.   Thus,   blocking   neurotransmission   or   completely   eliminating  
motor  neurons  both  appear  to  lead  to  apoptosis-­‐‑mediated  muscle  cell  death.    
  
3.3.4. Slow  myosin  expressing  myofibers  are  generated  in  paralyzed  muscles  
To   examine   the   impact   of   neurotransmission   blockade   on   primary   myotube  
generation,   transverse   sections   of   distal   hindlimbs   were   co-­‐‑immunostained   with  
antibodies   against   slow   myosin   (MyHC)   and   laminin.   Like   R26fxDTAxOlig2Cre   mice,  
myofibers  expressing  slow  MyHC  isoforms  were  generated  within  paralyzed  muscles  
of  R26fxTeNTxOlig2Cre  mice  throughout  embryogenesis  until  E18.5.    
  
Figure  3.17:  Apoptosis  mediates  reduced  muscle  mass  in  R26fxTeNTxOlig2Cre  mice.  
(a-­‐‑b)  High  magnification  view  of  E15.5  (a)  control  and  (b)  R26fxTeNTxOlig2Cre  transverse  distal  hindlimb  
sections.  Apoptotic   cells   (labeled  with   cleaved   caspase   3   and  marked   by   arrowheads)  were   elevated  
within   muscle   fibers   of   mutant   mice.   Scale   bar:   20   µμm.   (c)   Quantification   of   apoptotic   cells   within  
muscle  fibers  of  control  and  mutant  mice  at  different  developmental  stages.  At  least  three  sections  from  
each   of   three   control   and  mutant   embryos  were   counted   for   each   time   point.   Data   are   presented   as  






Figure  3.18:  Slow  myosin  pattern  was  preserved  in  paralyzed  muscles  until  E18.5.  
(a-­‐‑d)  E15.5  transverse  distal  hindlimb  section  showing  (a,  c)  general  and  (b,  d)  slow  muscle  pattern  in  
(a-­‐‑b)   control   and   (c-­‐‑d)  R26fxTeNTxOlig2Cre  mice.   Scale   bar:   250  µμm.   (e-­‐‑h)  Higher  magnification   of   E15.5  
transverse  TA  muscle  stained  with  (e,  g)  desmin  and  (f,  h)  slow  myosin  antibody.  Slow  myosin  pattern  
was   relatively   similar   in   both   (h)  mutant   and   (f)   control  mice.   Bold   lines   demarcate   TA  muscle   and  
dotted   lines   indicate   border   of   hindlimb.   Scale   bar:   100   µμm.   (i-­‐‑l)   Transverse   distal   hindlimb   section  
showing  E16.5  (i,  k)  general  and  (j,  l)  slow  muscle  pattern  in  (i-­‐‑j)  control  and  (k-­‐‑l)  R26fxTeNTxOlig2Cre  mice.  
Scale   bar:   250  µμm.   (m-­‐‑p)  Transverse   distal   hindlimb   section   showing  E18.5   (m,   o)   general   and   (n,   p)  





Also,  at  all  stages  examined  (E15.5,  E16.5  and  E18.5)  (Figure  3.18  a-­‐‑p),  an  overview  of  
transverse   hindlimb   sections   revealed   a   reduction   in   general   muscle   mass   only   at  
E18.5   (Figure   3.18  m-­‐‑p).   Examination   at   higher  magnification   of   TA  muscle   did   not  
reveal   any   altered   patterns   of   slow   myosin   distribution   in   mutant   mice.   Taken  
together,   the  preserved  relative  pattern   in  hindlimb  in  R26fxTeNTxOlig2Cre  mice  showed  
that   paralysis   from   perturbed   neurotransmission   did   not   seem   to   impact   primary  
myotube  specification  or  formation.  
  
3.3.5. Neurotransmission   blockade   does   not   abolish   primary   and   secondary  
formation  in  R26fxTeNTxOlig2Cre  muscles  
Examination   of   transverse   distal   hindlimb   sections   from   E18.5   TA   and   S   muscle  
revealed  that  EdU+  nuclei  were  present  at  an  appreciable  number  within  muscle  fibers  
of  both  control  and  R26fxTeNTxOlig2Cre  mice  (Figure  3.19  a-­‐‑d).  The  presence  of  secondary  
myotubes   in   paralyzed   muscles   was   confirmed   by   EdU-­‐‑labeling   of   myotubes   with  
centralized   nuclei   (Figure   3.19   c-­‐‑d),   which   did   not   appear   to   be   satellite   cells.  
Additionally,   absolute   muscle   mass   of   R26fxTeNTxOlig2Cre   hindlimbs   increased   as  
development   progresses,   thereby   indicating   that   secondary   myotubes   were   formed  
and  added  to  the  muscle  bulk  to  contribute  to  muscle  mass  increase.  Taken  together,  I  
have  provided  evidence  that  secondary  myotubes  are  generated  even  in  the  absence  of  
nerve   activity   despite   claims   from   researchers   that   secondary   myogenesis   was  
profoundly   inhibited   following   d-­‐‑tbc   administration   (McLennan,   1983b;   Sohal   and  
Sickles,  1986).  Secondary  myotubes  were  also  affected  by  paralysis,  but  not  as  severely  
as  by  wholesale  motor  neuron  ablation,  as  determined  by  lesser  muscle  mass  lost  after  







To   determine   if   there   was   a   compensatory   response   in   the   number   of   EdU-­‐‑labeled  
cells   after   blocking   neural   activity,   as   is   the   case   for   R26fxDTAxOlig2Cre   mice   after  
ablating  motor  neurons,  quantification   for   the  number  of  EdU+  nuclei  present  within  
muscles  of  control  and  R26fxTeNTxOlig2Cre  mice  must  be  performed  in  parallel  with  Pax7+  
satellite   cell   quantification.   Interestingly,   the   CSA   of   muscle   fibers   qualitatively  
appeared   to   be   slightly   enlarged   in  mutant   fibers,   although   the   incidence   of  mature  
fibers   with   perinuclei   was   higher   in   muscles   of   R26fxTeNTxOlig2Cre   mice   than  




Figure  3.19:  Secondary  myogenesis  occurs  in  paralyzed  muscles.  
(a-­‐‑d)  Co-­‐‑immunohistochemistry  on  E18.5   transverse  distal  hindlimb  sections  of   (a,   c)  TA  and   (b,  d)  S  
muscle   from   (a-­‐‑b)   control   and   (c-­‐‑d)  R26fxTeNTxOlig2Cre  mice.  Nuclei   of  muscle   fibers   generated   during  
secondary  myogenesis  were  incorporated  with  EdU.  Secondary  muscle  fibers  were  detected  in  muscles  





3.3.6. Blocking  neurotransmission  results  in  an  increase  of  motor  neurons  
Analysis  of  transverse  lumbar  spinal  cord  sections  of  mutant  mice  at  E18.5  revealed  an  
evident   increase   in   the   number   of   motor   neurons   (Figure   3.15   h   and   j).   To   further  
investigate   this,   transverse   thoracic   spinal  cords  of  E18.5  mice  were  also  analyzed   to  
rule  out  that  any  increase/alteration  in  motor  neurons  was  specific  to  a  certain  level  of  
the   spinal   cord.   Indeed,   thoracic  motor  neurons  were   also   found   in  higher  numbers  
within  mutant  spinal  cord  (Figure  3.20  c-­‐‑d)  as  compared  to  controls  (Figure  3.20  a-­‐‑b).    
To  assess  if  blocking  neurotransmission  would  alter  projections  to  target  muscles,  the  
diaphragm,   a   relatively   thin   muscle,   was   examined   using   whole   mount  
immunostaining.   Control   E18.5   diaphragm   showed   clustering   of   AChRs   located  
postsynaptically  apposed  with  secondary  branches  arising  from  the  central  branch  of  
the   phrenic   nerve   (Figure   3.21   a).   Contrastingly,   although   the   main   trunk   of   the  
phrenic   nerve   formed   in   diaphragm   of  R26fxTeNTxOlig2Cre  mice,   there   was   a   dramatic  
excess   of   secondary   and   tertiary   branching,   with   a   substantial   fraction   of   muscle’s  
width  covered  by  the  nerve  in  mutants  than  in  controls  (Figure  3.21  b).    
  
Figure  3.20:  Conditional  expression  of  TeNT  augments  motor  neuron  survival.  
(a-­‐‑d)  E18.5  transverse  thoracic  spinal  cord  sections  of  (a-­‐‑b)  control  and  (c-­‐‑d)  R26fxTeNTxOlig2Cre  mice.  (b,  d)  
Boxed   area   of   thoracic   spinal   cord   at   higher  magnification.   vAChT   labeling   revealed   increased  motor  
neuron  numbers  within  spinal  cord  of  mutant  mice.  Dotted  lines  indicate  boundaries  of  spinal  cord.  a  and  





AChRs   in   mutants   were   formed,   but   localized   to   a   narrower   endplate   width   and  
seemed   to   be   closely   associated   with   the   primary   nerve   branch.   Moreover,   the  
aberrant  branching  pattern  in  mutants  was  confined  to  the  intramuscular  portions  of  
the  nerve,  suggestive  of  faulty  nerve-­‐‑muscle  interactions.  Taken  together,  the  increase  
in  motor  neuron  numbers  after  abolishing  vesicular  release  can  be  justified  either  by  1)  
the  increased  proliferative  ability  of  motor  neuron  progenitors  and  2)  the  augmented  
survival   of   motor   neurons   caused   by   reduction   in   cell   elimination   during   the  
programmed   cell   death   period.   The   latter   hypothesis   is   more   probable   as   it   is  
supported  by  results  from  Oppenheim  and  colleagues  (Oppenheim,  1986;  Oppenheim  
et  al.,  1986;  Oppenheim,  1991)  who  observed  that  blocking  neural  activity  by  using  α-­‐‑
BTX  and  d-­‐‑tbc  led  to  an  increase  in  motor  neuron  numbers,  presumably  by  the  loss  of  
activity-­‐‑dependent   competition   between   motor   neuron   axons   while   establishing  
synaptic  connectivity  with  their  target  muscles.  
  
  
Figure  3.21:  Blocking  neurotransmission  results  in  hyperinnervation  of  target  muscles.  
(a)  Central  branch  of  phrenic  nerve  innervating  the  E18.5  diaphragm  was  identified  with  neurofilament  
whereas   postsynaptic   acetylcholine   receptors   (AChRs)   were   labeled  with   fluorescence-­‐‑conjugated   α-­‐‑
bungarotoxin  (α-­‐‑BTX).  AChRs  were  apposed  to  secondary  branches  derived  from  the  main  branch  of  
the  phrenic  nerve.  (b)  Diaphragm  muscles  of  R26fxTeNTxOlig2Cre  mice  exhibited  an  increase  in  secondary  
and   tertiary   nerve   branches.   AChRs   were   misaligned   to   a   narrower   endplate.   Neurofilament,   pan  





3.3.7. Inactivating  the  Chat  gene  results  in  reduced  muscle  mass  
Muscle   mass   after   neurotransmission   blockade   in  R26fxTeNTxOlig2Cre  mice   was   not   as  
severely  affected  as  R26fxDTAxOlig2Cre  mice,  and  was  observed  to  be  lost  at   later  stages  
beyond  E15.5.  This  discrepancy  could  reflect  myogenic  requirements  for  other  nerve-­‐‑
components   besides   neural   activity   or   that   TeNT   expression   in   the  R26fxTeNTxOlig2Cre  
mice  did  not  completely  block  all  aspects  of  motor  neurotransmission.  Consistent  with  
the   latter   hypothesis,   spontaneous   action   potential-­‐‑independent   neurotransmission  
appears  to  utilize  different  vesicle  release  machinery  that  does  not  stringently  require  
the   association   of   synaptobrevin   to   the   plasma   membrane   for   vesicular   fusion  
(Deitcher   et   al.,   1998;   Schoch   et   al.,   2001).   Therefore,   it   cannot   be   ruled   out   that  
remnant  spontaneous  neural  activity  might  still  prevail  in  R26fxTeNTxOlig2Cre  mice,  thus  
resulting  in  the  observed  milder  impact  on  myogenesis  compared  to  wholesale  motor  
neuron   ablation   in  R26fxDTAxOlig2Cre  mice.   To   address   this,  mice   deficient   for  Chat   (a  
gene   encoding   the   enzyme   choline   acetyltransferase   that   is   responsible   for   ACh  
biosynthesis)   which   have   been   extensively   used   in   the   study   of   neuromuscular  
junction   formation   were   morphometrically   analyzed.   They   displayed   normal   gross  
morphology   with   kyposis-­‐‑like   posture,   hyperinnervation   of   muscles   and   they   die  
perinatally   (Misgeld   et   al.,   2002;   Brandon   et   al.,   2003).   More   importantly,   both  
spontaneous   and   evoked   nerve   activity   is   completely   abolished   in   Chat   mutants  
(Brandon  et  al.,  2003).    
Cross-­‐‑examination   of   hindlimbs   revealed   that   skeletal   muscle   mass   was   severely  
reduced   in   the  Chat-­‐‑deficient   embryos,   as   compared   to   the   control   embryos   (Figure  
3.22  a-­‐‑b).  Strikingly,  quantification  of  remaining  muscle  mass  in  the  hindlimb  of  Chat  
mutants  and  their  age-­‐‑matched  controls  at  E14.5  and  E18.5  showed  a  degree  of  muscle  
reduction   closely   similar   to  R26fxDTAxOlig2Cre   mice.   The   onset   of   muscle   loss   in  Chat  
deficient  embryos  was  detected  at  E14.5  with  a  13%  reduction  and  at  E18.5,  remaining  





at  a  significantly  higher  number  in  transverse  distal  hindlimb  sections  of  mutant  mice  
at  both  stages  analyzed  (Figure  3.22  d).    
  
At   E14.5,   the   number   of   apoptotic   cells   in   mutants   was   around   52   per   section   as  
compared   to   about   20   per   section   in   controls.   At   E18.5,   the   average   number   of  
apoptotic  cells  remained  at  around  54  per  section  for  mutant  mice  in  contrast  to  21  per  
section   in   control  mice.   A   likely   increase   and   progressive   decline   in   the   number   of  
apoptotic   cells   as   observed   in   the   previous  mouse   lines   could   occur   in   between   the  
stages  analyzed  (E14.5  and  E18.5).  Conditional  deletion  of  Chat,  which  resulted  in  the  
abolishment   of   both   spontaneous   and   evoked   neurotransmission,   exacerbated   the  
severity   of   muscle   loss   in   comparison   to   only   blocking   vesicular   release   in  
  
Figure  3.22:  Deleting  the  Chat  gene  has  severe  impacts  on  myogenesis.  
(a-­‐‑b)  E18.5   transverse  distal  hindlimb  sections  of   (a)   control  and   (b)  Chat-­‐‑/-­‐‑  mice.  Mutant  muscles  were  
drastically  reduced  when  compared  to  controls.  Akin  to  what  was  observed  before  with  R26fxDTAxOlig2Cre  
and   R26fxTeNTxOlig2Cre  mice,   some   groups   of  muscles  were   absent  whereas   others  were  merely   reduced.  
Scale  bar:  250  µμm.  (c)  Quantification  of  muscle  mass  remaining  in  the  hindlimb  of  control  and  Chat-­‐‑/-­‐‑  mice  
at  E14.5  and  E18.5  revealed  a  similar  pattern  of  progressive  muscle  loss  that  occurred  in  R26fxDTAxOlig2Cre  
mice.  (d)  Quantification  of  apoptotic  cells  within  E14.5  and  E18.5  muscles  of  control  and  mutant  mice.  At  
least   three   sections   from   each   of   three   control   and  mutant   embryos  were   counted   for   each   time  point.  
Data  are  presented  as  mean  ±  SEM  (two-­‐‑tailed  Student’s  t  test  with  unequal  variance,  n=3  per  genotype,  





R26fxTeNTxOlig2Cre  mice.   Furthermore,   the   extent   of  muscle   reduction   in  Chat   mutants  
was   comparable   to   R26fxDTAxOlig2Cre   mice   with   complete   motor   neuron   removal.  
Herein,  based  on  the  assumption  that   there   is  residual  spontaneous  vesicular  release  
in   R26fxTeNTxOlig2Cre   mice,   that   two   conclusions   can   be   made:   (1)   spontaneous   nerve  
activity  is  critical  for  myogenesis  during  early  development,  and  evoked  nerve  activity  
becomes   increasingly   important   further   into   development;   (2)   ACh   is   the   central  
nerve-­‐‑derived  molecule  which  could  act  with  other  factors  to  relay  nerve  activity  into  
signals  to  activate  expression  of  both  muscle-­‐‑specific  and  muscle-­‐‑associated  genes.  
  
3.3.8. Blocked  evoked  neurotransmission  did  not  disrupt   sarcomere   formation  or  
organization    
I  have  shown  in  Figure  3.13  that  sarcomere  structures  were  disrupted  and  indistinct  in  
R26fxDTAxOlig2Cre   mice   after   motor   neuron   removal.   However,   it   was   yet   unclear   if  
promotion   of   myofibrillogenesis   (the   formation   of   sarcomeres)   is   driven   by   motor  
neuron   activity,   trophic   factors   released   from   motor   nerve,   or   simply   by   signals  
transduced   by   molecules   activated   via   nerve-­‐‑muscle   contact.   To   narrow   down   the  
possibilities,  E18.5  longitudinal  muscle  fibers  were  co-­‐‑immunostained  with  MF20  and  
desmin   to   visualize   probable   alteration   to   sarcomere   pattern   in   skeletal   muscles   of  
R26fxTeNTxOlig2Cre   mice.   The   striated   pattern   arising   from   units   of   sarcomeres   was  
surprisingly  well  preserved   in  mutant  muscle   fibers,  having  a   similar   appearance   to  
control  fibers  (Figure  3.23  a-­‐‑b),  a  stark  contrast  to  R26fxTeNTxOlig2Cre  mice.    
Gene   analysis   demonstrated   no   overt   disparity   in   the   expression   of   sarcomere-­‐‑
associated   genes,   regardless   of   the   localization   of   the   proteins   they   encode   to   the  
different   components   of   the   sarcomere.   With   the   exception   of   7   genes   (sorted  
according   to   ≥1.5   fold-­‐‑change,   p-­‐‑value≤0.05,   expression   level≥100),   no   significant  





normalized   expression   value   of   sarcomere-­‐‑associated   genes   in   control   and  
R26fxTeNTxOlig2Cre  mice,  as  well  as  the  statistical  analysis  can  be  found  under  Table  3.2.    
  
This  finding  therefore  suggests  that  nerve  activity  is  dispensable  in  the  differentiation  
process  to  allow  muscle  fibers  to  become  functionally  contractile,  assuming  that  both  
spontaneous  and  evoked  neural  activity   is   completely  eliminated   in  R26fxTeNTxOlig2Cre  
mice.   Alternatively,   and   more   likely,   if   there   is   remnant   spontaneous   activity   in  
mutants,   it   can   be   concluded   that   evoked   nerve   activity   is   not   required   in   the  
differentiation   process   to   allow   muscle   fibers   to   become   functionally   contractile.  
Rather,  nerve   contact,   spontaneous  nerve  activity,  or  nerve-­‐‑derived   factors   could  act  
as   critical   determinants   in   promoting   myobrillogenesis   as   part   of   the   terminal  
differentiation  program  to  form  functionally  contractile  muscle  fibers.    
  
Figure  3.23:  Striated  muscle  pattern  is  intact  in  paralyzed  muscles.    
(a-­‐‑b)  Co-­‐‑immunostaining  of  control  E18.5   (a)  control  and  (b)  R26fxTeNTxOlig2Cre   longitudinal  muscle   fiber  
with  desmin  and  MF20  antibodies   revealed  a   striated  pattern  with  well-­‐‑aligned   sarcomeres.  Sarcomere  






Table  3.2:  List  of  sarcomere-­‐‑associated  genes  in  control  and  R26fxTeNTxOlig2Cre  mice.    
Relative  units  of  gene  expression  are  shown  under  ‘control’  and  ‘mutant’  field.  Data  under  ‘control’  and  
‘mutant’  field  are  presented  as  mean  relative  units  of  gene  expression.  (One-­‐‑tailed  Student’s  t  test  with  





3.4. Gene  profiling  of  R26fxDTAxOlig2Cre  aneural  muscles  
3.4.1. Differential  gene  expression  underlying  myogenesis  in  the  absence  of  motor  
neurons  
In   the   adult,   denervation   is   mainly   mediated   by   ubiquitin-­‐‑proteolysis   via   the  
proteasome,   with   the   end   result   being   skeletal   muscle   atrophy.   Additionally,  
denervation-­‐‑induced   apoptosis,   also   implicated   during   adult   denervation,   also  
contributes   to   muscle   mass   reduction   that   occurs   around   2   weeks   following  
denervation   (O'ʹLeary   et   al.,   2012).   In   contrast,   muscle   loss   in   the   R26fxDTAxOlig2Cre  
embryo  spans  a  course  of  merely  5  days  (from  E14.5-­‐‑E18.5)  before  birth  when  muscle  
reduction   is   most   severe.   Upon   embryonic   denervation,   muscles   failed   to   undergo  
terminal  differentiation  and  were   rapidly   lost   in  R26fxDTAxOlig2Cre  mice  via  apoptosis.  
The   altered   structural   muscle   properties   in   these   aneural   mice   could   already   be  
detected  by  the  lack  of  sarcomeres  at  E14.5  (data  not  shown).  My  results  indicate  that  
the  time  course  for  the  activation  of  denervation-­‐‑induced  apoptotic  signaling  pathway  
resulting  in  muscle  mass  reduction  progresses  faster  in  the  embryos,  and  the  structural  
muscle  properties   that  are  altered  after  denervation  are  also   fundamentally  different  
from   that   observed   after   adult   denervation.   These   findings,   taken   together,   imply  
different   requirements   of   motor   nerve   input   for   embryonic   myogenesis   on   the   one  
hand  and  maintenance  of  adult  muscle  on  the  other.  
While   molecular   pathways   implicated   in   the   muscle   atrophy   resulting   from  
denervation  in  the  adult  are  rapidly  emerging  (Bodine  et  al.,  2001;  Moresi  et  al.,  2010;  
Macpherson  et  al.,  2011;  O'ʹLeary  et  al.,  2012),  little  is  known  about  the  pathways  and  
mechanisms  involved  in    the  response  of  embryonic  muscle  towards  denervation.  To  
address   this,   I   have   thus   performed   RNA   sequencing   and   gene   microarray  
experiments  using  whole  hindlimb  musculature  isolated  from  E14.5  and  E15.5  control  
and  R26fxDTAxOlig2Cre  mice,   respectively,   in   order   to   identify   in   an   unbiased  manner  





represent   the   transcriptome   data   which   revealed   195   differentially   downregulated  
genes   (Figure   3.24)   and   218   upregulated   genes   (Figure   3.25)   which   were   sorted  
according   to   the   following   criteria:      ≥1.5   fold-­‐‑change,   p-­‐‑value≤0.05   and   expression  
level≥100.   Expression   of   housekeeping   genes   such   as   Gapdh   (glyceraldehyde-­‐‑3-­‐‑
phosphate   7l)   and  Tuba1b   (tubulin,   α1B)   in   control   and  mutant  muscles   showed   no  
significant  difference.  
  
Figure  3.24:  Downregulated  gene  profiles  in  R26fxDTAxOlig2Cre  muscles.  
(a)  Heatmap  representation  of  downregulated  genes  following  microarray  analysis  in  E15.5  muscles  of  
R26fxDTAxOlig2Cre  mice.  The  threshold  level  for  gene  expression  was  set  to  ≥100  relative  units.  (b)  Venn  
diagram  showing  overlap  of  68  differentially  downregulated  genes  obtained   from  muscles  of  mutant  
mice   following   microarray   processing   (left,   total   194   genes)   and   RNA   sequencing   (right,   total   153  
genes).  The  genes  were  sorted  accordingly  to  the  following  criteria:  ≥1.5  fold-­‐‑change  and  p-­‐‑  value≤0.05.  







RNA   sequencing   data   revealed   153   downregulated   and   32   upregulated   genes,   of  
which  68  downregulated  genes  and  5  upregulated  genes  overlapped  (downregulated  
genes   32.2%   overlap,   upreguated   genes   2.1%   overlap)   with   differentially   regulated  
genes   obtained   from   the  microarray   experiments   (Figure   3.24   and   Figure   3.25).   The  
complete   set   of   differentially   expressed   genes   were   classified,   separately   for  
  
Figure  3.25:  Heatmap  of  upregulated  genes  in  R26fxDTAxOlig2Cre  muscles.    
(a)   Heatmap   representation   of   upregulated   genes   following  microarray   analysis   in   E15.5  muscles   of  
R26fxDTAxOlig2Cre  mice.  The  threshold  level  for  gene  expression  was  set  to  ≥100  relative  units.  (b)  Venn  
diagram  showing  overlap  of  5  differentially  upregulated  genes  obtained  from  muscles  of  mutant  mice  
following  microarray  processing  (left,  total  218  genes)  and  RNA  sequencing  (right,  total  32  genes).  The  
genes  were  sorted  accordingly  to   the  following  criteria:  ≥1.5   fold-­‐‑change  and  p-­‐‑  value≤0.05.  Red,  high  





downregulated  and  upregulated  genes,  according  to  the  Panther  classfication  system  
(Mi  et  al.,  2010;  Mi  et  al.,  2012).    
  
  
Figure   3.26:  Biological   function  profiles  of  differentially   expressed  genes  obtained  via  microarray.  
Differential   expressed   genes   in   R26fxDTAxOlig2Cre   muscles   were   classified   based   on   their   known  
biological  functions  (see  different  categories).  For  downregulated  genes,  171  genes  were  recognized  as  
the   total   number   of   gene   input   and   a   total   of   200   function   hits   were   found   for   these   genes.   For  
upregulated   genes,   181   genes  were   recognized   as   the   total   number   of   gene   input   and   a   total   of   359  
function   hits   were   found   for   these   genes.   Gene   hit:   percentage   of   input   gene   hit   over   total   genes;  






The   most   prominently   represented   biological   processes   associated   with   the   thus  
identified   innervation-­‐‑dependent  genes  were   cellular,  metabolic,   cell   communication  
and   developmental   processes   (Figure   3.26   and   Figure   3.27).   Interestingly,   DAVID  
analysis   (Huang   da   et   al.,   2009b;   Huang   da   et   al.,   2009a)   demonstrated   that  
  
Figure   3.27:   Biological   function   profiles   of   differentially   expressed   genes   obtained   via   RNA  
sequencing.  Differentially   expressed  genes   in  R26fxDTAxOlig2Cre  muscles  were   classified  based  on   their  
known   biological   functions   (see   different   categories).   For   downregulated   genes,   135   genes   were  
recognized  as  the  total  number  of  gene  input  and  a  total  of  449  function  hits  were  found  for  these  genes.  
For  upregulated  genes,  26  genes  were   recognized  as   the   total  number  of  gene   input  and  a   total  of  97  
function   hits   were   found   for   these   genes.   Gene   hit:   percentage   of   input   gene   hit   over   total   genes;  





differentially   downregulated   genes   largely   take   part   in   canonical   KEGG   pathways  
relating  to  cardiac  muscle  contractibility  and  diseases  (Table  3.3).    
  
This  finding  is  in  agreement  with  my  conclusion  that  motor  innervation  is  required  to  
drive   the   terminal   differentiation   of   skeletal  myotubes   into   contractile   fibers   (direct  
inference   since   cardiac  and  skeletal  muscles  are  both   striated  muscles  and  are  hence  
comparable).   Additionally,   the   fact   that   pathways   associated   with   cardiac   diseases  
  
Table  3.3:    DAVID  analysis  of  top  up-­‐‑  or  downregulated  canonical  pathways.  
Differentially   regulated   genes   obtained   from   (a)   microarray   profiling   experiment   and   (b)   RNA  
sequencing   experiment  were   shown   to   largely   have   functions   related   to   the   signaling   pathways   listed  
above.  Gene  list   input  was  selected  as  per  the  following  criteria:  ≥1.5  fold-­‐‑change  and  p-­‐‑value≤0.05.  The  





such   as   hypertrophic   cardiomyopathy   (HCM),   a   disease   primarily   associated   with  
myocardium  hypertrophy,  sarcomere  disarray  and  mutations  in  sarcomeric  genes,  are  
implicated  in  aneural  muscles  of  R26fxDTAxOlig2Cre  mice  not  only  reinforces  my  finding  
that  myofibrillogenesis   is   defective   in   the   skeletal  muscles   of     R26fxDTAxOlig2Cre  mice,  
but  could  also  account   for   the  hypertrophy  of  denervated  muscle   fibers  described   in  
earlier  sections.  
  
3.4.2. Potential  myogenic  effectors  regulated  by  motor  innervation  
Removal   of   motor   neurons   affected   the   expression   of   several   genes,   which   were  
considered   “candidate   genes”   based   on   their   potential   role(s)   in   translating   neural  
activity   and/or   contact-­‐‑dependent   signals   into   the   promotion   of   embryonic  
myogenesis.   Candidate   genes   were   selected   based   on   a   set   of   criteria   based   on  
significance  and  amplitude  of  altered  expression  levels  (1.5≥fold-­‐‑change,  p-­‐‑value≤0.05  
and  relative  expression  value≥100),  as  well  as   their  potential   function  in  myogenesis.  
Since   muscle   mass   reduction   was   already   observed   at   E15.5,   differential   gene  
regulation  that  could  be  secondary  consequences  of  motor  neuron  ablation  had  to  be  
considered   and   filtered   out.   Thus,   expression   of   these   genes   has   been   verified   via  
quantitative  polymerase  chain  reaction  (qPCR)  throughout  three  developmental  stages  
(E13.5,   E15.5   and  E18.5)   respectively   reflecting   stages   before,   during   onset   and   end-­‐‑
stage   of   muscle   degeneration.   A   discrete   set   of   genes   encoding   potential   myogenic  
factors   was   downregulated   as   early   as   E13.5,   a   stage   that   is   prior   to   the   onset   of  
denervation-­‐‑induced   muscle   degeneration   and   after   the   initiation   of   primary  
myogenesis   (Figure   3.28   a-­‐‑d).   These   genes   were   therefore   tentatively   classified   as  
“early  response”  genes.  These  include  genes  encoding  the  muscle  LIM  protein  (Sapd)  
which  is  localized  to  the  sarcomere  and  has  been  characterized  as  a  positive  regulator  
of  myogenesis,  transcription  factor  Myfd  which  is  a  member  of  the  MRF  family  and  is  





zinc-­‐‑finger   family   transcriptional   repressors   implicated   in   carcinogenesis   and  
embryogenesis   and   Fgfd,   a   fibroblast   growth   factor   specifically   accumulated   in  
skeletal  muscles  during  myogenesis  was  also  downregulated.    
  
Because   these   genes   were   impacted   early   by   motor   neuron   removal   they   were  
therefore   considered   as   prime   candidate   effectors   of   motor   innervation-­‐‑dependent  
  
Figure   3.28:   qPCR   verification   of   downregulated   candidate   gene   expression   profiles   throughout  
development.  
(a-­‐‑d)   Early   response   genes   such   as   (a)   Sapd,   (b)  Myfd,   (c)   Snaid   and   (d)   Fgfd  were   chosen   as   prime  
candidate  genes  because  they  displayed  a  differential  response  to  motor  neuron  removal  very  early  in  
development  at  E13.5  in  muscles  of  R26fxDTAxOlig2Cre  mice.  (e-­‐‑h)  Late  response  genes  such  as  (e)  Foxdm,  
(f)   Hhd,   (g)   Cxcld   and   (h)   Prkctd   were   selected   as   candidate   genes   that   showed   differential  
downregulation   only   after   E13.5.   They   are   potentially   downstream   effectors   of   positively   identified  
prime  candidate  genes.  (Two-­‐‑tailed  Student’s  t   test  with  unequal  variance,  min  n=3  per  genotype,  per  





myogenesis.   Among   other   downregulated   candidates   with   potential   myogenic  
activities,  some  were  considered  as  ‘late  response’  genes  because  their  expression  was  
downregulated   after   E15.5   and   beyond   but   not   at   E13.5   (Figure   3.28   e-­‐‑h).   These  
include   genes   encoding   Foxdm,   a  member   of   the   forkhead  winged/helix   box   (FOX)  
family   of   transcription   factors   which   is   implicated   in   various   processes   including  
metabolism   and   cell   proliferation;   Hhd,   a   member   of   the   hedgehog   family   of  
morphogenic   proteins   implicated   in   organogenesis   (Yao   et   al.,   2002)   and   Cxcld,   a  
putative   member   of   the   secreted   chemokine   family   of   proteins,   which   are   secreted  
proteins   and   are   important   for   the   migration   of   muscle   precursor   cells   during  
myogenesis   (Vasyutina   et   al.,   2005;   Yusuf   et   al.,   2006),   as   well   as   for   macrophage  
infiltration  of  damaged  muscle   tissues  (McLennan,  1996).  Additionally,   transcripts  of  
Pkctd   that   encodes   for   ´novel´   calcium-­‐‑independent   but   phospholipid-­‐‑dependent  
protein  kinase  C   (Madaro  et  al.,   2012),   the  PKC   isoform  expressed  predominantly   in  
skeletal  muscles,  were  also  negatively  regulated  in  aneural  muscles.  This  PKC  isoform  
is   known   to   take  part   in   various  muscle   regenerative  processes   (Moraczewski   et   al.,  
2002).   It   is   possible   that   the   ‘late   response’   genes   are   effectors   of   the   positively  
identified   ‘early   response’   genes,   but   they   may   also   be   secondarily   affected   by   the  
process   of  muscle   degeneration   (see   Table   3.4   for   normalized   relative   expression   of  
candidate  genes  and  statistical  analysis).    
  
3.4.3. Muscle-­‐‑associated  genes  affected  by  the  removal  of  motor  neurons  
Besides   the   abovementioned   candidate   genes   (Figure   3.28),   examination   of   the  
downregulated   group   and   verification   with   qPCR   also   revealed   several   muscle-­‐‑
associated   genes   (Figure   3.29),   including   myofilament   genes   such   as  Myl2   (myosin  
light  chain,  cardiac  slow  isoform,  data  not  shown),  Myl3  (myosin  light  chain,  skeletal  
slow   isoform)   and  Myh3   (myosin   heavy   chain,   embryonic   isoform);  members   of   the  





was   only   performed   for  Ankrd1);   genes   encoding  muscle-­‐‑specific  metabolic   proteins  
Ckm   and   Eno3;   gene   encoding   the   transcription   factor   Fhl1  which   is   upregulated  
during   embryonic   skeletal   muscle   development   (Loughna   et   al.,   2000)   and   is  
implicated   in   the  modulation   of  muscle  mass   (Cowling   et   al.,   2008);  muscle   spindle  
specific  gene  Etv4;  and  orphan  nuclear  receptor  gene  Esrrb  (Figure  3.29).  In  the  mouse,  
Myh3   is   expressed   in   embryonic   muscles   whereas  Myh8,   the   perinatal   isoform   of  
myosin  heavy  chain   is   found   in   fetal  muscles.  Microarray  and  qPCR  results   showed  
that  Myh8  expression  was  unaltered  in  muscles  of  R26fxDTAxOlig2Cre  mice  at  E15.5  or  all  
developmental   stages   investigated,   respectively.  Myh8   was   nevertheless   included   in  
the  analysis  as  a  comparison  to  Myh3  expression  which  is  associated  with  the  initiation  
of  sarcomere  formation  (Karsch-­‐‑Mizrachi  et  al.,  1989).  The  downregulation  of  Ankrd1,  
a   gene   that   promotes   hypertrophy   implies   that   the   increase   in  muscle   fiber   CSA   in  
Figure  3.6  was  less  likely  to  be  attributed  to  bona  fide  hypertrophy,  but  could  be  a  sign  
of   degeneration.   Intriguingly,   the   drastic   reduction   in   the   expression   of  Myl3  was  
observed  already  at  E13.5,  just  one  day  after  muscle  mass  cleavage  completion  and  the  
formation  of   first  myotubes.  The  early   response  of  Myl2   and  Myl3   seems   to   indicate  
that  motor   innervation  plays  a   crucial   role   in  promoting   the  expression  of   structural  
genes.   Under   normal   conditions,   the   expression   of   muscle   creatine   kinase   (Ckm),  
forkhead  LIM-­‐‑domain  protein  (Fhl1)  and  beta  enolase  (Eno3)  is  the  defining  feature  of  
the   maturation   of   skeletal   muscles   during   myogenesis   (Fougerousse   et   al.,   2001;  
Cowling   et   al.,   2008;   Messina   et   al.,   2010).   Together   with   the   failure   to   induce  
sarcomeric   gene   expression,   the   reduced   expression   of   these   genes   in   mutant  
R26fxDTAxOlig2Cre  muscles  strongly  suggests  a  block  in  myofiber  terminal  differentiation  






Figure  3.29:  qPCR  verification  of  structural  gene  expression  in  aneural  muscles  throughout  different  
developmental  stages.  
(a-­‐‑b)  The  expression  of   (a)  embryonic   isoform  of  myosin  heavy  chain  (Myh3)  was  downregulated  but  
the  fetal  isoform  of  myosin  heavy  chain  (Myh8)  remained  unaffected.  (c)  Ankrd1,  a  hypertrophy  marker,  
was  downregulated  at  E13.5,  indicating  that  bona  fide  hypertrophy  is  not  the  cause  for  increase  in  CSA  
of  mutant  fibers.  (d)  Myosin  light  chain  (Myl3)  expression  was  reduced  drastically  just  a  few  days  after  
myogenesis   was   initiated.   (e-­‐‑g)   Hallmark   of   maturation   of   embryonic   muscles   into   fetal   muscles   is  
represented  by  the  expression  of  (e)  Muscle  creatine  kinase  (Ckm),  (f)  Forkhead  LIM  protein  (Fhl1)  and  
(g)  beta  Enolase  (Eno3)  genes.  (h-­‐‑i)  Genes  encoding  muscle  spindle  markers  (h)  Etv4  and  (i)  Esrrb  were  
also  downregulated,   suggesting   that   formation  of  muscle   spindles  might   be   impaired  without  motor  
neurons.   (Two-­‐‑tailed   Student’s   t   test   with   unequal   variance,   min   n=3   per   genotype,   per   stage).   ***,  





In  addition  to  the  dependence  of  extrafusal  myofiber  formation  on  motor  innervation,  
sensory   innervation   (proprioception)   has   been   established   to   be   essential   for   the  
differentiation   of   intrafusal   myofibers   associated   with   muscle   spindles   (Zelena   and  
Soukup,  1974;  Zelena,  1976),  while   it  has  recently  been  reported  that  sensory  neuron  
axons   depend   on   preformed   motor   neuron   axons   to   successfully   project   to   their  
targets   (Wang  et  al.,   2011b).  Therefore,   the  downregulation  of   the  gene  encoding   for  
muscle   spindle   marker   Etv4   in   aneural   muscles   likely   reflects   defective   intrafusal  
myofiber   formation   and/or   terminal   differentiation   resulting   from   the   failure   of  
sensory  projections  to  limb  muscle  as  a  consequence  of  motor  neuron  removal.  While  
no   characterized   function   and   binding   ligand   has   yet   been   identified   for   Esrrb,   an  
orphan  nuclear  receptor  family,  its  related  member  Esrrg  is  a  well-­‐‑known  marker  of  γ-­‐‑
motor  neurons  (Friese  et  al.,  2009)  (see  Table  3.5  for  normalized  expression  levels  and  
statistical  analysis).    
  
  
Table  3.4:  List  of  positively  identified  candidate  genes  in  aneural  muscles.    
Downregulated  candidate  genes  in  muscles  of  control  and  R26fxDTAxOlig2Cre  mice  were  verified  by  qPCR  at  






3.4.4. Embryonic   denervation   utilizes   a   set   of   molecules   distinct   from   adult  
denervation  pathway     
The   pathways   underlying   adult   denervation   are   surfacing,   including   a   set   of   genes  
upregulated  following  denervation  induced  by  sciatic  nerve  transection  in  the  adult  is  
believed   to   be   responsible   for   translating   the   lack   of  motor   innervation   into  muscle  
atrophy   (Moresi   et   al.,   2010;   Macpherson   et   al.,   2011).   To   test   whether   there   are  
parallels  between  the  molecular  pathways  induced  adult  and  embryonic  denervation,  
I  selectively  investigated  the  expression  of  genes  implicated  in  adult  denervation  after  
motor  neuron  ablation  in  the  embryo.  Notably,  microarray  and  RNAseq  data  showed  
no  significant  difference  in  the  expression  level  of  genes  upregulated  after  denervation  
in  the  adult  (Figure  3.30  a).    
  
Table  3.5:  List  of  downregulated  structural  genes  in  aneural  muscles.    
Negatively  regulated  structural  genes  in  muscles  of  control  and  R26fxDTAxOlig2Cre  mice  verified  by  qPCR  at  
various  developmental  stages.  Removing  motor  neurons   led   to  significant  downregulation  of  structural  







Additionally,   the   transcripts   of   E3   ubiquitin   ligases,   which   appear   to   be   the   final  
effectors   in  mediating   adult  muscle   atrophy   (Bodine   et   al.,   2001;  Moresi   et   al.,   2010;  
Macpherson   et   al.,   2011),   were   not   differentially   regulated   between   control   and  
R26fxDTAxOlig2Cre   embryos,   and  had  a   subthreshold  expression   (<100   relative  units)   in  
E15.5   embryonic   hindlimb   muscles.   This   suggests   that   embryonic   denervation   acts  
through  pathways  differing  from  the  adult  denervation  pathways  involving  Atrogin-­‐‑1  
and  MuRF1/Trim63  E3   ubiquitin   ligases.   Likewise,  myogenin   (a  member   of   the  MRF  
family),   a   developmental   gene   important   for   embryonic   myogenesis   (Eftimie   et   al.,  
1991;   Borycki   and   Emerson,   1997)   whose   expression   was   shown   to   reappear   after  
nerve   transection   postnatally   (Moresi   et   al.,   2010;  Macpherson   et   al.,   2011)   was   not  
differentially  regulated  in  the  aneural  R26fxDTAxOlig2Cre  embryos.  To  determine  if  there  
was  a  period  during  which  myogenin  was  impacted  during  development,  I  tested  for  
  
Figure  3.30:  Embryonic  denervation  operates  through  a  distinct  pathway  than  adult.    
(a)   No   significant   difference   in   the   expression   level   of   a   set   of   genes   implicated   during   adult  
denervation   was   detected   between   E15.5   control   and   R26fxDTAxOlig2Cre   muscles.   Transcripts   of   E3  
ubiquitin   ligases,   Atrogin-­‐‑1   and  MuRF1/Trim63   were   exceptionally   low   in   E15.5   muscles.   (b)   qPCR  
expression  of  analysis  of  myogenin,  a  member  of  the  MRF  family,  throughout  different  developmental  
stages.  Myogenin  transcripts  were  increased  in  mutant  muscles  at  E18.5  significantly.  Data  are  presented  
as   normalized   values   to   control.   (Two-­‐‑tailed   Student’s   t   test   with   unequal   variance,   min   n=3   per  





myogenin   gene   expression   using   qPCR   on   control   and   aneural   muscles   at   distinct  
embryonic   stages.   Indeed,   it  was   confirmed   that  while   levels  of  myogenin   transcripts  
were  unchanged  at  E13.5  and  E15.5  (early  embryonic  stages),  it  was  however  slightly  
upregulated  in  the  muscles  of  R26fxDTAxOlig2Cre  mice  at  E18.5  (Figure  3.30  b).  The  reason  
for   the   latter   observation   is   unclear,   but   might   be   attributed   to   increased   satellite-­‐‑
derived  myogenesis   involving  myogenin   observed   in   late-­‐‑gestation   aneural  muscle.  
Alternatively,   this  observation  may  reflect  a   transition   to  a  more  postnatal/adult-­‐‑like  
stage   of  myogenesis  with   the   end   of   gestation   and   thus,   the   partial   initiation   of   an  
adult-­‐‑like  denervation  pathway  in  E18.5  aneural  embryos.  
  
3.4.5. Motor  innervation  regulates  Ntf5  and  Ntrk2  transcript  levels  in  muscles    
Early  studies  have  underlined  the  importance  and  expression  of  neurotrophic  factors  
after   motor   neuron   elimination   (Houenou   et   al.,   1991;   Oppenheim,   1991).   During  
development,   the   skeletal  muscle   is   identified  as  an  essential   source  of  neurotrophic  
support   for   motor   neurons   (Griesbeck   et   al.,   1995;   Chevrel   et   al.,   2006).   Previous  
studies  have   also  demonstrated   that  denervation   in   the   adult   resulted   in   changes   in  
muscle   neurotrophin   level   (Griesbeck   et   al.,   1995;   Stuerenburg   and   Kunze,   1998;  
Sakuma   et   al.,   2001).   Hence,   it   would   be   interesting   to   investigate   motor   neuron-­‐‑
mediated  regulation  of  neurotrophic   factor  expression   in   the  muscles.  Herein,   I  have  
used  qPCR  to  assess  the  response  of  genes  encoding  various  neurotrophic  factors  and  
their  receptors  to  the  lack  of  motor  innervation  in  E15.5  muscles  (Figure  3.31).  Out  of  
the  7  neurotrophic   factors  and   receptors   tested,   the   transcript   levels  of  neurotrophin  
4/5   (Ntf5)   and   neurotrophic   tyrosine   kinase   type   2   (Ntrk2)   were   the   only   ones  
significantly  altered  in  muscles  of  R26fxDTAxOlig2Cre  mice  compared  to  controls  (Figure  
3.31   c   and  d).  Contrary   to  preceding   studies   that  described  Nt4/5   as  being  neurally-­‐‑





Nt4/5   expression   (Sakuma   and   Yamaguchi,   2011),   Ntf5   transcripts   were   instead  
upregulated  in  my  findings.    
  
This   disparity   may   be   a   stage-­‐‑dependent   response   in   the   requirement   for   motor  
innervation,  supported  by  the  observation  that  Ntrk2  which  encodes  for  a  membrane  
protein   receptor   that   binds   specifically   to   Bdnf   and   Nt4/5   was   correspondingly  
upregulated   (Figure   3.31   d).  Genes   encoding   other   neurotrophic   factors  which  were  
  
Figure  3.31:  qPCR  verification  of  growth  factors  and  receptors  expression  in  aneural  E15.5  muscles.  
(a-­‐‑f)  No  significant  difference  could  be  detected  in  the  expression  of  (a)  neurotrophin  3  (Ntf3),  (b)  glial-­‐‑
derived  nerve  factor  (Gdnf),  (e)  nerve  growth  factor  (Ngf)  and  (f)  ciliary  nerve  trophic  factor  (Cntf)  gene  in  
R26fxDTAxOlig2Cre   muscles.   Transcript   levels   of   (c)   neurotrophin   4/5   (Ntf5)   and   (d)   tyrosine   kinase  
receptor   type   2   (Ntrk2)   were   differentially   regulated   in   mutant   muscles   by   1.31   and   1.40   fold,  
respectively.  Data   are   represented  as  normalized  values   to   controls.   (Two-­‐‑tailed  Student’s   t   test  with  





tested   but   displayed   unaltered   expression   included   neurotrophin   3   (Ntf3),   glial-­‐‑cell-­‐‑
line-­‐‑derived   neurotrophic   factor   (Gdnf),   nerve   growth   factor   (Ngf)   and   ciliary  
neurotrophic   factor   (Cntf)   (Figure   3.31   a,   b,   c,   and   f).   Surprisingly,   the   potent  
neurotrophic   factor   Gdnf   that   is   known   to   be   strongly   expressed   during   early  
myogenesis  to  promote  survival  of  motor  neurons  (Sakuma  and  Yamaguchi,  2011)  did  
not  display  differential  gene  expression  after  motor  neuron  ablation.  Additionally,  the  
transcripts   of   brain-­‐‑derived   neurotrophic   factor   (Bdnf),   claimed   to   be   differentially  
expressed  in  skeletal  muscles  during  numerous  pathological  and  physiological  states  
in  the  adult  (Chevrel  et  al.,  2006)  were  undetected  in  E15.5  muscles  (data  not  shown).  
This  may  be  attributed  to:  (1)  the  low  expression  or  absence  of  Bdnf  in  the  embryonic  
muscles  or  (2)  the  absence  of  Bdnf  expression  in  the  muscles  of  both  embryo  and  adult  
but  this  question  remains  controversial  (Griesbeck  et  al.,  1995;  Sakuma  et  al.,  2001).    
  
3.5. Gene  expression  profiles  in  paralyzed  muscles  of  R26fxTeNTxOlig2Cre  mice  
As   described   in   earlier   sections,   blocking   evoked   neuromuscular   transmission   in  
R26fxTeNTxOlig2Cre   mice   only   partially   recreates   the   effects   on   muscle   caused   by  
wholesale   removal   of   motor   neurons   or   neuromuscular   transmission   in  
R26fxDTAxOlig2Cre  mice  or  Chat-­‐‑/-­‐‑  mice,  respectively.  I  therefore  tested  to  what  extent  the  
identified   core   set   of   genes   de-­‐‑regulated   upon   motor   neuron   removal   would   be  
affected   upon   blocking   evoked   neuromuscular   transmission.   Hence,   transcriptome  
profiling   was   performed   using   hindlimb   muscles   of   E15.5   R26fxTeNTxOlig2Cre   mice.  
Shown   in   Figure   3.32   is   the   heatmap   representation   of   the  microarray   data   attained  
(Figure   3.32   a-­‐‑b).   Altogether,   only   25   genes   were   detected   as   significantly  
downregulated   and   9   genes   were   upregulated   in   the   paralyzed   muscles   of  
R26fxTeNTxOlig2Cre  mice  (Figure  3.32  c-­‐‑d).  The  markedly  smaller  group  of  genes  detected  
as   being   differentially   regulated   likely   reflects   the   lower   degree   of  muscle   loss   and  





R26fxDTAxOlig2Cre   mutants.   The   question   to   what   extent   the   molecular   pathways  
regulated   by   neuromuscular   innervation   would   overlap   with   those   regulated   by  
neuromuscular   transmission   thus   awaits   the   transcriptome   analysis   of   muscle   gene  
expression  in  Chat-­‐‑deficient  mice  lacking  both,  evoked  and  spontaneous  ACh  release  
at  the  neuromuscular  junction.  
Nevertheless,   the   observation   that   two   genes   encoding   myogenic   factor   and  
sarcomere-­‐‑associated   protein   Sapd   and   Myfd   which   were   affected   both   by   motor  
neuron   ablation   as  well   as   evoked   neuromuscular   transmission   blockade   implicates  
both  factors  as  prime  candidates  for  coordinating  the  response  of  myoblasts   towards  
innervation.     
  
Figure  3.32:  Gene  profile  of  E15.5  R26fxTeNTxOlig2Cre  muscles.    
(a-­‐‑b)   Heatmap   representation   of   differentially   regulated   genes   in   R26fxTeNTxOlig2Cre   muscles.   (a)   25  
negatively   regulated   and   9   positively   regulated   genes   were   identified   in   E15.5   muscles   of   mice   after  
blocking   evoked  neurotransmission.  Red,   high   level   of   expression;   Blue,   low   level   of   expression.      (c-­‐‑d)  
Venn   diagrams   comparing   overlap   of   differentially   (c)   downregulated   and   (d)   upregulated   genes   in  
R26fxDTAxOlig2Cre   and  R26fxTeNTxOlig2Cre  muscles.  Genes  were   sorted  accordingly   to   the   following   criteria:  






4.1. Addressing  the  role  of  innervation  in  embryonic  myogenesis  
Previous   studies   regarding   the   role   of   innervation   on   myogenesis   gave   rise   to   two  
divergent   conclusions:   (1)   first,   primary   myotube   formation   is   dependent   on  
innervation,  while  secondary  myotube  formation  is  indirectly  affected  by  denervation  
due  to  their  reliance  on  the  presence  of  primary  myotubes  (Ontell  et  al.,  1988;  Condon  
et  al.,  1990;  Fredette  and  Landmesser,  1991b),  and  (2)  second,  primary  myotubes  form  
cell  autonomously  whereas  the  formation  of  secondary  myotubes  requires  innervation  
(Butler  et  al.,  1982;  McLennan,  1983b;  Ross  et  al.,  1987;  Wilson  and  Harris,  1993).  These  
discrepancies   likely   arose   due   to   the   variability   in   the  methodology   available   at   the  
time   these   studies   were   conducted,   namely   the   mechanical   surgical   ablation   of  
embryonic   spinal   cord   or   the   whole-­‐‑embryo   application   of   neural   and/or   muscle  
activity   blockers   to   address   the   role   of   innervation   in   embryonic   myogenensis.  
Methodologically,  inducing  denervation  by  neural  tube  removal  or  partial  spinal  cord  
transection   is   inherently   non-­‐‑specific,   since   other   cell   types   in   the   spinal   cord   (i.e.,  
interneurons,  glial  cells)  besides  motor  neurons  are  also  eliminated.  Additionally,  with  
this   approach   there   is   no   control   over   the   completeness   of   denervation   or   possible  
reinnervation,  as  well  as  the  side  effects  of  surgery  on  the  morphogenesis  of  embryos.  
Further,  application  of  neural  and/or  muscle  activity  blockers  (for  e.g.,  d-­‐‑tbc,  curare,  α-­‐‑
BTX,  TTX)  were  largely  inconclusive  because  application  of  paralyzing  agents  at  early  
stages  could  affect   the  pattern  of  activation  of   immature  muscles,   leading  to  artifacts  
such   as   tension-­‐‑induced   damage   (Landmesser   and   Szente,   1986).   In   addition,  
discrepancies   in   results  may   have   arisen   from   the   incomplete   elimination   of   neural  
influence   resulting   from   the   incomplete   blockade   of   postsynaptic   receptors   or  
neurotransmission.  For   instance,  drugs  meant   to  perturb  neurotransmitter   release  or  
neurotransmission   may   do   so   by   inhibiting   evoked   but   not   spontaneous   release  





Deitcher  et  al.,  1998).  Because  of  this,  developmental  programs  that  were  concluded  to  
be   activity-­‐‑independent   may   actually   require   spontaneous   activity   that   was   not  
eliminated   by   a   particular   drug   (Misgeld   et   al.,   2002).   Moreover,   drugs   used   in  
previous  studies  may  have  nonspecific  detrimental  effects  on  myogenesis,  such  as  the  
commonly  used  β-­‐‑BTX  to  destroy  nerve,  which  was  reported  to  be  directly  myotoxic  
(Creazzo   and   Sohal,   1981).   Lastly,   differences   in   the   time   of   induced   denervation,  
neurotransmission   blockade   or   paralysis   could   give   rise   to   markedly   varying  
outcomes.   For   instance,  due   to   technical   limitations,   the   earliest   time  point   at  which  
spinal  cord  ablation  was  possible  in  mouse  embryos  was  at  E14.5  (Hughes  and  Ontell,  
1992)   an   inappropriate   stage   to   study   the   impacts   of   innervation   on   myogenesis  
because   the   motor   nerve   has   already   projected   into   the   muscles   and   primary  
myogenesis  has  ended.  Thus,   impacts  of  neurotransmission  blockade  on  myogenesis  
generally   correlated   with   the   developmental   stage   at   which   neurotransmission  
blockers  were  administered   (McLennan,  1983b;  Sohal  and  Sickles,  1986;  Fredette  and  
Landmesser,  1991a).  Taken  together,  due  to  these  method-­‐‑inherent  variations  the  exact  
role  of  innervation  during  embryonic  myogenesis  remains  unclear.  
To  circumvent  ambiguities   inherent   to  previous  approaches  and  to  precisely  address  
the  role  of  innervation  in  myogenesis,  I  have  employed  a  molecular  genetic  method  in  
mouse  that  allows  for  the  wholesale  removal  of  motor  neurons  from  the  outset,   thus  
excluding   any   neural   influence   on   muscle   development.   In   addition,   through   this  
method,   detrimental   consequences   on   embryo   morphogenesis   after   surgical  
manipulation,   factors   arising   from   stage   differences   due   to   delayed   timing   of  
denervation  as  well  as  incomplete  or  nonspecific  drug-­‐‑effects  can  be  circumvented.  As  
a   proof   of   principle,   in   both   R26fxDTAxOlig2Cre   and   Isl2fxDTAxOlig2Cre  mice,   only   motor  
neurons   and   oligodendrocytes   (only   in   R26fxDTAxOlig2Cre   mice)   were   ablated   whilst  
other  cells  in  the  spinal  cord  were  left  intact,  thereby  demonstrating  the  specificity  of  
both  mouse   lines.  More   importantly,   a   similar  pattern  of   skeletal  muscle  hypoplasia  





neurons   are   ablated   at   the   progenitor-­‐‑stage   and   postmitotic-­‐‑stage,   respectively,  
indicating   that   impacts   on  muscles   observed  were   specifically   caused  by   the   lack   of  
motor   innervation.   Thus,   this   genetic   approach   allowed  me   to   selectively   study   the  
impact  of  innervation  on  embryonic  myogenesis  while  eliminating  variables  inherent  
to  mechanical  or  laser  ablation  of  the  spinal  cord,  and  pharmacological  application  to  
create  aneural  or  paralyzed  muscles.  
  
4.2. Primary  and  secondary  myotubes  form  aneurally  
That   functional   innervation   is   required   for   maintaining   muscle   integrity   and/or  
survival   is   widely   accepted   (McLennan,   1994),   but   to   what   extent   muscle  
development,  specifically  primary  or  secondary  myogenesis  or  myotube  maintenance  
are   vulnerable   to   denervation      remains   a   contested   issue.   Contrary   to   the   two  
opposing   views   on   the   dependence   of   either   primary   or   secondary   myogenesis   on  
innervation,  my  results  obtained   from  selective  and  complete  genetic   suppression  of  
innervation   show   that   denervation   affects   both   primary   and   secondary  myotubes.   I  
found  that  primary  myotubes  form  in  muscles  of  R26fxDTAxOlig2Cre  mice  (evidenced  by  
the  presence   of   slow  MyHC+   fibers),   but   eventually  degenerate   via   apoptosis   by   the  
end   of   gestation.   This  was   based   on  my   observation   that   reduced  muscle  mass  was  
manifested   in  aneural  embryos  at  stages  prior   to   initiation  of  secondary  myogenesis.  
Thus,  the  initial  generation  of  primary  myotubes  does  not  appear  to  depend  presence  
of  nerves.  Rather,  innervation  seems  to  be  crucial  for  myofiber  terminal  differentiation  
(discussed  further  below).  
Previous  studies  based  on  β-­‐‑BTX  injection  in  rodents  concluded  that  the  generation  of  
secondary,  but  not  primary  myotubes  is  a  nerve-­‐‑dependent  process  (Ross  et  al.,  1987;  
Wilson  and  Harris,  1993).  Contrastingly,  I  found  that  muscle  fibers  with  EdU+  central  
nuclei,   which   are   generated   during   secondary   myogenesis,   were   present   in   motor  





muscle   mass   increases   as   development   proceeds   even   after   the   period   of   primary  
myogenesis;   the   source   of   which   could   only   come   from   the   continuous   addition   of  
newly   formed   secondary   fibers,   until   the   appearance   of   satellite   cells   at   E16.5.   The  
disparity  between  my  results  and  that  of  earlier  studies  (Ross  et  al.,  1987;  Wilson  and  
Harris,  1993)  most  likely  come  from  the  latter’s  use  of  β-­‐‑BTX  to  destroy  nerves  and  its  
inherent   problems   (see   above).   However,   relative   muscle   mass   was   progressively  
reduced  even  after  primary  myogenesis  in  R26fxDTAxOlig2Cre  mice  when  normalized  to  
controls,   and   is   likely   attributed   to   the  degeneration  of   secondary  myotubes.  Hence,  
my   results   conclusively   show   that   in   genetically-­‐‑induced   aneural  muscle,   secondary  
myofibers   are   generated,   but   eventually   degenerate   in   the   continued   absence   of   the  
nerve.   However,   due   to   current   technical   limitations,   the   extent   (if   at   all)   of  
compromised  secondary  myotube  generation  in  these  embryos,  which  could  likely  be  
a  consequence  of  ongoing  primary  myofiber  degeneration  and  thus  lack  of  structural  
support  (Kelly  and  Zacks,  1969)  for  their  formation,  can  currently  not  be  ruled  out.  
Fredette   and   Landmesser’s   (1991)   estimate   of   the   ratio   of   primary   to   secondary  
myotubes  was  derived   from  chick  muscle   sections  stained  with  an  anti-­‐‑slow  myosin  
(avian  slow  MyHC  2  and  3  isoforms)  antibody.  However,  because  the  amount  of  slow  
MyHC  2  and  3  isoforms  was  reduced  in  denervated  (and  paralyzed)  chick  myotubes  
(Crow  and  Stockdale,  1986;  McLennan,  1994),  the  antibody  may  not  sufficiently  detect  
affected  myotubes,  and  may  thus  give  an  inaccurate  representation  of  the  proportion  
of   primary   to   secondary   myotubes.   In   my   studies,   I   have   also   used   an   antibody  
recognizing   slow  myosin   isoform   to   identify   primary  myotubes,   but   this   particular  
myosin   isoform   (Myh7)   was   unaffected   after   denervation   in   R26fxDTAxOlig2Cre  mice.  
Another   study   supporting   the   hypothesis   by   Fredette   and   Landmesser   (1991)   was  
based   on   inducing   denervation   in   E14.5   mouse   embryos   via   laser   ablation   of   the  
lumbosacral   spinal   cord   (Hughes   and   Ontell,   1992).   A   major   caveat   in   the   latter  
experiment   is   the  differentiation  of  primary  and   secondary  myotubes  based  on   size.  





at   the   onset   secondary   myogenesis,   secondary   myotubes   also   rapidly   increase   in  
diameter  as  development  proceeds  (McLennan,  1994).  Therefore,  while  this  technique  
is   informative   at   early   stages   of   embryogenesis,   it   is   less   so   at   later   stages   when  
primary   and   secondary   myotubes   have   comparable   sizes   and   may   be  
indistinguishable  from  one  another,  thus  preventing  a  precise  estimation  of  primary  to  
secondary   fiber   ratios.   Interestingly,   to  my  knowledge,   none  of   the  previous   studies  
addressed  possible   impacts  denervation  or   lack   of   neuromuscular   transmission  may  
have  on   the  subsequent  differentiation  of  myotubes.  Although  muscles  were   formed  
aneurally   in  R26fxDTAxOlig2Cre  mice,   I   observed   that   they   indeed   exhibited   profound  
morphological  defects  such  as  hypertrophy  and  terminal  differentiation  blockade  that  
preceded  myotube  degeneration.  These  events  were  further  heralded  by  impairments  
in  the  regulation  of  the  expression  of  several  genes  encoding  essential  components  of  
the   skeletal   muscle   fiber   contractile   apparatus,   as   demonstrated   by   the   early  
downregulation  of  these  genes  at  E13.5  prior  to  detection  of  muscle  loss.  Thus,  while  
primary   and   secondary  myogenesis   are   initiated   in   the   absence   of   innervation,   they  
still  depend  on  innervation  for  eventual  survival.  
  
4.3. Paradoxical  hypertrophy  of  aneural  muscle  fibers  
It   is   established   that   in   the   adult   after   denervation,   muscle   fibers   undergo   atrophy  
brought   about   by   increased   protein   breakdown   (Bodine   et   al.,   2001;   Moresi   et   al.,  
2010).  Unexpectedly,  although  skeletal  muscle  hypoplasia  and  decreased  fiber  density  
was   observed   in   R26fxDTAxOlig2Cre   mice   following   motor   neuron   removal,   the  
individual   muscle   fibers   exhibited   an   increase   in   the   average   CSA   (cross   sectional  
area),   suggesting   that   the   muscle   fibers   hypertrophied   in   the   absence   of   motor  
innervation.   Hypertrophy   is   a   multifaceted   process   that   can   be   activated   through  
different  mechanisms.   However,   the   larger   diameters   of   aneural   fibers   encountered  





proteins  involved  in  the  underlying  pathways,  including  Insulin-­‐‑like  growth  factor  1-­‐‑
Akt   kinase/Protein   kinase   B,   (Igf-­‐‑Akt1/Pkb)   and   their   downstream   effectors,   such   as  
mammalian   target   of   rapamycin   (Mtor),   S6   kinase   (S6k)   and   Glycogen   synthase  
kinase-­‐‑3   beta   (Gsk3b)   (Schiaffino   and   Mammucari,   2011),   were   not   differentially  
regulated  by  embryonic  dennervation  according  to  transcriptome  data  that  I  obtained  
in   this   study.   Additionally,   a   downregulation   in   the   expression   of   genes   encoding  
putative   hypertrophic  markers,   Ankrd1   and  Ankrd2,   which   are   involved   in   dilated  
cardiomyopathy   (DCM)   and   skeletal   muscle   hypertrophy   in   response   to   prolonged  
mechanical  stretch  (Kojic  et  al.,  2004;  Moulik  et  al.,  2009),  respectively,  was  observed  in  
aneural  R26fxDTAxOlig2Cre  muscles.   Thus,   the  mutant  muscle   fibers  with   a   larger  CSA  
may   undergo   compensatory   hypertrophy   as   a   consequence   of   their   degeneration  
and/or  defective  separation  of  secondary  from  primary  fibers.    
Consistently,   it   was   previously   found   that   the   slow   anterior   lattisimus   dorsi   (ALD)  
muscles   in   the   chick   (increased   by   30%   after   3   weeks   of   denervation),  while   other  
reports  suggested  that  in  adult  rat  and  mouse  denervation  induces  an  increase  in  fiber  
area   and   size   (Jung   and  Wu,   1962;   Feng   and   Lu,   1965;   James,   1976;   Connold   et   al.,  
1993).  Notably,   the  degenerative   changes  observed   in  R26fxDTAxOlig2Cre  muscle   fibers,  
such  as  elevated  apoptosis  and  centralized  myonuclei,  were  akin  to  those  described  in  
denervated   atrophic  muscles   (Jung   and  Wu,   1962).   A   clue  might   come   from   genes,  
including  Kcnc4   and  Scn3b   encoding   skeletal  muscle-­‐‑specific   ion   channels   that  were  
also  negatively  affected  by  the   lack  of  motor  neurons.   It   is   therefore  conceivable  that  
the  increase  in  muscle  fiber  CSA  in  these  embryos  was  an  additive  degenerative  effect  
caused   by   the   abnormal   influx   and   efflux   of   ions   into   and   out   of   the   muscle   cell.  
Denervated   embryonic   “swollen”  muscle   fibers   have   also   been  described   by  Wilson  
and  Harris  (1993),  which  was  ascribed  to  degeneration.  Alternatively,  since  secondary  
fibers  form  on  the  scaffold  of  larger  primary  fibers  and  separate  from  the  parent  fiber  
after  maturation  to  be  encased  in  its  own  basal  lamina,  it  is  possible  that  the  increase  







Regarding   potential   compensatory   responses   to   denervation,   increases   in   Pax7+  
satellite   cells   after   denervation   have   been   reported   by   studies   performed   in   adult  
rodents   (McGeachie,   1989;   Viguie   et   al.,   1997).   The   number   of   satellite   cells   was  
highest   in   adult   limb   muscles   1   week   postdenervation   when   compared   to   the  
contralateral   innervated   limb,   and   this   proliferation   sustained   for   about   4   weeks  
before   the  pool  of  satellite  cell  precursors   finally  became  depleted   (McGeachie,  1989;  
Viguie   et   al.,   1997).   Likewise,   an   elevation   of   Pax7+   cells   in   muscles   of   embryonic  
R26fxDTAxOlig2Cre   mice   was   detected,   suggesting   increased   proliferation   and/or  
activation   of   satellite   cells   as   a   compensatory   response   to   the   progressive   loss   of  
muscle   mass   following   denervation.   Therefore,   it   appears   that   the   recruitment   of  
satellite  cells  after  denervation  is  a  common  response  both  in  the  embryo  and  adult.  
  
4.4. Innervation  drives  terminal  differentiation  of  muscle  fibers  
The   failure   of   sarcomeres   to   form   in   R26fxDTAxOlig2Cre   mice   indicates   a   failure   of  
myotube   terminal   differentiation   in   R26fxDTAxOlig2Cre   embryos.   During   muscle   fiber  
terminal   differentiation   nascent   elongated   myotubes   form   the   contractile   apparatus  
through  myofibrillogenesis  that  normally  commences  after  myoblast  fusion  is  initiated  
(Eftimie  et  al.,  1991).  In  the  adult,  long-­‐‑term  denervation  can  result  in  a  similar  poorly  
developed   contractile   system   in   newly   formed   myotubes   and   defective   terminal  
differentiation   (Borisov   et   al.,   2005).   Research   performed   in   chronically   denervated  
rats   by   Borisov   and   colleagues   (2005)   showed   that   most   of   the   underdeveloped  
satellite   cell-­‐‑derived  myotubes  undergo  degeneration,   and   those   remaining   that   had  
previously  formed  on  the  surface  of  parent  myotubes  beneath  the  basal  lamina  did  not  
contain   developed   myofibrils.   In   agreement   with   their   results,   denervation   during  





secondary   muscle   fibers   which   contained   no   sarcomeres   and   were   susceptible   to  
apoptosis.  The  stage  at  which  mice  were  denervated  could  be  a  possible  explanation  as  
to  why  Hughes  and  Ontell   (1992)  reported  normal  muscle  fiber  morphology  with  no  
terminal   differentiation   blockade   upon   denervation.   Mice   used   in   their   study   were  
denervated   by   laser   ablation   of   the   lumbosacral   spinal   cord   at   E14.5,   a   time   when  
hindlimb  muscles  are  already  functionally  innervated.  Thus,  existing  neural  influence  
present   during   E14.5   might   be   sufficient   to   drive   terminal   differentiation,   thereby  
alleviating   potential   denervation-­‐‑induced   skeletal   muscle   fiber   defects   in   these  
embryos.  
Terminal   differentiation,   besides   sarcomere   formation   events,   also   features   the  
transcriptional   activation   of   a   battery   of   muscle-­‐‑specific   genes   leading   to   the  
expression   of   metabolic   enzymes,   ion   channels   and   neurotransmitter   receptors  
(Eftimie  et  al.,  1991).  The  switch  from  embryonic-­‐‑type  to  adult-­‐‑type  nAChRs,  a  feature  
of  muscle  maturation,   is   similarly   thought   to   be   under   the   influence   of   innervation  
(Adams  et  al.,  1995).  Denervated  adult  muscle   fibers  exhibit  hypersensitivity   to  ACh  
(Axelsson  and  Thesleff,  1959),  caused  by  increases  in  levels  of  embryonic-­‐‑type  nAChR  
RNAs   within   24-­‐‑48   h   postdenervation   (Goldman   et   al.,   1988).   Contrary   to   these  
findings,   transcripts   of   β-­‐‑subunit   (Chrnb1)   of   nAChRs   were   found   to   be   1.24-­‐‑fold  
higher   in   innervated  embryonic  muscles   compared   to  R26fxDTAxOlig2Cre  muscles   (data  
not  shown),  whereas  no  significant  differences  were  detected  for  transcripts  of  α-­‐‑,  δ-­‐‑,  
γ-­‐‑  and  ε-­‐‑subunits.  The  reason  for  this  discrepancy  is  unclear,  but  could  be  due  to  age  
difference   as   studies   performed   on   denervation-­‐‑induced   muscle-­‐‑specific   gene  
transcriptional   control  were  mostly  on  adult  mice.  Alternatively,   the   initialization  of  
muscle-­‐‑AChR   clusters   is   documented   to   occur   around   E13.5-­‐‑14.5,   and   E15.5   (a   time  
when   transcriptome   profiling   was   done)   may   be   too   early   to   observe   any   possible  
adverse  effects  of  denervation  on  gene  expression  of  AChR  subunits,  which  may  only  
become  apparent  at  later  stages  of  development.  Hence,  from  current  results  it   is  not  





since   their   gene   expression   has   not   yet   been   examined   beyond   E15.5   in  
R26fxDTAxOlig2Cre  mice.  
Myogenin   and   MyoD   proteins   are   known   to   be   under   the   influence   of   electrical  
activity,  as  well  as  to  bind  to  enhancers  or  promoters  of  muscle-­‐‑specific  genes  such  as  
Ckm   and  Myl   in   order   to   activate   their   transcription   during   muscle   differentiation  
(Edmondson  and  Olson,  1989;  Lassar  et  al.,  1989;  Brennan  and  Olson,  1990).  Consistent  
with   this,   without  motor   neurons,   genes   encoding   structural   proteins   and   enzymes  
such   as   Myl2,   Myl3   and   Ckm   were   downregulated   at   E13.5   or   E15.5   in   aneural  
R26fxDTAxOlig2Cre  muscles.   Intriguingly,   at   E15.5,   genes   encoding   both   MRF   proteins  
were   not   differentially   expressed   between   control   and   aneural   R26fxDTAxOlig2Cre  
muscles,  suggesting  that  the  downregulation  of  muscle-­‐‑specific  genes  was  unlikely  the  
result   of   modulation   by   myogenin   and   MyoD.   Rather,   this   could   normally   be  
mediated   by   another   closely   related   MRF   member,   Myfd,   whose   transcripts   were  
congruently  decreased  before  E15.5   in  my  study  and  which  can  bind  to   the  same  cis  
elements  as  myogenin  and  MyoD  (Murre  et  al.,  1989).  In  line  with  this  hypothesis,  all  
variants   of  Myfd   null  mice   express   significantly   lower   levels   of  MyHC-­‐‑emb   isoform  
(Braun   and   Arnold,   1995;   Patapoutian   et   al.,   1995;   Zhang   et   al.,   1995;   Olson   et   al.,  
1996),   indicating   that  Myfd   can   indeed   regulate   genes   independent   of   other   MRF  
proteins.  The  lower  levels  of  MyHC-­‐‑emb  in  Myfd  null  mice  can  also  be  reasoned  to  be  
effects   from   the   reduction   of   Myf5   expression   that   consequently   accompanies   the  
deletion  of  the  Myfd  allele  (Braun  and  Arnold,  1995).  However,  MyHC-­‐‑emb  transcripts  
were   also   detected   at   significantly   lower   levels   in   aneural   R26fxDTAxOlig2Cre  muscles  
with  dampened  Myfd  gene  expression,  while  Myf5  gene  expression  was  unchanged.  In  
the   attempt   to   identify   possible   genes   transactivated   by   Myfd,   further   analysis  
involving   Myfd   binding   sites   contained   within   enhancers   of   other   muscle-­‐‑specific  
genes  and  ‘late  response’  genes  would  be  helpful.    





myotubes   of   R26fxDTAxOlig2Cre   mice,   it   was   well   preserved   in   myotubes   of  
R26fxTeNTxOlig2Cre  mice.  Nerve  activity-­‐‑induced  effects,  specifically  Ca2+  transients,  could  
be   an   underlying   cause   for   this   disparity   observed.   Ca2+   transients   induced   after  
depolarization  of  end  plate  potentials  stimulated  by  ACh  release  from  the  presynaptic  
motor  nerve  and  the  resultant  contractile  activity  is  known  to  govern  most  aspects  of  
myofibril   assembly,  protein   turnover,   and  myofibril  maintenance   (Sharp   et   al.,   1993;  
Berchtold  et  al.,  2000).  Specifically,  spontaneous  Ca2+  transients  normally  occur  during  
embryonic   myogenesis   to   phosphorylate   myosin   light   chain   kinase   (Mylk)   that   is  
permissive  for  myosin  thick  filament  assembly  (Flucher  and  Andrews,  1993;  Ferrari  et  
al.,   1996;   Ferrari   et   al.,   1998).   These   Ca2+   transients   are   expected   to   be   abolished   in  
completely  aneural  R26fxDTAxOlig2Cre  mice  with  motor  neuron  removal,  which  may,  in  
addition   to   transcriptional   regulation  by  MRFs,  explain   the  downregulation  of  genes  
encoding   several   myosin   heavy   and   light   chain   isoforms   observed   in   these   mutant  
mice.  Consequently,  blocking  Ca2+   transients  will  also   lead  to  the  disruption  of  actin,  
titin  and  capZ  organization  in  the  sarcomere  (Li  et  al.,  2004).    
The   interaction   between   actin   and   myosin   is   required   for   later   stages   of  
myofibrillogenesis   in   the   advanced   consolidation   of   the   myofibril   (Flucher   and  
Andrews,   1993).   This   interaction   is   disrupted   in   the   absence   of   Ca2+   transients   in  
R26fxDTAxOlig2Cre   mice,   which  may   in   part   underlie   the   loss   of   sarcomeric-­‐‑associated  
gene   expression   in   these   mutant   mice.   Thus,   assuming   that   only   evoked  
neurotransmission  was  completely  suppressed   in  R26fxTeNTxOlig2Cre  mice,  spontaneous  
Ca2+   transients   would   still   be   generated,   and   might   be   sufficient   to   establish   the  
periodic  organization  of  sarcomeres  observed  in  these  mice.  Furthermore,   if   terminal  
differentiation  blockade  was  indeed  manifested  by  the  downregulation  of  Myfd,  which  
is  downregulated   in  both  R26fxTeNTxOlig2Cre  and  R26fxDTAxOlig2Cre  mice,  Myfd  does  not  
seem  to  act  solely   to  promote  terminal  differentiation.  Rather,   it  may  involve  several  
other   cofactors   which   are   obligatory   in   regulating   the   differentiative   properties   of  





nonetheless   differentiated   muscles   of   R26fxTeNTxOlig2Cre   mice.   Electrical   or   trophic  
activity  derived  from  the  motor  nerve  has  been  suggested  to  have  significant  effects  on  
the  terminal  differentiation  of  myotubes  (Borisov  et  al.,  2005).  Herein,  Ca2+   transients  
can   be   regarded   as   one   of   many   outcomes   of   neural   influence   on   myogenesis,  
triggering   downstream  pathways   that   support   terminal   differentiation   of  myotubes.  
As   Ca2+   transients   can   also   arise   from   cholinergic-­‐‑driven   spontaneous   activity,   it   is  
pertinent  to  thoroughly  examine  the  sarcomere  structure  and  organization,  in  addition  
to   gene   expression,   in   muscles   of   motor   neuron   Chat-­‐‑deficient   mice   in   order   to  
uncover  possible  roles  for  ACh-­‐‑mediated  spontaneous  activity  in  myogenesis.  
  
4.5. Primary  and  secondary  myotubes  are  formed  during  embryonic  paralysis    
Removal   of   neurotransmission   in  R26fxTeNTxOlig2Cre  mice   resulted   in  markedly  milder  
skeletal  muscle  hypoplasia   and  a   later   onset   of  muscle   loss  when   compared   to  mice  
with   wholesale   motor   neuron   ablation.   Intriguingly,   absence   of   neuromuscular  
transmission   in   Chat   null   mice   appear   to   completely   mirror   the   effects   on   muscle  
observed  in  aneural  embryos.  The  later  loss  in  muscle  mass  in  older  R26fxTeNTxOlig2Cre  
embryos  strongly  suggest  subsequent  degradation  of  later-­‐‑generated  secondary  fibers,  
although   it   cannot   be   ruled   out   that   paralyzed   primary  myotubes  may   also   have   a  
delayed  degeneration.  It  is  noteworthy  that  TeTx  (tetanus  toxin)  has  been  shown  to  act  
differentially   in   blocking   spontaneous   and   evoked   neurotransmission.   TeTx  
completely  blocks  evoked  (action  potential-­‐‑dependent)  neurotransmission  whereas   it  
only  reduces  spontaneous  quantal  release  by  preventing  the  fusion  of  docked  synaptic  
vesicles   with   the   plasma  membrane   of   nerve   endings   (Humeau   et   al.,   2000).   In   the  
crayfish   motor   synapses,   TeNT   (TeTx   light   chain)   does   not   affect   the   frequency   of  
spontaneous   events   whereas   these   were   reduced   moderately   in   transgenic   TeNT-­‐‑
expressing   Drosophila   larval   neuromuscular   synapses   (Sweeney   et   al.,   1995).   This  





proposed  to  be  in  part  attributed  to  the  possible  different  apparatus  underlying  their  
vesicle   release   (Broadie   et   al.,   1995;   Deitcher   et   al.,   1998;   Yoshihara   et   al.,   1999).  
Assuming   that   spontaneous   release   is   still   present   even   at   a   reduced   rate   in   the  
R26fxTeNTxOlig2Cre  mice,   it   can   be   hypothesized   that   constant   spontaneous   release   is  
likely  to  be  critical  for  early  myogenesis,  before  neuromuscular  apparatus  are  properly  
specialized   and   before   evoked   action   potentials   are   initiated.   This   hypothesis   can  
thereby   explain   the  milder   skeletal  muscle  phenotype   observed   in  TeNT  mutants   in  
comparison  to  R26fxDTAxOlig2Cre  mice,  as  well  as  the  later  onset  of  muscle  loss  observed  
during   advanced   stages   of   development   (when   nerve-­‐‑evoked   activity   becomes  
predominant).   Alternatively,   the   reason   why   skeletal   hypoplasia   was   less   severe   in  
R26fxTeNTxOlig2Cre  mice   could   be   because   TeNT   only   cleaves   synaptobrevin   which   is  
potent   in   preventing   small   vesicle   fusion   (neurotransmitter-­‐‑containing   vesicles),   but  
not  dense  core  vesicles  containing  peptides.  If  the  exocytosis  of  dense  core  vesicles  is  
unaffected   by   TeNT,   contents   in   dense   core   vesicles   would   still   be   periodically  
delivered   to   developing   muscles   and   might   be   supportive   of   the   formation,  
differentiation   and/or  maintenance   of  myotubes.  However,  while   it   is   expected   that  
vesicle   release   is   blocked   in   R26fxTeNTxOlig2Cre  mice,   it   remains   to   be   directly   tested  
whether   or   not   spontaneous   vesicle   release   would   still   be   present   in   the  
neuromuscular   junctions   of  R26fxTeNTxOlig2Cre   embryos   or  whether   these   results  were  
due   to   insufficient   TeNT   expression   levels   resulting   in   an   incomplete   block   of  
neuromuscular  transmission.  
Previous  work  using  paralyzing  agents  (d-­‐‑tbc,  α-­‐‑BTX)  have  pointed  out  that  the  nerve  
supports   secondary   myotube   formation   (Sohal   and   Holt,   1980;   Fredette   and  
Landmesser,  1991b;  Ashby  et  al.,  1993a)  and  hinted  towards  ACh  as  having  a  trophic  
effect   on  myogenesis   (Drachman,   1967).   Even   so,   the   extent   of   the   requirements   for  
ACh  during  embryonic  myogenesis  should  not  be  conclusively  determined  solely  by  
observing  the  effects  caused  by  preventing  the  activation  of  postsynaptic  acetylcholine  





drugs   administered   (see   above).   Besides  R26fxTeNTxOlig2Cre  mice,   this   study   also   used  
Chat  null  mice  with  both   spontaneous  and  evoked  ACh  neurotransmission  blockade  
(Brandon   et   al.,   2003).   Mice   lacking   Chat   were   also   born   with   complete   paralysis  
(Brandon   et   al.,   2003),   and   phenocopied   skeletal   muscle   defects   in   R26fxDTAxOlig2Cre  
mice.  This  finding  is  in  line  with  the  hypothesis  that  spontaneous  activity  is  important  
in  early  stages  of  muscle  development  whereas  evoked  activity  plays  an  indispensable  
role   during   later   stages   of   development.   Moreover,   the   phenotypic   stunted   muscle  
mass   in   Chat   null   mice   is   likely   to   be   attributed   to   the   loss   of   ACh,   although  
possibilities  such  as  Chat  having  other  nonenzymatic  activities  and  nonspecific  effects  
from   Schwann   cells   (which   have   been   known   to   express  Chat   in   culture)   cannot   be  
ruled  out  (Brockes,  1984).    
Despite  these,  the  use  of  Chat-­‐‑deficient  mice  permits  the  exclusion  of  effects  from  other  
trophic   factors   on   skeletal   muscle   development;   combining   data   obtained   from  
R26fxTeNTxOlig2Cre  and  Chat  null  mice  strongly  suggests  quantal  release  of  ACh  to  be  the  
main  nerve-­‐‑derived  component  responsible  for  the  upkeep  of  myotubes  during  early  
stages   of   myogenesis   (probably   E12.5-­‐‑E15.5)   whereas   action   potential-­‐‑dependent  
evoked   release   of  ACh   is   supportive   of  myotube   survival   after   E15.5  when   there   is  
increasing  evoked  activity   (Moody  and  Bosma,  2005).  This  proposition  substantiated  
with  existing  results,  pending  on  the  efficacy  of  TeNT,  though  attractive,  does  not  yet  
address   if   (1)   primary   or   secondary   myotubes   are   preferentially   affected   by   nerve  
activity  and  if  (2)  terminal  differentiation  of  myotubes  is  dependent  on  ACh-­‐‑mediated  
neural   activity.   Also,   because   a   systemic   knockout   of   Chat   was   used   in   this   study,  
unlikely  nonspecific  effects   from  the   lack  of  ACh   in   the  sympathetic  nervous  system  
cannot  be  ruled  out  as  yet.  Herein,  the  abovementioned  points  can  be  easily  addressed  
by   the  use  of   transgenic  mice  with  Chat  conditionally   removed   from  motor  neurons,  
and   labeling   myotubes   at   different   stages   with   EdU   as   well   as   examining   skeletal  






4.6. Different  requirements  of  innervation  for  embryonic  and  postnatal  muscles  
The   selective   genetic   extirpation   of   motor   neurons   in   both   R26fxDTAxOlig2Cre   and  
Isl2fxDTAxOlig2Cre  mice  resulted  in  skeletal  muscle  hypoplasia  in  parallel  with  increased  
cell   death   mediated   largely   by   apoptosis,   demonstrating   that   motor   innervation   is  
required   as   an   obligatory   stimulus   for   the   formation   and   continued  maintenance   of  
embryonic  muscle  fibers.  This  is  evidenced  by  the  block  in  terminal  differentiation  of  
aneural  myotubes  and  progressive  muscle  loss  in  both  mutant  embryos.    
In   the   adult,   denervation-­‐‑induced   degeneration   is   a   biphasic   process   that   can   be  
separated   into   an   early   phase   and   a   late   phase   (Borisov   et   al.,   2001;   O'ʹLeary   et   al.,  
2012).  The  early  myogenic  response  represents  a  systemic  reaction  of  the  muscle  to  the  
loss  of  neural  input,  is  characterized  by  the  reactivation  of  myogenesis  in  the  muscle,  
starting  between  days  10-­‐‑21  postdenervation  and  dominates  during  the  first  2  months  
following  nerve  transection  (Borisov  et  al.,  2001).  On  the  other  hand,  during  the  later  
phase,  muscle  fibers  gradually  decrease  in  numbers  with  progressive  postdenervation  
atrophy,   with   cell   death   accompanying   the   atrophic   process   (Borisov   et   al.,   2001).  
Denervation-­‐‑induced   atrophy   involves   protein   degradation   that   is   mediated   by   a  
series  of  intracellular  signaling  networks,  including  the  lysosomal  and  Ca2+-­‐‑dependent  
proteases,  ubiquitin-­‐‑proteasome-­‐‑mediated  proteolysis,  matrix  metalloproteinases  and  
autophagy   (Ventadour   and  Attaix,   2006;   Plant   et   al.,   2009).   Apoptotic   pathways   are  
also  activated  during  adult  denervation  (O'ʹLeary  et  al.,  2012),  as  it  has  been  found  that  
inactivating   caspase   3   in  mice   partially   protects   against   denervation-­‐‑induced   skeletal  
muscle  atrophy  (Plant  et  al.,  2009).  Similarly,  double  knockout  Bax/Bak   (proapoptotic  
factors)  mice   also   display   40%   attenuation   in  muscle   atrophy   following  denervation  
(O'ʹLeary   et   al.,   2012).   However,   apoptosis   in   denervation-­‐‑induced   signaling   is   only  
one   of   the   causes   of   loss   of   muscle   mass,   and   further   cannot   account   for   the  
predominant  muscle  fiber  atrophy  occuring  under  these  conditions  (Plant  et  al.,  2009).  





atrophy   appears   to   be   mediated   predominantly   by   ubiquitin-­‐‑proteasome-­‐‑mediated  
proteolysis  (Beehler  et  al.,  2006).    
Apoptosis-­‐‑mediated  muscle  mass   reduction   is   observed   around   2  weeks   after   nerve  
transection  in  adult  mice  (O'ʹLeary  et  al.,  2012).  In  this  regard,  the  time  course  for  the  
activation   of   apoptotic   signaling   pathway   resulting   in   muscle   mass   reduction  
ostensibly   differs   between   embryonic   and   adult   denervation.   While   caspase   3-­‐‑
activation  was  detected  in  2-­‐‑week-­‐‑denervated  adult  muscles,  a  significant  elevation  in  
cleaved   caspase   3+   cells   could   already   be   observed   within   aneural   muscles   of  
R26fxDTAxOlig2Cre   and   Isl2fxDTAxOlig2Cre   mice   by   E13.5,   approx.   3-­‐‑4   days   after   motor  
neurons  were   ablated   and   1-­‐‑2   days   after   the   initiation   of   primary  myogenesis.   This  
difference  between  the  activation  of  denervation-­‐‑induced  apoptotic  signaling  pathway  
may   hint   at   fundamental   distinctions   in   the   requirements   of   innervation   between  
embryonic   and   postnatal   muscles.   Consistent   with   this,   biochemical   and   structural  
muscle  properties   that  were   altered   after   embryonic  denervation   are   also   essentially  
different   from   that   observed   after   adult   denervation.   While   adult   muscle   fibers  
atrophied   after  denervation,   denervation  during   embryogenesis   resulted  not   only   in  
skeletal   muscle   hypoplasia,   but   also   in   “hypertrophy”   or   “swelling”   of   individual  
muscle   fibers.   Additionally,   although   structural   changes   including   sarcomere  
dissolution,   endothelial   degradation   (Oki   et   al.,   1995)   and   cellular   changes   such   as  
fewer   mitochondria   numbers   (Rifenberick   et   al.,   1973),   accumulation   of   connective  
tissue  and  an  abolition  in  apoptotic  myonuclei  (Oki  et  al.,  1995)  are  seen  in  the  adult  
muscle   cell   undergoing  denervation-­‐‑induced   atrophy,   denervation   in   the   embryonic  
muscle  fibers  is  manifested  by  a  block  in  terminal  differentiation.  It  can  be  argued  that  
the   lack   of   sarcomeres   in   myotubes   of   R26fxDTAxOlig2Cre   mice   could   be   caused   by  
degenerative  changes   leading  to  sarcomere  disassembly.  However,  sarcomeres  never  
seemed  to  form  in  aneural  embryonic  muscle  fibers,  as  ultrastructural  examination  of  
E15.5   muscles   showed   sparse   myofibrils   in   nascent   aneural   myotubes   and   no  





pattern  of  skeletal  muscles  was  not  detected  in  E14.5  muscle  fibers  of  R26fxDTAxOlig2Cre  
mice  by  sarcomeric-­‐‑antibodies.  
In   the   adult,   catabolic   pathways   which   partake   in   neurogenic   atrophy,   notably   the  
proteasome   pathway   (ubiquitin-­‐‑mediated   proteolysis)   and   autophagy   (lysosomal-­‐‑
dependent  degradation)  are  starting  to  be  elucidated  (Beehler  et  al.,  2006;  Moresi  et  al.,  
2010;   Bricceno   et   al.,   2012;   O'ʹLeary   et   al.,   2012).   In   contrast,   the   precise   molecular  
mechanisms  underlying  embryonic  denervation  remain  undefined,  and  it  is  similarly  
unclear   if   they   operate   in   a   similar   fashion   as   in   the   adult.   The  key   feature   of   adult  
proteasome  pathway  controlling  neurogenic  atrophy  is  the  upregulation  of  myogenin,  
an  essential  regulator  of  embryonic  myogenesis  (Moresi  et  al.,  2010).   In  the  postnatal  
muscle   gene   regulatory   circuit,   the   lack   of   innervation   causes   an   upregulation   of  
Hdac4/5   leading   to   the   inhibition   of   Dach2,   thereby   permitting   myogenin   to   be  
transcriptionally  active  and  to  bind  to  E-­‐‑boxes  located  upstream  of  E3  ubiquitin  ligase  
genes  such  as  MuRF1  and  Atrogin-­‐‑1,  finally  resulting  in  muscle  atrophy  (Bodine  et  al.,  
2001;   Moresi   et   al.,   2010;   Macpherson   et   al.,   2011).   Gene   expression   profiles   of  
R26fxDTAxOlig2Cre  hindlimbs  obtained  in  this  study  suggest  that  embryonic  denervation  
operates   through   pathways   differing   from   the   adult   denervation   pathways,   because  
none   of   the   genes   implicated   in   the   proposed   pathway,   including  MAFbx/Atrogin-­‐‑1  
and   MuRF1/Trim63   were   differentially   affected   in   R26fxDTAxOlig2Cre   mice,   while  
transcripts  encoding  E3  ubiquitin  ligases  MuRF1  and  Atrogin-­‐‑1  remained  at  very  low  
levels  in  both  control  and  mutant  embryos.  
Myogenin  was   identified   as   having   dual   roles:   being   an   essential   factor   in   driving  
myogenic  differentiation  (Hasty  et  al.,  1993),  and  participating  in  neurogenic  atrophy  
(Moresi  et  al.,  2010).  Hence,  it  was  unforeseen  that  its  expression  was  unaffected  in  the  
absence  of   innervation  at  E15.5.  Nevertheless,   qPCR  analysis  of  myogenin   expression  
conclusively  determined  its  significant  upregulation  at  late  perinatal  stages  (E18.5),  in  





ubiquitin-­‐‑proteasome   pathway   in   response   to   postnatal   denervation   (Moresi   et   al.,  
2010;  Macpherson  et  al.,  2011).  Therefore,  while  it  is  evident  that  embryonic  and  adult  
denervation   pathway   function   via   diverse   effector   molecules,   the   finding   that  
myogenin  is  only  upregulated  at  late  developmental  stages  could  suggest  the  existence  
of  a  transitional  time  point  by  late  gestation  during  which  the  remaining  muscle  fibers  
switch   to   a  more   adult-­‐‑like   response   towards   continuing   denervation.  Additionally,  
previous   studies   in   adult   mice   reported   that   innervation   is   responsible   for  
downregulating   embryonic-­‐‑type   nAChRs   (Schuetze   and   Role,   1987)   and   adhesion  
molecules   (Covault   et   al.,   1986),   leaving   the   expression   of   gene   encoding   muscle-­‐‑
specific   enzymes   or   structural   proteins   such   as   creatine   kinase   (Ckm),   myosin   light  
chain   (Myl)   and   skeletal   α-­‐‑actin   (Acta1)   wholly   unaffected   (Eftimie   et   al.,   1991).  
However,  in  my  study,  genes  encoding  these  muscle-­‐‑specific  genes  were  expressed  at  
significantly   lower  levels   in  aneural  R26fxDTAxOlig2Cre  muscles.  Reduction  in  Myl2  and  
Myl3   transcript   levels   in  aneural  muscles  could  already  be  detected  as  early  as  E13.5  
(before   the   onset   of   muscle   loss),   thereby   excluding   the   possibility   that   their  
downregulation   was   due   to   secondary   effects   caused   by   muscle   degeneration,   but  
rather  by  a  block  in  terminal  differentiation,  reflected  by  their  failure  to  fully  express  
genes  encoding  certain  isoforms  of  contractile  proteins.  Taken  together,  the  differences  
in   the   response   of  muscles   (i.e.,   hypertrophy   vs.   atrophy,   sarcomere   dissolution   vs.  
terminal   differentiation   block),   signaling   pathways   involved   (excluding   apoptosis),  
time   course   in   activation   of   caspase   3,   as   well   as   the   downstream   genes   towards  
embryonic   and   adult   denervation   underscore   the   different   requirements   that  
embryonic  and  postnatal  muscles  may  have  for  innervation.  
Finally,  since  many  pathways  mediate  denervation-­‐‑induced  degeneration  in  the  adults  
(O'ʹLeary  et  al.,  2012),  one  relevant  question  is  whether  apoptosis   is  the  sole  pathway  
that   is   activated   during   embryonic   denervation.   Hence,   it   would   be   worthwhile   to  
determine   this   by   ablating   motor   neurons   in   proapoptotic   factors   Bax   and   Bak  





hypoplasia   can   be   attenuated   or   rescued   completely   under   these   conditions.  
Furthermore,   microRNA   206   (miRNA   206)   has   been   identified   to   be   implicated   in  
adult   musculature   circuit   in   providing   positive   feedback   to   Hdac4/5   to   promote  
regeneration  (Williams  et  al.,  2009).  It  is  still  elusive  whether  miRNAs  are  involved  in  
post-­‐‑transcriptional  modifications  during  embryonic  denervation,  even  though  Dicer,  
an   miRNA   processing   enzyme,   has   been   shown   to   be   involved   in   embryonic  
myogenesis   (O'ʹRourke   et   al.,   2007).   As   such,   it   would   be   interesting   to   screen   for  
embryonic-­‐‑specific   miRNAs   that   could   potentially   target   some   of   the   positively  
identified  candidate  genes  or  even  the  non-­‐‑differentially  regulated  genes  in  this  study.  
  
4.7. Working  model  
My  findings  provide  conclusive  evidence  that  innervation  is  dispensable  for  initiation  
of  both  embryonic  myotubes,  but  is  absolutely  required  for  the  terminal  differentiation  
and   maintenance   of   both   primary   and   secondary   myotubes,   thus   resolving   a  
longstanding  controversy  regarding  the  precise  role  of  innervation  during  embryonic  
myogenesis.  A  working  model  can  be  proposed  according  to  current  results  obtained  
(Figure   4.1).   Several   permissive   cues   and   effectors   could   mediate   the   effects   of  
innervation  on   the   terminal  differentiation  of  myotubes.   Interestingly,  myoblasts  can  
be  induced  to  differentiate  and  form  sarcomeres  autonomously  in  vitro,  in  the  absence  
of   motor   neurons.   The   difference   from   the   in   vivo-­‐‑situation   likely   reflects   the  
optimization   of   these   long   established   protocols   for   achieving   in   vitro  muscle   fiber  
differentiation  with  extensive  use  of  combinations  of  growth  factors,  which  may  act  in  
concert  to  sidestep  myotube  requirements  for  innervation  in  vivo.  Transcriptome  data  
showed   a   set   of   genes  which   could   reflect   the   potential  myogenic   requirements   for  
innervation.  These  identified  factors  obtained  can  be  thought  of  as  effectors  mediating  
neural   influences   to   muscles.   Together,   they   may   constitute   a   muscle   intrinsic  





transcription   of  muscle-­‐‑specific   and   contractile   genes   to   allow  myotubes   to   be   fully  
functional   (i.e.,   contractile   machinery   formation,   optimized   to   handle   metabolic  
demands,   etc.).   Finally,   denervation,  which   perturbs   the   expression   of   genes   (hence  
protein  activity)  implicated  in  the  innervation-­‐‑dependent  program,  is  hypothesized  to  
cause   incomplete   terminal   differentiation   of   myotubes,   leading   to   their   progressive  
elimination  via  apoptosis-­‐‑mediated  degeneration.  
  
Figure  4.1:  Working  hypothesis.    
Innervation   exerts   its   influence   via   yet-­‐‑unidentified   pathway(s)   and  molecules   to   activate   identified  
candidate   genes,   which   collectively   could   operate   in   an   embryonic   innervation-­‐‑dependent   program.  
These  nerve-­‐‑dependent  genes  may  act  as  effectors   to   turn  on  transcription  of  muscle-­‐‑specific  genes,  a  
step   required   for   terminal   differentiation   to   proceed   normally.   Perturbation   in   the   activation   of   this  
program  results  in  the  progressive  elimination  of  non-­‐‑terminally  differentiated  myotubes  via  apoptosis-­‐‑





On   the   basis   of   time-­‐‑course   qPCR   analysis,   proteins   encoded   by   ‘early   response  
genes’,   especially   Myfd   and   Sapd   might   be   upstream   of   the   signaling   pathway   to  
regulate   genes   affected   by   denervation.   Given   evidence   that   Myfd   trancripts   are  
blunted   (27%)   in   E19  muscles   of   mice   following   laser   ablation   of   their   lumbosacral  
spinal  cord  (Washabaugh  et  al.,  2007),  and  that  Sapd  which  is  localized  to  the  Z-­‐‑disks  
of   the   sarcomere   acts   as   an   obligatory   calcineurin-­‐‑anchoring   protein   in   combination  
with   α-­‐‑actinin   and   calsarcin-­‐‑1   (Heineke   et   al.,   2005),   both   proteins   may   be   directly  
modulated   by   innervation.   Furthermore,   drastic   reduction   in   Sapd   expression   levels  
was   implicated   in   cardiac   myopathy   (Heineke   et   al.,   2005),   and   mutant   Sapd  
heterozygotes   showed   distinct   hypertrophic   response   with   pronounced  
cardiomyocyte   elongation   accompanied   by   reduced  NFAT   transcriptional   activation  
after   induced-­‐‑myocardial   infarction   (Heineke   et   al.,   2005),   suggesting   that  Sapd  may  
also  be  responsible  for  skeletal  muscle  defects  resulting  from  motor  neuron  removal.  
While   functional   studies   of   Snaid   are   rare,   one   in   vitro   study   has   pointed   out   to   its  
possible   role   as   a   differentiation   repressor   (Kataoka   et   al.,   2000),   contradicting   my  
hypothesis   that   differentiation   is   disrupted   in   the   absence   of   innervation.  However,  
while   speculative,   the   early   downregulation   of   Snaid   may   reflect   the   existence   of   a  
negative   regulatory   feedback   mechanism   after   denervation.   Fgfd,   another   ‘early  
response’   gene,   has   both   repressive   and   inductive   roles   in   myogenesis   in   a   dose-­‐‑
dependent  manner   (Armand   et   al.,   2005).   Postnatally,   a   high  dose   of   Fgfd   serves   to  
stimulate  proliferation  of  myogenic  precursors,  whereas  at   lower  doses   it  modulates  
muscle  differentiation  via  the  calcineurin-­‐‑signaling  pathway  (deLapeyriere  et  al.,  1993;  
Armand  et  al.,  2005).  Members  of  the  Fgf  family  are  known  to  interact  with  the  bHLH  
MRF  proteins;  Fgf2  has  been  shown  to  limit  gene  expression  of  at  least  myogenin  and  
MyoD  in  myogenic  cultures  (Vaidya  et  al.,  1989),  and  terminal  differentiation  in  Myfd-­‐‑
expressing   cells   was   inhibited   in   serum-­‐‑free   medium   supplemented   with   basic   Fgf  
(Rhodes   and   Konieczny,   1989).   Since   Fgfd   transcripts   begin   to   accumulate   in  





tempting  to  hypothesize  that   (1)  both  proteins   interact  with  each  other  as  part  of   the  
nerve-­‐‑dependent   intricate   network   consisting   of   positive   and   negative   regulatory  
circuits,  or  (2)  via  Fgfd  modification  of  specific  coregulators  that  interact  with  Myfd  to  
control  myogenesis  during  terminal  differentiation.    
An  equally  imperative  question  that  warrants  further  investigation  is  the  mechanisms  
in   the   regulation   of   candidate   genes   by   innervation   and   the   signaling   molecules  
involved.   Interesting   candidate   pathways   and   molecules   that   could   potentially  
regulate  this  intermediary  step  would  be  (1)  Calcineurin-­‐‑NFAT  pathway  and  (2)  ACh-­‐‑
mediated   spontaneous   activity.   A   large   body   of   work   has   pointed   to   myogenic  
requirements  for  signals  from  Ca2+  and  Ca2+-­‐‑dependent  pathways  (Kegley  et  al.,  2001).  
Firstly,  calcineurin,  a  Ca2+-­‐‑calmodulin  regulated  serine/threonine  protein  phosphatase  
and   a   molecular   target   of   Ca2+,   has   been   documented   to   partake   in   MRF   gene  
expression   (Friday   and   Pavlath,   2001),  myoblast   differentiation   (Delling   et   al.,   2000;  
Friday  et  al.,  2000),  hypertrophy  (Dunn  et  al.,  1999;  Musaro  et  al.,  1999).  Secondly,  one  
downstream   effector   of   calcineurin   is   the   nuclear   factor   of   activated   T   cells   (NFAT)  
which,  when  dephosphorylated  by  calcineurin,  translocates  from  the  cytoplasm  to  the  
nucleus  where   it   acts  as  a   transcription   factor   in   combination  with  Mef2  or  Gata2   in  
skeletal  muscles  (Dolmetsch  et  al.,  1997;  Chin  et  al.,  1998;  Musaro  et  al.,  1999).  Various  
NFAT   isoforms   (c1,   c2  and  c3)  are  expressed  specifically   in   the  muscles;   inactivating  
Nfatc2  in  mice  resulted  in  fiber  type  abnormalities  and  reduced  muscle  size  (Horsley  
et   al.,   2001),   whereas   inactivating   Nfatc3   led   to   reduced   myofiber   numbers   hence  
decreased  muscle  mass  (Kegley  et  al.,  2001).  Even  though  genes  encoding  calcineurin  
and   NFAT   were   not   differentially   expressed   between   control   and   aneural  
R26fxDTAxOlig2Cre  muscles,  posttranslational  modifications  and  activity  level  in  the  two  
effectors  might   be   responsible   for   differences   in   downstream   target   gene   expression  
(possibly  calcineurin-­‐‑  or  NFAT-­‐‑dependent).  This  could  perhaps  involve  the  binding  of  
NFAT  to  the  enhancer/promoter  regions  of  candidate  genes,  or  the  recruitment  of  co-­‐‑





regulation.  One  such  co-­‐‑activator  might  be  Mef2,  known  to  be  de-­‐‑repressed  by  NFAT.  
Additionally,  a  high  expression  level  of  Myf5  (member  of  MRF)  could  be  induced  via  
calcineurin-­‐‑NFAT   signaling   pathways   in   primary   myoblast   cells   treated   with  
ionomycin   (a  bacterial   ionophore  used   to   increase   intracellular  Ca2+   levels)   (Friday  et  
al.,   2000;   Perez-­‐‑Ruiz   et   al.,   2007).   Together,   previous   studies   indicate   that   there   is   a  
direct   interaction  between  calcineurin  pathway,  MRF  expression  and  skeletal  muscle  
differentiation   (Al-­‐‑Shanti  and  Stewart,   2009).  Therefore,   it   is   important   to  examine   if  
components  in  Ca2+-­‐‑dependent  pathways  are  differentially  affected  by  the  removal  of  
motor  neurons  at  the  protein  level  in  order  to  uncover  the  causative  link  between  the  
lack   of   innervation,   downregulation   of   candidate   genes   and   finally   terminal  
differentiation   failure   in   aneural  muscles.   Likewise,   the   possible   importance   of  ACh  
release  especially  during  spontaneous  activity  that  could  serve  as  an  important  trigger  
for  downstream  signaling  pathway   cannot  be  undermined,   and  has   to  be   addressed  
with  conditional  motor  neuron  Chat  knockout  mice.    
  






5.1. In   ovo   electroporation   as   a   screening   platform   for   innnervation-­‐‑dependent  
myogenic  candidate  genes  
Even   though  I   identified  a  set  of  candidate  genes  which  could  potentially   link  nerve  
influence   to   the  promotion  of  myogenesis,   a   challenging  yet  essential   task  will  be   to  
explore  their  functions  during  embryonic  skeletal  muscle  development  in  the  presence  
and  absence  of  the  nerve.  Addressing  this  exclusively  through  gain-­‐‑  or  loss-­‐‑of-­‐‑function  
studies   in   rodents   for   all   genes   of   interest   is   largely   precluded   by   the   limited  
availability   of  mouse   lines,   as  well   as   the   cost,   time,   labor   and   resource-­‐‑consuming  
nature  of   establishing  mouse  genetic  models   for   each   candidate  gene.  Another   issue  
could  be  complications  arising  from  conventional  gene  targeting  studies   in  mice.  For  
instance,  attempts  at  uncovering  the  context  of  gene  activation  by  MRFs  by  using  gene  
targeting  strategies  in  rodents  were  complicated  by  the  cis  interaction  between  closely  
linked  genes  on  a  chromosome,  such  that  deletion  of  one  gene  would  inherently  affect  
the   expression   of   the   other   gene   (Olson   et   al.,   1996).   Therefore,   another   alternative  
screening   platform   is   compulsory   for   addressing   the   role   of   innervation-­‐‑dependent  
candidate  genes  for  embryonic  myogenesis.  
As  a  choice  model,  screening  procedures  for  suitable  candidate  genes  can  be  shifted  to  
the   the   chick   embryo   (Gallus   gallus   domesticus).   Electroporation   is   a   widely-­‐‑used  
technique  for  transfecting  neural  and  mesodermal  tissues  in  chick  embryos  (Wang  et  
al.,  2011a),  and  studies  utilizing  the  somite  and  neural  tube  electroporation  technique  
have   also   been   published   (Delfini   and   Duprez,   2004;   Gros   et   al.,   2004;   Fournier-­‐‑
Thibault   et   al.,   2009).   The   chick   shares   many   conserved   features   regulating  
developmental   processes   and   shows   extensive   homology   in   the   organization   of   the  
nervous   and   skeletal   muscle   systems   with   mammals   (Uchikawa,   2008),   including  





development   (Mok   and   Sweetman,   2011),   thereby   making   in   ovo   electroporation   a  
suitable  as  well  as  a  time-­‐‑  and  cost-­‐‑efficient  method  for  rapid  gene  transfer  to  muscles,  
and  an  alternative  to  rodent  transgenics.  Preliminary  results  obtained  via  chick  somite  
electroporation   using   transposon-­‐‑based   plasmid   constructs   showed   highly   effective  
stable   and   unbiased   gene   transfer   into   limb   muscle   cells   of   late-­‐‑gestation   chick  




Figure  5.1:  A  screening  platform  for  candidate  gene  function.    
(a-­‐‑b)  E9  chick  embryo  with  (a)  brightfield  and  (b)  fluorescence  illumination.  Robust  eGFP  expression  is  
specific  to  hindlimb  of  chick  embryo.  (c-­‐‑h)   Immunostaining  of  (c-­‐‑e)  whole  mount  and  (f-­‐‑h)  transverse  
section  of  E9  chick  hindlimb  with  MF20  and  GFP  antibodies.  Transfected  muscle  fibers  colocalized  with  
MF20+  muscle  fibers  demonstrating  a  high  transfection  efficiency.  (i-­‐‑k)  Fast  myosin  antibody  revealed  
that   MLC1F/3F   promoter   is   not   specfic   to   any   specfic   type   of   muscles,   but   drives   ectopic   gene  
expression  in  all  muscle  fibers.    Muscle  fibers  which  were  negative  for  fast  myosin  were  also  transfected  
and  expressed  eGFP.  Dotted  line  demarcate  slow  and  fast  muscles.  MF20,  pan  muscle  fiber  marker;  F59,  





To   analyze   gene   function   in   the   context   of   denervation   and   to   circumvent   using  
manual   dissection   or   pharmacological   applications   in   chick   embryos,   rescue  
experiments  making  use   of   the   in   ovo   electroporation   of   the   neural   tube   and   somite  
technique  can  be  performed  by  using  the  constructs  listed  in  Figure  5.2  a.    
  
Methodologically,   limb   somites   can   be   co-­‐‑injected   with   transposon   vectors   driving  
expression  e.g.  of  Myfd  as  the  gene  of  interest.  To  genetically  ablate  motor  neurons  in  
chick   embryos,   the   neural   tube   lumen   can   be   injected   and   transfected   into   neural  
progenitor  cells  via  in  ovo  electroporation  with  constructs  driving  expression  of  DTA.  
  
Figure  5.2:  Strategy  to  study  candidate  gene  function  in  context  of  denervation.  
(a-­‐‑b)  To  ablate  motor  neurons  and  overexpress  candidate  genes   in  muscles   for   rescue  experiments   in  
chick   embryo,   (a)   different   vectors   for   in   ovo   neural   tube   and   somite   electroporation  were   used.   (b)  
Schematic  of  site  of  injection  and  positioning  of  electrodes.  (c)  Isl½+  motor  neurons  were  absent  from  the  
transfected   side   of   the   atrophied   spinal   cord.   Dotted   line   demarcates   border   and   bold   line   marks  
midline   of   spinal   cord.   (d)   High   magnification   view   of   transfected   longitudinal   muscle   fibers  
immunostained  with   GFP   and   V5-­‐‑tag   epitope.   Ectopic  Myfd   expression  was   localized   to  myonuclei  





Thereafter,  the  chick  embryo  is  placed  between  two  platinum  electrodes,  followed  by  
electroporation  (Figure  5.2  b).  Successful  removal  of  motor  neurons  can  be  assessed  by  
the  atrophy  of  the  ventral  horn  (lamina  IX)  on  the  transfected  side  of  the  spinal  cord  
and   the   absence   of   Isl   ½+   cells   in   the   ventral   part   of   the   spinal   cord   (Figure   5.2   c).  
Similarly,   successful   ectopic   expression   of   transgene   in   muscle   fibers   can   also   be  
determined  by   immunostaining  with  V5-­‐‑epitope   tag   and  GFP   antibodies   (Figure   5.2  
d).   Taken   together,   this   method   is   applicable   for   future   bioassay   exploring   the  
functions  of  candidate  genes  which  have  been  obtained  in  this  study.  
  
5.2. Spinal  motor  neuron  dependence  on  target  muscles  
Although   this   project   is   dedicated   to   studying   the   dependence   of   muscles   on   their  
innervating  motor   neurons  during   embryogenesis,   it   is   also   inherently   linked   to   the  
converse   dependence   of   motor   neuron   survival   on   retrograde   signals   provided   by  
their   peripheral   target   muscles.   This   is   indeed   one   of   the   oldest   paradigms   in  
developmental  neurobiology,  which  was  based  on  the  observation  that  motor  neurons  
die  after  chick  limb  removal  during  early  embryogenesis   (Oppenheim,  1991).  During  
embryonic   development,   almost   half   of   the   motor   neurons   which   were   generated  
readily   undergo   PCD   (programmed   cell   death),   and   this   event   coincides   with   the  
initiation   of   synaptogenesis   between   motor   nerve   terminals   and   muscle   cells  
(Hamburger   and   Levi-­‐‑Montalcini,   1949;   Hamburger,   1975;   Oppenheim,   1991).   The  
death   of   motor   neurons   has   been   hypothesized   to   reflect   their   failure   to   obtain   a  
sufficient   amount   of   neurotrophic   factors   (Oppenheim,   1989;   Snider   and   Johnson,  
1989).   This   hypothesis   has   been   studied   extensively   and   much   effort   has   been  
undertaken  to  identify  skeletal  muscle-­‐‑derived  neurotrophic  factors  which  contribute  
to  the  survival  of  developing  motor  neurons  in  the  spinal  cord.  A  more  recent  study  
used   knockout   mice   lacking   MRF   members,   Myf5   and   MyoD   (known   muscle   cell  





(Kablar  et  al.,  2003),  but  fail  to  differentiate  into  myoblasts  and  myotubes  (Rudnicki  et  
al.,  1993;  Kablar  and  Rudnicki,  1999;  Kablar  et  al.,  2003),  resulting  in  mouse  embryos  
that   are   from   the   outset   amyogenic.   Through   their   study   they   found   that   motor  
neurons   are   progressively   lost   from   the   spinal   cord   of  Myf5-­‐‑/-­‐‑;MyoD-­‐‑/-­‐‑  mice   during  
gestation,   and   attributed   this   to   the   lack   of   trophic   support   from   muscle   normally  
providing   neurotrophic   factors   Bdnf,   Nt3,   Nt4/5   and   Gdnf   (Kablar   and   Belliveau,  
2005).  Since  these  studies  only  analyzed  spinal  cord  sections  from  E13.5  mice  and  not  
later  in  development,  potentially  altered  molecular  programs  of  motor  neurons  devoid  
of  muscle-­‐‑derived  neurotrophic  factors  or  other  molecules  were  not  examined.  Hence,  
it  will  be  highly  interesting  to  re-­‐‑examine  the  prerequisites  for  motor  neuron  survival  
and   identify  possible  regulatory  factors   involved   in   this  process,  which  may  provide  
novel  insights  into  extrinsic  cues  driving  motor  neuron  survival  that  may  profoundly  
contribute   to   our   understanding   of   human   pathological   conditions   in   which   motor  
neurons  degenerate.  
  
Figure  5.3:  Different  mouse  lines  to  genetically  abolish  myogenesis.  
(a-­‐‑b)  E18.5   transverse   lumbar  spinal  cord  sections  of   (a)  heterozygous  control  and  (b)  double  knockout  
mice.  Mice  were  crossed  with  HB9-­‐‑GFP  mice  to  genetically  label  motor  neurons  (green).  Mutant  mice  are  
amyogenic   because   their   muscle   precursor   cells   failed   to   undergo   specification   and   differentiation.    
(c-­‐‑d)  E18.5  transverse  lumbar  spinal  cord  sections  of  (c)  control  and  (d)  R26fxDTAxMyoGcre  mice.  Specified  
muscle   cells   were   specifically   ablated   in   mutant   mice,   thereby   blocking   further   differentiation   and  
resulting  in  amyogenic  mice.  In  both  mutant  mouse  lines,  the  lack  of  target  muscles  led  to  the  complete  






Preliminary  results  obtained  from  Myf5+/-­‐‑;MyoD+/+  and  Myf5-­‐‑/-­‐‑;MyoD-­‐‑/-­‐‑  mice  crossed  
with  HB9-­‐‑GFP  mice   to   genetically   label  motor   neurons   showed   that  motor   neurons  
were  completely  eliminated  by  E18.5  in  the  double  knockout  mutants  (Figure  5.3  a-­‐‑b),  
thereby   confirming   that   motor   neurons   die   in   the   absence   of   target   muscles.  
Genetically   labeling   motor   neurons   with   GFP   enables   better   visualization   of   motor  
neurons  and  facilitates  the  identification  of  motor  neuron  columns,  which  can  thereby  
be  isolated  and  processed  for  transcriptome  profiling  to  uncover  genetically  encoded  
factors   potentially   functioning   as   effectors   of   muscle-­‐‑derived   survival   factors.  
Alternatively,   R26fxDTA   mice   crossed   with   MyoGCre   mice   to   yield   amyogenic  
R26fxDTAxMyoGCre  mutant  embryos  may  also  be  used   for   transcriptome  profiling.  This  
would  provide  the  advantage  of  a  simpler,  less  time-­‐‑consuming  breeding  scheme  and  
the   higher   probability   of   obtaining   embryos   with   desired   genotypes,   compared   to  
Myf5-­‐‑/-­‐‑;MyoD-­‐‑/-­‐‑  mice  (Rudnicki  et  al.,  1993).  Muscle  precursor  cells  in  R26fxDTAxMyoGCre  
mice  are   specified,  but   fail   to  differentiate   (Gensch  et   al.,   2008).  However,   consistent  
with   findings   by   Gensch   et   al.   (2008),   efficient   killing   of   muscle   cells   in  
R26fxDTAxMyoGCre   mice   was   not   detected   before   E14.5   (data   not   shown).   This   was  
attributed   to   a   delay   between   the   activation   of   promoter   activity   driving   Cre-­‐‑
recombinase   expression,   Cre-­‐‑mediated   recombination   of  DTA   locus   and   ablation   of  
muscle   cells   in   R26fxDTAxMyoGCre   mice   (Gensch   et   al.,   2008).   Despite   the   delayed  
ablation  of  muscles,  I  found  that  R26fxDTAxMyoGCre  mutants  were  completely  devoid  of  
motor   neurons   by   E18.5   (Figure   5.3   c-­‐‑d),   similar   to  Myf5-­‐‑/-­‐‑;MyoD-­‐‑/-­‐‑;HB9-­‐‑GFP   mice.  
Thus,   motor   neurons   critically   depend   on   continuing   support   by   muscle-­‐‑derived  
factors   for   their   survival   and   further  development  during   embryogenesis,   providing  
an   entry   point   for   identifying   novel   genetically   encoded   factors   underlying   motor  
neuron  survival.  
  






The  interdependency  of  motor  neurons  and  the  skeletal  muscle  is  a  classical  example  
for  instructive  and  trophic  tissue  interactions  during  development  and  adult  life.  It  is  
well  established  that  skeletal  muscles  undergo  atrophy  in  the  absence  of  motor  neuron  
innervation.   In   the  adult,  molecular  pathways  underlying   the  dependency  of  muscle  
fibers  on  innervation  have  begun  to  emerge.  However,  it  is  much  less  clear  how  and  to  
what   extent   motor   neuronal   input   contributes   to   myogenesis   during   embryonic  
development.   Previous   studies   using  manual   dissection   and   systemic   application   of  
pharmacological  paralyzing  agents  have  led  to  two  main  yet  divergent  conclusions  on  
the   myogenic   requirements   from   the   nerve   as   well   as   the   myogenic   response   to  
denervation.    
The   aim   of   my   thesis   project   was   to   resolve   these   issues   through   selective   gene  
manipulation  in  the  mouse.  Targeted  genetic  suppression  of  motor  neuron  generation,  
leaving  skeletal  muscle  from  the  outset  devoid  of  motor  innervation,  did  not  affect  the  
formation  of  primary  or  secondary  myotubes.  At  the  same  time,  however,  the  absence  
of  motor   innervation  completely  prevented  terminal  differentiation  of  myotubes   into  
functionally  contractile  fibers  and  resulted  in  their  progressive  apoptotic  elimination.  
This  in  turn  led  to  a  compensatory  proliferation  of  satellite  cells  to  make  up  for  muscle  
fiber   loss.   The   impacts   caused   by   wholesale   removal   of   motor   innervation   were  
faithfully  phenocopied  in  the  absence  of  cholinergic  neuromuscular  transmission.  On  
the  other  hand,  milder  skeletal  muscle  hypoplasia  was  observed  after  selective  genetic  
suppression   of   evoked,   but   not   spontaneous   neuromuscular   transmission.  
Transcriptome   profiling   revealed   a   unique   immediate   early   response   of   myotubes  
lacking   motor   innervation   that   differed   from   the   pathways   operating   during   adult  
denervation.  Herein,   embryonic   innervation   appears   to   operate   through   a  dedicated  





differentiation.   Taken   together,   my   studies   provide   conclusive   evidence   that   motor  
innervation  is  dispensable  for  the  principal  formation  of  both  primary  and  secondary  
myotubes,  but  is  absolutely  required  for  their  terminal  differentiation  into  contractile  
fibers   and   subsequent   survival,   thus   resolving   a   long-­‐‑standing   controversy  
surrounding   the   role   of   innervation   in   skeletal   myogenesis.   I   further   found   that  
developmental  and  adult  innervation  operate  through  distinct  molecular  pathways  to  
promote   muscle   fiber   differentiation   and   survival,   and   identified   a   candidate  
myogenic   program   which   may   underlie   innervation-­‐‑dependent   embryonic  
myogenesis.    
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